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Summary
A.actinomycetemcomitans. H.aphrophilus and Capnocytophaga 
species are capnophilic Gram-negative rods that have been 
isolated frequently from dental plaque. They have been 
studied to varying extents with regard to the role that 
they may play in the aetiology of human periodontal
disease. A.actinomycetemcomitans has been the most 
extensively studied of the three bacteria and has been 
implicated in the aetiology of periodontitis, particularly 
localized juvenile periodontitis. Capnocytophaga species 
have been implicated in some forms of periodontitis,
though the evidence is far from complete and more studies 
are needed to verify their role. However, few studies have 
addressed the aetiological role of H .aphrophilus in
periodontitis.
In the present study a number of A.actinomycetemcomitans,
H.aphrophilus and Capnocytophaga strains freshly isolated 
from subgingival plaque samples, together with type 
strains of each bacterium, were examined for their ability 
to produce the following virulence factors. First the 
ability of each organism to haemagglutinate human 
erythrocytes was measured. Secondly, their ability to
xx
produce a leukotoxin capable of killing HL60 cells and 
human PMNLs was determined by using two assay systems, the 
trypan blue exclusion and luminol-dependent
chemiluminescence inhibition assays respectively. Thirdly, 
the ability of human PMNLs to phagocytose strains of 
A .actinomycetemcomitans. H.aphrophilus and Capnocytophaga 
species was tested by using a luminol-dependent 
chemiluminescence assay. Fourthly, the ability of these 
groups of bacteria to interfere with the proliferation of 
cultured human skin fibroblasts was examined by using a 
bio-assay to measure the metabolic activity of cultured 
fibroblasts. Finally the ability of the organisms to 
cleave human IgA by production of an IgA protease was 
investigated by using SDS-PAGE and immunoblotting 
techniques.
The results obtained in the current study indicated that 
all three groups of bacteria studied are capable of 
producing virulence factors that may cause ranging degrees 
of damage to host tissues. The results of this study also 
indicated that strains of H.aphrophilus are capable of 
producing virulence factors, though not to the same extent 
as the other two tested bacteria. To verify the role of
H.aphrophilus in periodontitis more studies are clearly
xxi
required. These should include careful examination of the 
epidemiology.
xxii
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Chapter 1
Introduction and review of the literature
1 Introduction and review of literature
1.1 Introduction
Periodontal diseases may be thought of as a group of 
pathological conditions that affect individual or 
multiple sites of the periodontium. The search for 
aetiological agents of destructive periodontal disease 
has been progressing for over 100 years (Socransky and 
Haffajee, 1992). Although periodontal disease 
(gingivitis and periodontitis) has been recognised for 
centuries, it was only relatively recently that the 
aetiology of periodontal disease has been related 
clearly and scientifically to microbial agents. Over 
the years different potential periodontal pathogens 
have been singled out as causative agents of 
periodontal disease, though the progress in these 
studies has been slow and sometimes uncertain because 
of the special characteristics which make these studies 
difficult. Some of these problems include the large 
number of bacterial species present in subgingival 
plaque as it is estimated that about 300-400 species 
are capable of colonizing the mouth and can be cultured 
from periodontal sites; some bacteria are difficult or
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some times impossible to culture and identify; some 
pathogens are present in small numbers in the 
periodontium of healthy individuals and this makes it 
difficult to study their role in causing periodontal 
disease. Furthermore, only a few species (about 10-30) 
may cause the disease and the search and identification 
of this small group, has occupied workers in this field 
for the past 100 years (Haffajee and Socransky, 1994). 
A detailed account of the difficulties experienced in 
research in this field are discussed by Socransky and 
Haffajee (1987).
In this review of literature the aetiology of 
periodontal disease, suspected periodontopathogens and 
their role in causing the disease, including virulence 
factors, will be presented and discussed.
1.2 The periodontium
The supporting structures of the teeth are known 
collectively as the periodontium (from the Greek word 
"peri" meaning around and "dontos" a tooth). The 
periodontium consists of gingiva, periodontal ligament, 
cementurn and alveolar bone. The functions of 
periodontium include the attachment of the teeth in the 
correct position to the alveolar bone, and the
resolution of the forces generated by mastication, 
speech and deglutition (Lindh and Karring, 1989).
The normal periodontium is characterised clinically by 
its pale pink colour, firm consistency, shallow sulcus 
with an intact junctional epithelium, and lack of 
bleeding on probing (Ainamo and Loe, 1966; Wennstrom
1988) .
1.2.1 Definition and classification of periodontal 
disease
The term periodontal disease, if used in the general 
sense, includes all diseases that affect the 
periodontium (Kinane and Davies, 1990) . Gingivitis and 
periodontitis are inflammatory diseases of the 
periodontium which are associated with the presence of 
dental plaque. Gingivitis is the most common form of 
periodontal disease and is manifested clinically by a 
change of colour and appearance (swelling and redness) 
with bleeding after probing (Taichman and Lindhe,
1989). Periodontitis is a disease of the deeper tissues 
of the periodontium including bone, the periodontal 
ligament and cementurn.
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In the World Workshop in Clinical Periodontics (1989) 
the different forms of periodontitis were classified as 
follows:
I Adult periodontitis
II Early-onset periodontitis
1- Prepubertal periodontitis (localized and 
generalized)
2- Juvenile periodontitis (localized and generalized)
3- Rapidly progressive periodontitis
III Periodontitis associated with systemic disease.
IV Necrotizing ulcerative periodontitis.
V Refractory periodontitis.
It should be noted that an overlap exists between 
different types.
Adult periodontitis is the most common form of 
periodontal disease and it is characterised by an age 
of onset of 35 years or older. The presence of 
microbial deposits is in proportion to the amount of 
periodontal destruction seen. The disease is not 
confined to any particular teeth (Page et al., 1983). 
Prepubertal periodontitis is seen early in life around 
the time of eruption of the primary teeth. In the 
generalized form all primary teeth became affected, and 
is characterised by inflammation and rapid destruction
of the alveolar bone. In localized periodontitis little 
or no inflammation is present around the affected 
teeth, and the condition is rare. It has been suggested 
that there is a genetic component to this condition. 
(Page and Schroeder 1982).
The onset of juvenile periodontitis occurs at puberty. 
Lesions are confined predominantly to the first 
permanent molars and/or incisors (Baer, 1971).
The onset of rapidly progressive periodontitis is 
between puberty and about the age of 35 years. In this 
form of disease the lesions are generalized and affect 
most of the teeth without any consistent pattern (Page 
and Schroeder, 1982).
Necrotizing ulcerative periodontitis is characterised 
by the formation of ulcers in the papillae. The lesions 
may be confined to a few papillae or affect all 
available sites. The acute form of disease is 
accompanied by pain, bleeding and halitosis (Nisengard, 
Newman and Zambon, 1994).
1.2.2 Dental plague
Dental plaque is a layer of dense non-calcified 
bacterial mass attached firmly to the tooth surface. 
Bacteria in dental plaque adhere to one another or to
the tooth surface either directly or with a matrix of 
carbohydrates and proteins (inter-microbial matrix). 
The inter-microbial matrix forms from salivary proteins 
and extracellular products of bacterial metabolism. 
After the exposure of a clean tooth surface to saliva, 
an acellular and homogenous pellicle called the 
acquired pellicle is formed (predominantly 
glycoproteins from saliva). Bacteria attach to the 
pellicle and to the tooth surface. Dental plaque 
matures by a complex process involving the colonization 
and proliferation of bacteria which produces bacterial 
metabolites. The plaque becomes visible to the naked 
eye and increases in thickness to an optimal extent if 
not removed. The early predominant microflora is mainly 
Gram-positive bacteria (mainly Streptoccus species) 
though a small number of Gram-negative organisms are 
also present. After the initial colonization by Gram- 
positive bacteria, the number of Gram-negative 
organisms increases.
The changes in dental plaque are accompanied by gradual 
changes in the microorganisms present and the early 
Gram-positive colonizers are gradually displaced by 
more filamentous, Gram-negative microbiota (Listgarten,
1988). During three weeks of plaque accumulation, there
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is an increase of Gram-positive rods, especially 
A.israelii and of Fusobacterium, Veillonella and 
Treponema species. Further at this stage bacterial 
species associated with periodontitis lesions can be 
isolated with sites with gingivitis. Numbers of 
bacteria such as E.corrodens. Fusobacterium and 
Capnocytophaga species are also elevated in sites with 
gingivitis. Plaque is very resistant to removal by the 
washing action of saliva or the physiologic movement of 
soft tissues. Calculus is a hard mineral substance 
strongly adherent to tooth structure which results from 
calcification of dental plaque (Listgarten and Levin, 
1981; Pawlac and Hoag, 1984; Nyvad and Kilian, 1987; 
Marsh, 1993) .
1.2.3 Subgingival plaque
Plaque that forms below the gingival margin is 
associated with the accumulation of supragingival 
plaque, which influence the establishment and relative 
proportion of subgingival plaque organisms. 
Supragingival plaque accumulation and maturation is 
accompanied by changes in the gingival tissues adjacent 
to the plaque layer. These changes include inflammation 
and erythema. The swelling causes enlargement which
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increases the capacity of the subgingival area for 
bacterial colonization. This may result in an 
environment suitable for the growth of anaerobic 
microflora. Bacteria in this space are protected from 
the usual cleansing mechanisms; at the same time the 
crevicular fluid flow increases as does the pocket 
epithelial cell turnover. The end result is an altered 
ecological environment which is quite separate from the 
supragingival domain. The presence of the crevicular 
fluid, desquamated epithelial cells and bacterial end- 
products subsequently influence the establishment and 
relative proportions of subgingival microorganisms. The 
colonization of the subgingival area by microorganisms 
then follows, and as indicated above, this environment 
allows the fastidious strictly anaerobic (mainly Gram- 
negative and many spirochetes and other motile 
bacteria) bacteria to become predominate. Possibly 
because of local environmental changes, and host 
defence mechanisms, certain microorganims increase or 
decrease up to a stage when they can elicit disease 
(Page, 1986; Listgarten, 1988; Sanz and Newman, 1994). 
Studies by light and electron microscopy of extracted 
human teeth and their adjacent tissues have provided 
information about the internal structure of subgingival
plaque; these studies reported the separation of plaque 
into tooth associated, epithelium associated and 
connective tissue associated (Sanz and Newman, 1994). 
The microorganisms associated with the tooth are mainly 
Gram-positive filamentous bacteria, Gram-positive cocci 
and rods are also present. Gram-negative cocci and rods 
can be found also. The epithelium associated microflora 
is composed of mainly Gram-negative rods and cocci as 
well as large numbers of flagellated bacteria and 
spirochetes. The connective tissue microflora has been 
shown to be invaded by subgingival bacteria in all 
forms of periodontitis.
1.2.4 Aetiology of periodontal disease
The role of bacteria as causative agents in periodontal 
disease has been only 15 years ago acknowledged and the 
evidence implicating bacteria has been reviewed by 
Socransky and Haffajee (1994). Initially the evidence 
of bacterial involvement in periodontal disease was 
provided by early experiments in which oral hygiene 
measures were withdrawn from healthy individuals. This 
resulted in the accumulation of dental plaque and the 
development of gingivitis within 21 days. When oral 
hygiene measures were re-instituted the health of the
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gingival tissues returned to normal. These simple 
experiments led to the conclusion that dental plaque 
was the cause of gingivitis (Loe, Theilade and Jensen, 
1965; Theilade et al., 1966). Since then there have
been large numbers of studies presenting evidence 
indicating the causative role of one 'pathogen' or 
another, and in the quest for the aetiologic agents of 
periodontitis, two different theories have developed. 
The first is the "the non-specific theory" which 
suggests that periodontal disease is caused by the 
combined biologic effect of all the microorganisms 
present in plaque rather than the presence of specific 
plaque microorganisms. The second theory, "the specific 
theory" suggests that periodontitis is caused by the 
presence of a specific small number of bacterial 
species in dental plaque. The initial phase of the 
periodontal research for the specific theory was 
prominent upto 1930s. A middle stage was when the non­
specific theory dominated. Finally there was a return 
to the concept of specificity in the nineteen seventies 
(Tonetti, 1993; Socransky and Haffajee, 1994).
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Evidence for a primary role for bacteria in periodontal 
disease
There are a number of studies indicating that treatment 
of certain forms of periodontal disease by 
antimicrobial agents results in clinical improvement. 
For example Christersson and Zambon (1993) studied the 
possible elimination of Actinobacillus
actinomycetemcomitans (A.actinomycetemcomitans) from 35 
subgingival sites of 6 subjects with localized juvenile 
periodontitis, and reported that systemic tetracycline 
can be used to monitor A. actinomycetemcomitans in 
localized juvenile periodontitis. Antibiotics have been 
shown to be beneficial in the treatments of other forms 
of periodontal disease; Dibart et al., (1993) reported
that adjunctive systemic antibiotics used in 31 
subjects with adult periodontitis, resulted in an 
improved periodontal condition as evident from an 
increase in the periodontal attachment level and a 
reduction in the numbers of certain periodontal 
pathogens for example fewer sites were colonized by 
detectable numbers of P.gingivalis after treatment. van 
Winkelhoff, Tijhof and de Graaff, 1992) reported that 
mechanical treatment combined with antibiotics
(metronidazole and amoxicillin) were effective in 
suppressing subgingival A.actinomycetemcomitans in 
patients with severe periodontitis. Furthermore, a 
number of studies in the literature indicate that 
antimicrobial therapy may be effective in controlling 
the extent and rate of disease progression in patients 
with refractory adult periodontitis (Gorden et al., 
(1993). It should be observed though that even although 
the use of antimicrobial agents is successful in the 
treatment of patients in the diseased groups, a number 
of subjects did not respond positively probably due to 
differences in the aetiological agents. Additional 
evidence for the involvement of bacteria in periodontal 
disease is provided by a number of studies. In these 
studies the ability of certain suspected 
periodontopathogens to trigger the host immune response 
as indicated by an elevated serum antibody titre 
specific to certain subgingival organisms was reported 
(Ebersole et al., 1982; Gunsolly et al., 1990). Studies 
in experimental animals also provided additional 
evidence for implicating some oral bacterial species in 
the aetiology of periodontal disease (Kornman, Holt and 
Robertson, 1981; Kornman et al. , 1981; Holt et al.,
1988).
The search for specific aetiologic agents of 
periodontal disease is long-standing and as indicated 
above it is a complex problem that is hampered by many 
difficulties linked to clinical diagnosis and 
laboratory methodology (Socransky and Haffajee, 1987; 
Socransky and Haffjee, 1990).
Researchers have used Koch's postulates to help 
identify suspected periodontal pathogens. However, 
these are generally unsuitable criteria for chronic 
infections caused by a mixture of bacterial species and
therefore, workers in the field have extended Koch's
postulates to include the following:
1 Association with disease. This requires the 
detection of the suspected periodontopathogen more 
frequently and in higher numbers in disease sites than 
in healthy sites.
2 Treatment elimination. The basis of elimination 
studies is that the treatment given to a diseased
subject results in the reduction or elimination of the 
pathogen and at the same time halts the disease 
progression.
3 Induction of host immune response by periodontal
pathogens or their components.
4 The ability to cause disease in laboratory animals.
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5 The detection of virulence factors. The ability of 
certain species to produce virulence factors has been 
used to support the role that they may have in causing 
the disease (Tonetti, 1993; Socransky and Haffajee, 
1994) . Based on the evidence obtained using the above 
criteria, several periodontopathogens have been 
implicated in some forms of destructive periodontal 
disease. However, it is likely that in due course some 
of these species will be removed from the list and 
quite possible that others will be added (Socransky and 
Haffajee, 1992). Based on the criteria described above 
a number of organisms have been implicated in the 
aetiology of periodontitis. These studies have 
implicated the following organisms in adult forms of
periodontitis: Porphyromonas gingival is; Prevote 11a
intermedia; Eikenella corrodens ; Campylobacter
(Wolinella) rectus; Eubacterium species; Selenomonas
species; Bacteroides forsythus and spirochetes. A 
summary of suspected periodontopathogens and the 
supporting references are shown in Table 1.1. As 
mentioned above the evidence supporting each of these 
bacteria varies and some have been studied more 
frequently than others. All mentioned organisms 
implicated in periodontitis are reviewed by Haffajee
14
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and Socransky (1994). Other bacteria have been
implicated in juvenile form of periodontitis, these 
include A.actinomycetemcomitans, Eikenella corrodens, 
Prevotella intermedia. and Capnocytophaga species. 
E.corrodens is_ a Gram-negative small rod that has been 
associated in some studies with A.actinomycetemcomitans 
in localized periodontitis (Mandel, Ebersole and 
Socransky, 1987). There are a number of Gram-negative 
rods, capnophilic bacteria that can be isolated from 
the dental plaque samples frequently though the 
evidence implicating some of these bacteria varies, as 
some were studied more extensively than others. For
example A.actinomycetemcomitans has been the most 
extensively studied periodontopathogen and the
evidence supporting its aetiologic role in
periodontitis is overwhelming especially in localized 
juvenile periodontitis. Although Capnocytophaga species 
have been implicated as aetiologic agents in
periodontitis in some early studies (Slots, 1976; 
Mashimo et al., 1983), the role that they may play in 
the aetiology of periodontitis is not clear. There is 
only little information regarding H .aphrophilus and its 
aetiologic role in periodontitis and it was not studied 
as the other two mentioned capnophilic bacteria and
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clearly more studies are needed to verify the role that
H . aphrophilus may play in the aetiology of 
periodontitis. Therefore the present study was
undertaken to study the latter group of Gram-negative 
capnophilic bacteria to verify the role that they may 
have in periodontitis.
In the following sections, microbiological and clinical 
"historical" reviews about the 3 organisms will be 
presented, after which will follow a full detailed 
section dealing with the pathogenicity of
periodontopathogenic bacteria and virulence factors 
produced by suspected pathogens especially those which 
are the subject of this study.
I.3 H .aphrophilus. A.actinomycetemcomitans and 
Capnocytophaga species (Historical review)
1.3.1 H.aphrophilus
Haemophilus aphrophilus was first isolated and
described in 1940 by Khairat, who isolated the organism 
from blood cultures of a patient with endocarditis and 
suggested the species name "aphrophilus" because it 
required carbon dioxide for isolation (Khairat, 1940). 
In later years H .aphrophilus was isolated from various
16
infections and sites (see review by King and Tatum 
1962) . In 1978 Bieger, Brewer and Washington (1978) 
reviewed 90 cases of infections due to H .aphrophilus. 
the most common being endocarditis and brain abscess.
Morphological characteristics
Khairat (1940), described colonies of H .aphrophilus 
after 24 hours growth on blood agar (37°C; 5% C02 in
air) as circular, entire edged, convex, small, with a 
smooth glistening surface, homogeneous in structure 
with a butyrous consistency that could be easily 
emulsified. After incubation for up to 3 days, colonies 
were slightly larger, yellowish in colour, and the 
growth was confluent; olive-green discoloration of the 
blood agar observed was without clear haemolysis. Broth 
cultures were described as very granular with colonies 
sticking to the side of the glass container. Other 
colonial morphological variants were also described. 
For example similar descriptions were reported by 
Toschach and Bain (1958) and by King and Tatum (1962) . 
Tempro and Slots (1986) described the colonies of 
H.aphrophilus isolates grown on the selective medium 
TSBVF as circular, small (0.5 to 1mm in diameter), and 
convex.
Morphologically the organism was described as Gram- 
negative, coccoid to coccobacillary in shape, measuring 
about (1.5-2 by 0.4-0.5fim), non-capsulated, non-spore- 
forming and non-motile. After several passes in the 
laboratory, cells showed a tendency to become more 
definitely rod-shaped.
Metabolic and growth requirements
H .aphrophilus grows best in an atmosphere of air and 5% 
C02 Strictly anaerobic conditions potentially depressed 
growth while a heavy inoculum was essential for aerobic 
growth. It grew well at 37° C but not at 22° C (Khairat, 
1940) . When first isolated by Khairat (Khairat, 1940),
H .aphrophilus was haemin (X factor) dependent. 
Nicotinamide adenine dinucleotide (NAD)(V factor) was 
not required for growth and neither factor was required 
for anaerobic growth. Tempro and Slots (1986), reported 
that neither X or V factor was required. Later King and 
Tatum (1962) reported that H . aphrophilus was able to 
grow in an atmosphere of C02 (since a candle jar was 
used the authors did not determine the exact percentage 
of C02) , without the addition of either factor; this 
was later supported by Kilian and Schiott (1975). 
Growth on MacConkey agar, glucose or glycerol agar was
negative according to Khairat (Khairat, 1940) . However, 
King and Tatum (1962) reported that some H .aphrophilus 
strains showed visible growth on MacConkey agar after 3 
days incubation but there was no growth on Salmonella, 
Shigella, Citrate or Cetrimide agar. H .aphrophilus is 
commonly isolated on the selective medium for
Haemophilus species which contains X and V factors and 
bacitracin or other suitable antimicrobial agents to 
suppress the growth of other bacteria (Kilian, 
Prachyabrued and Theilade, 1976). However the
recognition of H .aphrophilus on general media for 
Haemophilus species is difficult because of the 
similarity in colonial and morphological
characteristics between a number of the different 
species. Later a selective medium for the isolation of
H .aphrophilus was formulated based on susceptibility 
studies and the ability of the organism to resist 
sodium fluoride. This medium was composed of Tryptic 
Soy Agar, heat inactivated horse serum, bacitracin, 
vancomycin and sodium fluoride and it was designated 
TSBVF (Tempro and Sots, 1986). The TSBVF medium yielded 
a three fold recovery of oral H .aphrophilus than other 
medium routinely used for the isolation of Haemophilus
species (for example Chocolate agar with 75fJ,g/ml 
bacitracin).
Biochemical characteristics
There are only a few studies in which the biochemical 
characteristics of H .aphrophilus have been addressed 
since the early reports by Khairat (194 0) and King and 
Tatum (1962) who examined and reported the major 
biochemical characteristics of H .aphrophilus isolates. 
These studies have agreed on the major biochemical 
characteristics of this organism, and H .aphrophilus is 
described as catalase and indole negative, and 
positive for nitrate reduction. The organism ferments a 
number of carbohydrates (glucose, sucrose, maltose, 
lactose), but failed to ferment mannitol, salicin, 
xylose, arabinose, cellobiose, rhamnose, sorbitol, and 
melezitose. Variable results were obtained with other 
carbohydrates (mannose, raffinose trehalose, glycerol 
(Liljemark et al., 1984; Tempro and Slots, 1986).
Ultra structure studies using electron microscopy 
techniques revealed that H.aphrophilus possessed a 
structure similar to other Gram-negative organisms 
(Holt et al., 1980).
1.3.2 A.actinomycetemcomitans (Historical review)
A.actinomycetemcomitans was first described in 1912 by 
Klinger who isolated the organism from a case of 
cervicofacial actinomycosis. After this initial 
isolation, A.actinomycetemcomitans was recovered 
frequently from patients with infections due to 
Actinomyces species. Some studies indicated that some 
of the isolated organisms were similar in their 
microbiological characteristics to A.actinomycetemcomi­
tans (Kaplan et al., 1989). Although A.actinomycetemco­
mitans was frequently isolated from patients with 
actinomycosis its potential to initiate and cause an 
infection was not widely accepted (Kaplan et al.,
1989) . In 1951 Holm suggested that
A.actinomycetemcomitans alone might cause disease in 
human as he frequently isolated the organism from 
actinomycosis lesions after the elimination of
Actinomyces israelii by penicillin (Holm, 1951) .
Subsequent studies labelled A.actinomycetemcomitans as 
a non pathogenic constituent of the oral microflora 
which rarely caused medical infections (Kaplan et al.,
1989) . In 1962 King and Tatum (1962) reported 32 cases 
of human infections due to A.actinomycetemcomitans and
provided evidence for the ability of A.actinomycetemco- 
mitans to cause disease.
Morphological and cultural characteristics of 
A.actinomycetemcomitans
The morphological and cultural characteristics of 
A.actinomycetemcomitans have been examined by a number 
of workers. The colonial morphology of the organism 
when grown on solid media is usually described as small 
(1mm in diameter after 2-3 days growth), circular, 
strongly adherent to the medium on primary isolation 
with a star-shaped appearance (Slots, 1982; Zambon, 
1985) . However, not all A.actinomycetemcomitans 
isolates possess this colonial morphology and smoother, 
non-adherent and non-star-shaped variants have been 
described (Rosan et al., 1988). Furthermore, after
primary isolation and a number of subcultures in the 
laboratory, the star-shaped characteristic can be lost 
(Rosan et al., 1988). The star-shaped colonies (rough 
type) of A.actinomycetemcomitans grow in broth and 
produce granules which adhere to the bottom and to the 
sides of the tube, leaving clear broth on top while the 
smooth type colonies produce a uniform turbidity 
(Zambon, 1985) .
A.actinomycetemcomitans is described as a non motile 
Gram-negative, coccobacillus that after several 
subcultures shows a tendency to become more rod-shaped 
(Zambon, 1985).
Holt, Tanner and Socransky (1980) examined the 
ultrastructure of A.actinomycetemcomitans by 
transmission electron microscopy. This revealed that 
the organism was similar morphologically to those of 
other Gram-negative bacteria, with several strains 
possessing some adherent, extracellular polymeric 
material. Numerous structures morphologically identical 
to lipopolysaccharide vesicles originated from and were 
continuous with the surface of the outer membrane and 
were also present in the external environment (Holt, 
Tanner and Socransky, 1980; Lai, Listgarten and 
Hammond, 1981). Scanning electron microscopy revealed 
that the organism had surface projections and an 
amorphous surface material which connected and covered 
adjacent cells. This material was thought to be a 
carbohydrate microcapsule (Zambon, Slots and Genco, 
1983) . Scannapieco, Kornman and Coykendall (1983), 
reported the presence of extracellular appendages 
resembling fimbriae on A.actinomycetemcomitans 
isolates. The freshly isolated strains of
A.actinomycetemcomitans were found to possess fimbriae 
as revealed by using electron microscopy examination. 
The presence of fimbriae correlated with colonial 
morphology as the star-shaped colonies were associated 
with fimbriae while non star colonies were shown to be 
devoid of fimbriae (Rosan et al., 1988). Further it has 
been showed in the same study that isolates that 
possess fimbriae adhered more to hydroxyapatite and 
saliva-coated hydroxyapatite than their non-fimbriated 
variants (Rosan et al., 1988).
Metabolic activity of A .actinomycetemcomitans
A.actinomycetemcomitans grew poorly on blood agar 
aerobically and required C02 for growth if the medium 
did not contain blood (King and Tatum 1962). Neither V 
nor X factor was required for growth and the optimum 
temperature was 37 °C. A number of media have been
developed for the selective recovery of A.actinomycete- 
comitans from subgingival plaque samples. For example 
Slots, Reynolds and Genco (1980) developed a medium 
containing Trypticase soy agar supplemented with heat 
inactivated serum and bacitracin, which supported the 
growth of more colonies of A.actinomycetemcomitans than 
other standard media for example enriched brain heart
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infusion blood agar. This selective medium also 
suppressed the growth of other oral microorganisms by 
3 to 6 log counts and A.actinomycetemcomitans colonies 
could be distinguished from the other bacterial species 
that proliferated (Slots, Reynolds and Genco, 1980). 
Mandell and Sockransky (1981) developed a selective 
medium that contained malachite-green which inhibited 
the growth of A.actinomycetemcomitans strains even at 
low concentration (Slots, 1982A) . At present, the most 
commonly used selective medium for the selective
recovery of this organism was developed by Slots
(1982), and contains Trypticase-Soy-Agar supplemented 
with heat inactivated horse serum, bacitracin and 
vancomycin (TSBV). The TSBV medium suppresses the 
growth of many oral bacteria and
A.actinomycetemcomitans can be distinguished from the 
few species that grow on this medium for example 
Neisseria species. A .ac t inomycet emcomi t ans can be
differentiated from the closely related H .aphrophilus 
and other capnophilic bacteria that may grow on the 
same medium such as Capnocytophaga species by distinct 
colonial morphology and positive catalase reaction
(Slots, 1982).
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Biochemical characteristics of A.actinomycetemcomitans
The biochemical characteristics of A.actinomycetemcomi­
tans have been investigated in a number of studies, and 
it is usually described as non-haemolytic, indole and 
urease negative. All strains reduce nitrate and ferment 
glucose; variable results are recorded for maltose, 
galactose, mannose, dextran, starch, xylose, mannitol 
and no reactivity noted for lactose, trehalose, 
sucrose, glycerol or raffinose. Catalase production was 
reported positive for all strains by most workers 
(Tanner et al., 1982; Miyasaki, Wilson and Genco, 1986) 
(King and Tatum, 1962; Slots, 1982A) . Some of the 
reported positive results in one study have been 
reported as variable in another study (Slots, 1982 A) , 
the author related this differences between studies to 
the differences in composition of the basal medium 
utilized and methods employed, he also indicated that 
strains of closely related bacteria such as
H .aphrophilus may have been mistaken for 
A.actinomycetemcomitans (Slots, 1982 A).
I.3.3 Capnocytophaga species (Historical review)
Capnocytophaga species was the name proposed for a 
group of Gram-negative non-flagellated, fusiform
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bacteria, that possess distinct cellular and
morphological features. They are able to glide over 
solid surfaces, and require carbon dioxide for growth. 
Since they were not readily equitable with members of 
any recognized genus, the name Capnocytophaga was 
proposed for the first time in 1979 by Leadbetter, Holt 
and Socransky. Further information about this group of 
bacteria was presented in further papers (Leadbetter, 
Holt and Socransky, 1979; Holt, Leadbetter and
Socransky, 1979; Socransky et al., 1979). Although
Capnocytophaga species have been mentioned in a number 
of studies, reports that addressed the biochemical
characteristics are rare since the distinct colonial 
and morphological characteristics are used for the 
isolation of this bacteria, for example Papapaou et 
al., (1993) isolated Capnocyt ophaga species from the 
subgingival plaque samples of a randomly selected 
subjects based on its cultural characteristics and Gram 
stain reaction only and no biochemical characterization 
was performed except for motility.
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The morphological and cultural characteristics of 
Capnocytophaga species
Capnocytophaga species comprise a group of three 
different species namely C.ochracea, C.sputigena and 
C.gingivalis. These strains were separated originally 
by morphological and physiological features 
(Leadbetter, Holt and Socransky, 1979) . Colonies of all 
isolates were described as flat and thin with an even 
edge that spread with time. Three different types of 
colonies were recognized when the organism was grown on 
blood agar, normally grey or white colonies, pink 
colonies and yellow colonies. Some isolates adhered to 
the agar surface and were difficult to remove. However, 
several factors influenced these characteristics, 
notably the composition of the medium. All members of 
this group possess the colonial characteristics similar 
to those recognized for gliding bacteria which include 
genera such as Myxococcus and Flexibacter (Leadbetter, 
Holt and Socransky, 1979). Cells of Capnocytophaga 
species were described as Gram-negative, fusiform, long 
or short rods, the size ranged from about 4.8-5.8 by 
0.42-0.6jLim for large cells and about 2.4-4.2 by 0.38- 
0. 5\xm for small cells though in addition to the 
differences in size among different isolates identical
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isolates varied in size when grown on different complex 
media (Holt, Leadbetter and Socransky, 1979). Scanning 
electron microscopy of the leading edge of the 
spreading colony on the agar plates revealed a large 
mass of cells at the periphery of the expanding 
colonies which were devoid of flagellae, fimbriae or 
pili (Newman et al., 1979). However, contrary to the
previous report, Scannapieco, Kornman and Coykendall
(1983) reported that one Capnocytophaga strain 
possessed fimbriae-like appendages when examined within 
a group of dental plaque bacteria by agar filtration 
and negative stain electron microscopy.
Metabolic and growth requirement of Capnocytophaga 
species
Capnocytophaga species grow well anaerobically 
(Hydrogen and Nitrogen when present did not affect the 
growth though 100% of either inhibited the growth of 
Capnocytophaga species) and in air supplemented with 
5-10 % C02 at 37°C. However, no detectable growth was 
evident in air or on MacConkey agar (Leadbetter, Holt 
and Socransky, 1979). No growth was observed at 25°C or 
at 45°C, but visible proliferation was noted at 30°C and 
at 35°C (Socransky et al., 1979). A medium has been
developed for the selective recovery of Capnocytophaga 
species from plaque and was formulated based on 
susceptibility studies to several antibiotics. This 
medium, designated TBBP contained Trypticase Soy Agar, 
sheep blood, bacitracin and polymyxin B and was 
reported by (Mashimo et al., 1983) . The medium
supported the growth of 34 Capnocytophaga stock 
cultures very well and suppressed the growth of a 
number of test stock cultures of common oral Gram- 
positive and Gram-negative bacteria, the medium was 
shown to have high recovery efficiency for 
Capnocytophaga species from deep subgingival plaque 
samples from subjects with severe periodontitis and 
insulin-dependent diabetes mellitus, than non selective 
medium such as Trypticase Soy agar supplemented with 
sheep blood.
Biochemical characteristics of Capnocytophaga species
The major biochemical characteristics of Capnocytophaga 
species are presented and discussed in detail 
(Socransky et al., 1979). Other studies in which the 
biochemical characteristics were addressed include a 
description of C.sputigena strain isolated from a 
patient with haematological malignancy. This strain was
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described as indole, urease, catalase and oxidase 
negative. The strain reduced nitrate and gelatine 
hydrolysis was also positive. The strain fermented a 
number of carbohydrates (glucose, maltose, sucrose) but 
did not ferment (lactose, galactose, raffinose) (Gomez- 
Garces et al., 1994). The biochemical characteristics 
described for the C.sputigena strain more or less 
similar to those described by Socransky et al., (1979). 
All strains of Capnocytophaga species were inhibited by 
several bacterial inhibitors like basic fuchsin 
(0.004%), crystal violet (0.0004%), sodium azide 
(0.05%), sodium chloride (4.0%), sodium fluoride 
(0.05%), 10% bile and malachite green (0.00002%)
(Socransky et al. , 1979) . The three species of
Capnocytophaga were distinguishable on the basis of 
certain biochemical characteristics, such as the 
fermentation of additional carbohydrates, hydrolysis of 
polymers and reduction of nitrite, though this can 
prove very difficult since the results of Socransky et 
al., (1979) indicate great similarities between the 
species with regard to a number of biochemical 
characteristics. There is also the variability of the 
results obtained with different species and within the 
single species.
1.3.4 Comparison between A.actinomycetemcomitans and
H .aphrophilus
A.actinomycetemcomitans and H .aphrophilus are Gram- 
negative capnophilic organisms and biochemical
characterization indicates that they are very similar,
since they share a number of cultural and biochemical 
characteristics. However, recent studies of the genetic 
relation ships of these organisms using multilocus 
enzyme electrophoresis analysis, has shown no 
significant overall genetic similarity between the two 
species (Caugant, Selander and Olsen, 1990). Also
Brondz and Olsen (1993) by means of multivariate
chemosystematic analysis methods showed that 
A.actinomycetemcomitans was a non-homogeneous group and 
could be divided into two groups; both groups were 
distinct from H .aphrophilus. Only a few biochemical 
reactions that can be used to differentiate between the 
two organisms (Slots, 1982A). Biochemical
characteristics that have commonly been used to 
separate and distinguish between the two organisms 
include the catalase reaction, fermentation of lactose, 
starch, sucrose and trehalose and the resistance to 
sodium fluoride (Slots, 1982 A) .
1.4 Sensitivity to antibacterial agents
The testing of suspected periodontopathogenic organisms 
for their susceptibility to antibiotics is important 
since it has been shown that the use of antimicrobials 
in the treatment of periodontitis can result in 
clinical improvement. This may possibly occur through 
inhibition of the suspected aetiologic agents in each 
disease such as A.actinomycetemcomitans in the case of 
localized juvenile periodontitis (Slots and Rosling, 
1983; Christersson and Zambon, 1993). In the case of 
juvenile periodontitis tetracyclines have been widely 
and successfully used for treatment (Smith et al., 
1994). Furthermore, Pavicic et al. , (1994) reported
that combined mechanical debridement together with 
antibiotics (metronidazole and amoxicillin) was 
successful in eliminating A.actinomycetemcomitans and 
this was accompanied by an improvement of the 
periodontal conditions of the patients.
A number of studies have been performed to investigate 
the sensitivity of A. actinomycetemcomitans.
H.aphrophilus and Capnocytophaga species to antibiotics 
in vitro (Baker et al., 1985). The sensitivity of 
A.actinomycetemcomitans to antibiotics is the most 
frequently studied, since it has been most clearly
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implicated as an aetiologic agent in some forms of 
periodontal disease especially localized juvenile
periodontitis (Kaplan et al., 1989). A.actinomyc­
etemcomitans has been shown generally sensitive to 
chloramphenicol, doxycycline, minocycline,
tetracycline, gentamicin and ciprofloxacin (Slots, 
1982A; Baker et al., 1985; Eng et al., 1986). The most 
tested antibiotic is tetracycline and it has been shown 
to be a useful adjunct to conventional treatment of 
periodontal disease (Seymour and Heasman, 1995).
A.actinomycetemcomitans is generally resistant to 
vancomycin, spiramycin, and bacitracin, while variably 
resistant to clindamycin, erythromycin, kanamycin, 
streptomycin and penicillin.
Capnocytophaga species has been reported as sensitive
to penicillin G, erythromycin, cefoxitin, clindamycin 
and chloramphenicol (Baker et al., 1985; Holt and 
Kinder, 1989). Capnocytophaga species have been shown 
to be resistant to colistin, kanamycin, nalidixic acid, 
gentamicin and tobramycin and variably resistant to 
cephalothin, cefazolin, vancomycin and oxacillin.
The sensitivity of H .aphrophilus to a number of 
antibiotics was examined by Baker et al., (1985); 
strains were generally sensitive to tetracycline,
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erythromycin and penicillin, while resistant to 
spiramycin and tyrothricin.
Thus in previous studies the 3 organisms under study 
were shown to be sensitive to the tetracycline the most 
commonly used antibiotic in the treatment of chronic 
periodontitis.
1.5 Prevalence of Haemophilus aphrophilus in the oral 
flora
Haemophilus aphrophilus is considered to be part of the 
normal oral flora and is present in dental plaque 
(Albritton, 1982). Haemophilus species and other 
facultative Gram-negative rods have not received 
adequate attention in most of the early studies on the 
oral microflora and were considered to account for a 
negligible part of the oral bacterial flora (Kilian and 
Schiott 1975). Sims (1970) reported that Haemophilus 
species can be isolated in large numbers from saliva 
and oral mucous membranes, especially when semi- 
selective media were used for isolation. However, Sims 
(1970) did not mention H .aphrophilus even though it was 
part of the control group organisms (used for 
comparisons) . Kilian, Heine-Jensen and Biilow (1972) , 
studying nasopharyngeal material from hospitalized
children for Haemophilus using a selective medium, 
found 137 strains of Haemophilus. but H.aphrophilus was 
not mentioned. In 1972 Kraut et al., (1972) reported 
the isolation of H .aphrophilus from gingival scrapings 
and interdental material in 35.5% of 45 subjects tested 
using a selective medium contained Tryptic Soy agar, 
hemin, bacitracin (TSAH). Furthermore, they concluded 
that H . aphrophilus was part of the oral microflora and 
that in the case of H . aphrophilus infections the mouth 
is probably the source of the organism. However, it 
should be mentioned that the dental oral health of the 
subjects used in this study was not determined.
H. aphrophilus was also isolated from 5 out of 14 
tonsils (Bieger, Brewer and Washington, 1978), and in 
1976 Kilian, Prachyabrued and Theilade reported the 
isolation of H.aphrophilus from the smooth surface of 
teeth. Brown (1976) studied the incidence of 
Haemophilus species by analysing about 4247 respiratory 
samples and found that H.aphrophilus was present in
I.5% of the samples. Liljemark et al., (1984) studied 
the distribution of Haemophilus species in 
supragingival and subgingival plaque samples collected 
from healthy maxillary first molars of a group of young 
adults. They found H .aphrophilus in 7 subgingival sites
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versus 4 of the supragingival plaque sites out of the 
14 sites tested.
1.6 Infections due to H .aphrophilus
H. aphrophilus was first isolated from a case of 
endocarditis in 1940 (Khairat, 1940). Since then, 
several reports have described the isolation of
H.aphrophilus from different infections. H.aphrophilus 
has been cultured from brain abscesses, meningitis, 
sinusitis, pneumonia, empyema, otitis media, wound and 
post operative infections, arthritis and osteomyelitis.
H. aphrophilus have been isolated also from 
endocarditis, paronychia, osteomyelitis of the jaw, 
appendicitis ((King and Tatum, 1962; Sutter and 
Finegold, 1970; Bieger, Brewer and Washington, 1978; 
Ellner et al. , 1979). H .aphrophilus may be isolated
from the urine and vagina from normal humans as other 
Haemophilus organisms (Kilian and Biberstein, 1984). 
However, the two most common infections associated with
H .aphrophilus are endocarditis and brain abscess. Cases 
of other clinical infections due to H .aphrophilus have 
been reported, including sinusitis (Page and King, 
1966) . Soft tissue or wound infections are particularly 
notable in that they are not commonly reported with
other Haemophilus species (Page and King, 1966; White 
et al. , 1981).
Kilian and Schiott (1975) reported the isolation of
H .aphrophilus from dental plaque, whereas Kraut et al., 
(1972) isolated H .aphrophilus from samples of gingival 
scrapings of 16 out of 45 sampled healthy adults. The 
dental health of all subjects was unknown. They 
concluded that the mouth is the likely source in
infections due to H .aphrophilus. Alberton (1982) 
presumed that the oral flora was the source of
H .aphrophilus in both endocarditis and brain abscess 
infections.
In spite of the fact that H . aphrophilus possess the 
potential to cause infection it is evident from the
reviewed literature, that little is known about the 
pathogenicity mechanisms or virulence factors involved. 
Furthermore, at present it is generally accepted that 
although H .aphrophilus is a part of the oral microflora 
its causal role in periodontitis is unknown but 
believed to be low (Tempro and Slots, 1986).
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1.7 Prevalence of A.actinomycetemcomitans in the oral 
flora
A.actinomycetemcomitans has been isolated frequently 
from the oral cavity. It was considered to be a non- 
pathogenic constituent of the oral microflora which 
could rarely cause medical infections (Zambon, 1985). 
In the later years A.actinomycetemcomitans have been 
isolated from dental plaque samples (Kilian and 
Schiott, 1975). Since these early reports there have 
been a number of studies indicating that the prevalence 
of A.actinomycetemcomitans from different parts of the 
oral flora of healthy volunteers and patients with 
different forms of periodontal disease varies 
considerably. In 1980 Slots, Reynolds and Genco, 
reported the isolation of this organism from 
subgingival plaque, tongue, cheek mucosa and saliva 
with the highest numbers present in the subgingival 
area. The authors concluded that dental plaque and the 
periodontal pocket area are the main oral sites for 
A.actinomycetemcomitans. Asikainen, Alaluusua and Saxen 
(1991) reported the isolation of
A.actinomycetemcomitans from stimulated saliva, tongue 
and subgingival sites in healthy and diseased subjects. 
Papapanou et al., (1993) reported the isolation of
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A.actinomycetemcomitans from 25% of subgingival plaque 
samples of 171 randomly selected subjects.
1.8 Systemic infections due to A.actinomycetemcomitans
A.actinomycetemcomitans has been associated with 
several human infections. These include abscesses of 
the hand; face; brain; chest wall; submandibular; 
mandibular; mediastinal; pulmonary and thyroid gland. 
It has also been associated with dentoalveolar 
abscesses and cervicofacial actinomycosis. The majority 
of extra-oral infections involving
A.actinomycetemcomitans are related to the heart, with 
more than 50 reported cases of infective endocarditis 
in the literature (Page and King, 1966; Zambon, 1985; 
Kaplan et al., 1989). Most of these infections occur in 
subjects with history of rheumatic heart disease or 
prosthetic valve replacement (Zambon, 1985) . Fifteen 
additional cases such as empyema, cervical adenitis and 
septic embolus, together with those previously reported 
cases are reviewed by Kaplan et al., (1989).
1.9 Oral infections related to A.actinomycetemcomitans
A.actinomycetemcomitans strains have been isolated and 
identified in plaque samples from supragingival and
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subgingival sites from individuals with healthy gums or 
with different forms of periodontitis (Kilian and 
Schiott, 1975; Newman and Socransky, 1977; Tanner et 
al., 1979; Slots, Reynolds and Genco, 1980; Mandell and 
Socransky, 1981). A.actinomycetemcomitans has been 
implicated in the aetiology of localized juvenile 
periodontitis in a number of studies (Slots et al., 
1982; Christersson and Zambon, 1993). The association 
of A.actinomycetemcomitans with other forms of 
periodontal disease has been shown also. For example it 
has been shown that A.actinomycetemcomitans may be 
important in severe adult periodontitis and refractory 
periodontitis (Zambon, 1985; Rodenburg et al., 1990).
The possible transmission of A.actinomycetemcomitans in 
the case of adult periodontitis has also been shown 
(Petit et al., 1993). However, a more detailed review 
the evidence for the involvement of
A.actinomycetemcomitans in periodontitis is presented 
in Section 1.13.
1.10 Prevalence of Capnocytophaga species in the oral 
flora
Simpson, Leadbetter and Holt (1975) reported the 
isolation of anaerobic gliding bacteria from human
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dental plaque. Two other groups of workers (Savitt et 
al., 1975; Newman and Socransky, 1977) reported 
isolation of the same organism from plaque associated 
with periodontal diseases. A few years later reports 
were published giving detailed descriptions of the 
morphology, biochemistry and taxonomy of these 
organisms which were named Capnocytophaga species 
(Leadbetter, Holt and Socransky, 1979; Holt, leadbetter 
and Socransky, 1979; Socransky et al., 1979; Williams 
and Hammond, 1979) . It has been shown that the dental 
plaque is its primary ecological niche (Mashimo et al., 
1983; Slots and Genco, 1984) and Capnocytophaga species 
have been isolated from 32% of the subgingival plaque 
of a randomly selected subjects though it was not 
identified to the species level (Papapanou et al.,
1993) .
1.11 Infections due to Capnocytophaga species
Forlenza, Newman and Blachman (1979) have reported that 
Capnocytophaga species can cause systemic disease in 
compromised patients. They reported that six patients 
with granulocytopenia and malignancy, 5 juveniles with 
leukaemia and 1 adult with carcinomas had sepsis, at 
the time of sepsis and when the organism isolated from
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blood no mature granulocytes were detected. Four 
episodes of sepsis were caused by C.sputigena and 2 
episodes with C.ochraceus. malignancies. Furthermore, 
all patients had; fever, mucosal ulceration, poor oral 
hygiene and most of them had gingival bleeding which 
may have served as an entry route of the bacteria to 
the blood stream. Infections have been reported in 
seven patients with leukaemia and one patient with an 
adenocarcinoma (Forlenza et al., 1980; Gilligan,
McCarthy and Bissett, 1981; Warwood, 1981). In addition 
there is a single report of a patient with Hodgkin's 
disease who developed Capnocytophaga sepsis (Appelbaum, 
Ballard and Eyster, 1979) . The probable site of entry 
in all these cases was almost certainly the oral cavity 
as all these patients demonstrated signs of periodontal 
disease. More recently a case of bacteremia due to 
C.sputigena in a patient with a haematological 
malignancy has been reported (Gomez-Garces et al.,
1994).
1.12 Oral infections related to Capnocytophaga species
In the nineteen seventies Capnocytophaga species were 
implicated in destructive forms of human periodontal 
disease (Newman et al., 1976; Newman and Socransky,
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1977). Socransky et al., (1979) reported the presence
of each of the three Capnocytophaga species in healthy 
gingival sulci as well as periodontal pockets from 
different forms of periodontal disease. However, no 
correlation was made between specific forms of 
periodontal disease and particular species. 
Capnocytophaga species have been implicated in 
localized juvenile periodontitis (Newman et al., 1976; 
Slots, 1976), and in periodontitis associated with 
insulin-dependent diabetes mellitus (Mashimo et al.,
1983). Although Capnocytophaga species have been linked 
in the aetiology of periodontal disease in some early 
studies (Mashimo et al., 1983A), currently the role of 
these oral organisms in periodontal disease is believed 
to be doubtful, in spite of the fact that strains of 
Capnocytophaga species have been shown to produce 
potential virulence factors for example an IgAl 
protease, In a comprehensive review of the microbial 
aetiological agents of destructive periodontal disease 
Haffajee and Socransky (1994), did not list 
Capnocytophaga species amongst the suspected 
periodontopathogens.
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1.13 Periodontopathogens
The search for the aetiological agents of periodontal 
disease is long standing but the detection of an 
aetiological agent of destructive periodontal disease 
is complex and hampered by technical difficulties 
(reviewed by Socransky et al., 1987; Socransky and 
Haffajee, 1990). Based on the evidence obtained using 
the criteria described in Section 1.2.4, several 
periodontopathogens have been implicated in some forms 
of periodontal disease. However, it is likely that in 
due course some of the species currently being 
investigated will be removed from the list and that 
others will be added as further research work is 
published (Socransky and Haffajee, 1992) .
The general approach used by investigators to define a 
suspected periodontopathogen, includes the
demonstration of an association between disease 
activity and the potential pathogen usually by pilot 
clinical microbiological culture studies, which if 
positive are verified in larger study groups by the use 
of selective media. In the past 8-10 years the use of 
molecular techniques to relate potential pathogens to 
periodontitis has been used commonly (Haffajee and 
Socransky, 1994). Based on these types of studies a
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range of bacterial species has been implicated in adult 
forms of the disease, and others have been implicated 
in the juvenile form of disease. All these groups of 
organisms and the evidence supporting their suspected 
role in periodontal disease were reviewed by Haffajee 
and Socransky (1994).
Currently there are more data to support pathogenic 
roles for A.actinomycetemcomitans and P.gingivalis than 
for other suspected periodontopathogens. A.actinomycet­
emcomitans was first recognized as a possible 
periodontopathogen by its increased frequency of 
detection and higher numbers in lesions of localized 
juvenile periodontitis compared with other periodontal, 
gingivitis conditions and health (Chung et al. , 1989;
Slots, Reynolds and Genco, 1980; Christersson and 
Zambon, 1993; Barr-Agholme et al., 1992). Another
criterion for the selection of a periodontopathogen is 
fulfilled by A.actinomycetemcomitans since elevated 
serum and local antibody levels have been detected in 
patients with localized juvenile periodontitis 
(Ebersole, Taubman and Smith, 1985; Ebersole et al.f 
1991; Taubman et al., 1992). The elimination or the
substantial reduction in the numbers of 
A.actinomycetemcomitans by local and antimicrobial
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therapy in patients with localized juvenile 
periodontitis has been linked with clinical success 
(Slots and Rosling, 1983; van Winkelhoff, Tijhof and de 
Graaff, 1992) . A. actinomycetemcomitans induced disease
in gnotobiotic rats as the injection of 
A.actinomycetemcomitans subcutaneously caused abscess 
at the injection site and the abscess ulcerated two 
days after injection (Chen et al., 1991). Furthermore,
A.actinomycetemcomitans strains have been reported to 
produce a range of virulence factors which include 
leukotoxin, collagenase, endotoxin, epitheliotoxin, 
fibroblast inhibitory factor and bone resorption 
inducing factor (Socransky and Haffajee, 1990; 
Socransky and Haffajee, 1992) . These factors are listed 
in Table 1.2 and reviewed later in this chapter 
A.actinomycetemcomitans has also been implicated in 
adult forms of periodontitis although its role is less 
clear (Haffajee and Socransky, 1994).
The evidence for a role for P.gingivalis in 
periodontitis consists of the detection of the organism 
in the lesions of adult periodontitis compared to its 
rare intraoral presence in health (Moore et al., 1991; 
Papapanou et al., 1993). Also when P.gingivalis is 
eliminated by therapy clinical improvement occurs
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(McNabb, Mombelli and Lang, 1992). An elevated level of 
serum and local antibodies in disease indicates its 
ability to induce host responses (Choi et al., 1990) 
and P.gingivalis can produce a number of potent 
virulence factors which include collagenase, trypsin­
like protease activity, fibrinolysin, other proteases, 
phospholipase A, phosphatases, endotoxin, H2S, ammonia, 
fatty acids and factors which adversely affect 
polymorphonuclear leukocytes (reviewed by Haffajee and 
Socransky, 1994). In experimental mixed infections in 
monkeys and dogs P.gingivalis has been shown to play an 
important role (Socransky and Haffajee, 1990; Ebersole 
and Kornman 1991).
In recent years and with the advances in molecular 
biology techniques, workers have been employing new 
technology to search for aetiological agents in 
periodontal disease. In the past most of the studies 
that investigated the bacterial composition of 
subgingival dental plaque samples used cultural 
techniques which are laborious, time-consuming and may 
be limited in their outcome, and subject to variability 
(Haffajee and Socransky, 1994). Recently workers have 
been using poly- or mono-clonal antibodies or specific 
DNA probes to detect specific organisms in dental
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plaque. These techniques reduce the time required for
sample analysis and therefore more samples can be
processed in a shorter period of time, though they
cannot be used to isolate new species and accurate 
quantification is not yet achievable (Haffajee and 
Socransky, 1994).
1.14 Virulence factors and pathogenicity
The search for aetiological agents in periodontitis as 
indicated above is complex and dependent on a number of 
host and microbial factors that require to occur and 
interact at the same time. It is now recognized that a 
pathogen may colonize a site but no disease progression 
occurs (Socransky and Haffajee, 1992; Socransky and 
Haffajee, 1993) due perhaps to the absence of or 
defects in virulence factors or the presence of
powerful host defence factors. The possible host 
parasite interactions that may occur are many and 
complex, for example a bacterial species may be present 
in a site that enhances infection or inhibits the 
pathogen's activity. The pathogen must be able to 
multiply and reach numbers sufficient to initiate or 
cause infection. The expression of virulence factors 
produced by a pathogen could be altered by the
environment and it is now clear that not all clonal 
types of a pathogenic species are equally virulent for 
a number of medically important infectious agents 
(Socransky and Haffajee, 1993).
The whole process of colonization prior to tissue 
destruction and disease depends on several factors 
including interactions between bacteria and the host 
and between the pathogen and other microorganisms 
present in the site. A range of factors are produced by 
periodontopathogens including some which aid 
colonization, others which assist in multiplication and 
growth. In addition there are factors that overcome the 
host defences and others that cause tissue destruction 
(Socransky and Haffajee, 1991). These are collectively 
known as virulence factors, which may be defined as the 
set of unique properties which allow the organism to 
colonize and defend itself but may subsequently cause 
damage to host tissues (Socransky and Haffajee, 1991). 
There are a number of virulence factors produced by 
periodontopathogenic organisms. Table 1.2 contains a 
list of a number of virulence factors produced by 
A.actinomycetemcomitans. an organism examined in this 
study. However other periodontopathogens such as 
P.gingivalis were shown to produce an array of potent
factors. These factors include some that assist in the 
colonization of a site since it is generally accepted 
that the ability of a periodontopathogen to adhere to 
the host surfaces is an important step for colonization 
prior to subsequent tissue damage (Slots and Genco,
1984) .
Adherence
Clearly the ability of a periodontopathogen to adhere 
to a host surface is an essential step for colonization 
and subsequent tissue damage (disease) (Gibbons and van 
Houte, 1975; Slots and Genco, 1984). P.gingivalis has 
been shown to adhere to oral tissues, as it has been 
showed that P.gingivalis was able to synthesise surface 
haemagglutinins which function as adhesins by which 
this organism attaches to host tissue or by using other 
mechanisms like the coaggregation with other oral 
bacteria (for example F.nucleatum) (Kolenbrander and 
Andersen, 1989; Progulske-Fox et al., 1993), and also 
to invade oral epithelial tissue culture cell lines 
(KB) in vitro (Sandros, Papapanou and Dahlen, 1993) .
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Table 1.2 Virulence factors produced by 
A.actinomycetemcomitans
Virulence factor Reference
Leukotoxin Taichman et al., (1991)
Fibroblast inhibitory 
factor
Helgeland and Nordby (1993)
Bone resorbing factor Meghji et al., (1994)
endotoxin Kily and Holt (1980)
epitheliotoxin Birkedal-Hansen et al., 
(1982)
invades epithelial 
cells in vitro
Meyer, Sreenivasan and Five- 
Taylor (1991)
Collagenase Rosanies et al., (1983)
Fc-binding components Tolo and Helgeland (1991)
alkaline and acid 
phosphatase
Slots (1981)
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Interactions with PMNLs
The interactions between human PMNLs and 
periodontopathogens are probably very important in the 
pathogenesis of periodontal disease since it have been 
shown that the neutrophils are the predominant 
leukocytes in the oral cavity and provide a first line 
of defence against attack by periodontal organisms (Van 
Dyke and Vaikuntam, 1994) . When PMNLs and 
periodontopathic bacteria interact a number of outcomes 
are possible; the PMNLs can interact directly and kill 
the pathogen by phagocytosis or by releasing their 
lysosomal enzymes into the pockets (Van Dyke and 
Vaikuntam, 1994). In contrast certain pathogens can 
protect themselves by either producing toxic substances 
that damage the neutrophils or protect themselves by 
means of various surface components (for example a 
capsule) which can protect the organism against 
phagocytosis. Examples of these two mechanisms are the 
capsule produced by P.gingivalis (Okuda and Takazoe, 
1988), and the leukotoxin produced by certain 
A.actinomycetemcomitans strains (Taichman et al., 
1991) . Furthermore, it has been shown that bacteria 
have adopted different mechanisms of interfering with 
phagocytosis and the killing mechanisms of human PMNLs
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(Yoneda, Maeda and Aono, 1990). For example 
lipopolysaccharide from P.gingivalis has been shown to 
inhibit PMNL chemotaxis in vitro thus avoiding the 
phagocytic activity of PMNLs (Seow et al., 1992). In
1992 Gillespie et al., (1992) showed that certain
strains of the oral organism Campylobacter rectus were 
able to produce an extracellular material that killed 
HL60 cells and human PMNLs as measured by the trypan 
blue exclusion assays. It was shown also that this 
toxic material was a protein with a molecular weight 
of 104 kilo-daltons as determined by SDS-PAGE. 
However, cell suspension of the bacterium were not 
toxic. This finding is significant for the involvement 
of C.rectus in periodontal disease since it is the 
second organism that produces a toxin which kills 
human PMNLs.
IgA-protease production by periodontopathogens
Another virulence factor that has been shown to be 
produced by certain periodontopathogens is IgAl 
protease, which is capable of cleaving human IgA 
(subclass IgAl). This immunoglobulin is recognized as 
an important line of defence against invading organisms 
(Kilian, 1981), and a range of bacteria have been shown
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to possess such activity. These include bacteria that 
colonize mucosal surfaces such as Neisseria 
meningitidis. Neisseria gonorrhoeae. and other bacteria 
important in dental plaque formation such as 
Streptoccus sanguis. Other pathogenic bacteria such as
H.influenzae and S.pneumoniae also possess such
activity. An example of an oral organism is 
Capnocytophaga species which has been shown to cleave 
human IgAl in vitro as well as in vivo (Frandsen et 
al., 1995).
Fibroblast inhibition factors
A few putative periodontopathogens produce fibroblast 
inhibiting factor(s) that interferes with the
proliferation of cultured human fibroblast cell lines. 
For example the lipopolysaccharide prepared from
P.gingivalis can inhibit the proliferation of cultured 
human gingival fibroblasts (Layman and Diedrich, 1986; 
Larjava et al., 1987). In addition Scragg, Cannon and 
Williams (1994) have shown that cultured fibroblast 
cell lines (Vero cells and human gingival fibroblasts) 
were affected by different concentrations of short
chain fatty acids produced by anaerobic periodontal 
bacteria (for example P.gingivalis). as have sonic
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extracts prepared from certain spirochetes such as 
Treponema denticola. A dose-dependent inhibition of 
both human and murine fibroblasts has been demonstrated 
with these extracts and the inhibitory factor was heat 
labile and not endotoxin (Boehringer, Taichman and 
Shenker, 1984). A number of periodontopathogens have 
been shown to produce enzymes that are capable of 
destroying host connective tissues an example of these 
enzymes is collagenase which can destroy collagen which 
is the principle component in human gingiva and its 
most important structural component (Page, 1972). 
Porphyromonas gingivalis (P.gingivalis) is collagenase 
positive and this property has been proposed as a
virulence factor (Slots, 1981; Grenier and Mayrand, 
1987; Robertson et al., 1982; Toda et al., 1984). Also 
Birkedal-Hansen et al. , (1988) have reported that
strains of P.gingivalis have collagenolytic activity 
capable of degrading collagen types I, II and III. 
Smally, Birss and Shuttleworth (1988) reported the
purification of a trypsin-like enzyme from cell and 
cell-free culture supernatants from P.gingivalis 
strain W50. This purified enzyme, together with
extracellular membrane vesicles, degraded collagen 
substrate and human plasma fibronectin. Their results
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have indicated that the release of proteolytic enzymes 
by P.gingivalis. either soluble or associated with 
extracellular membrane structures, may be important in 
the pathogenesis of periodontal disease. Smalley, 
Shuttleworth and Birss (198 9) also reported that the 
extracellular vesicle fraction of B .gingivalis strain 
W50 and the avirulent variant W50/BE1 have
collagenolytic activity. However, the rate of collagen 
depolymerization was greater with the extracellular 
vesicle fraction of W50 compared to that of the 
variant strain W50/BE1 (90% and 5% substrate
degradation respectively) over a 6 hour incubation 
period.
In the above section the role of bacteria in the 
aetiology of periodontal disease has been reviewed
briefly together with a summary of the known virulence 
factors produced by a number of suspected
periodontopathogens. In the following sections the 
main virulence factors produced by the three organisms 
under study will be presented and discussed.
1.14.1 Bacterial adhesion
The mechanisms of bacterial adhesion have been studied 
extensively. The attachment of a bacterium to one of
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the available host or microbial surfaces in the mouth 
is an important step for colonization and survival in 
the periodontium. Host surfaces include the tooth or 
host-derived substances binding to the tooth, the 
sulcular epithelium, while attachment may also occur to 
other adherent bacteria (Socransky and Haffajee, 1991). 
Adherence occurs when specific receptors are present on 
the host cells or saliva coated tooth surface to which 
specific molecules known as adhesins present on the 
bacterial surface can bind or attach. A number of 
receptors on several host surfaces have been 
identified. Clark et al., (1986) showed that only
strains of Actinomyces that possessed Type 1 fimbriae 
adhered to tooth surfaces and that fimbriae constituted 
the principle adhesin involved in this interaction. The 
Actinomyces strains possess different antigenically 
distinct fimbriae (Type 1 and Type 2 fimbriae) . The 
type 2 fimbriae have been shown to be involved in the 
mediation of lactose sensitive coaggregation. Many 
human oral isolates possess similar lectin activity and 
this has been associated with the presence of fimbriae 
that are genetically related (Clark et al., 1986).
Winkler et al., (1988) showed that strains from 
periodontopathogenic bacteria such as P.gingivalis and
A.actinomycetemcomitans adhered more strongly to the 
basement membrane of a connective tissue in vitro, than 
other Gram-positive oral microorganisms. Mangan et al.,
(1989) showed that Fusobacterium nucleatum possesses
lectin-like adherence factors and that Fusobacterium 
nucleatum adhered to human PMNLs. The adherence was 
inhibited by N-acetyl-D-galactosamine or lactose. 
Adhesins identified on the surface of subgingival 
bacteria include fimbriae (Clark et al., 1986; Isogai
et al., 1988) and cell associated proteins (Mangan et 
al., 1989). Coaggregation is another mechanism of 
attachment, in which some species unable to bind 
directly to a surface are able to attach to another 
bacterial species that is already attached to the host. 
Coaggregation between species has been shown to be a 
specific process both in vitro and in vivo and has been 
reported by (Kolenbrander, Andersen and Moore, 1989); 
Kaufman and Dirienzo, 1989).
Adherence of A.actinomycetemcomitans
Slots and Genco (1984) discussed in detail how putative 
periodontopathogenic bacteria interact with and 
colonize the host tissue and then destroy them, despite 
apparently effective host defences.
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A.actinomycetemcomitans was included in this study. 
A.actinomycetemcomitans can colonize oral mucosal 
surfaces, supragingival plaque and periodontal pockets 
(Genco, Zambon and Christersson, 1986; Zambon, 1985). 
Gibbons and Etherden (1983) have reported the ability 
of some A.actinomycetemcomitans strains to adhere to 
saliva-treated hydroxyapatite as have Kagermeiler and 
London (1985). In an electron microscopic study of the 
interbacterial matrix of subgingival plaque samples 
from patients with periodontal disease, Scannapie, 
Korman and Coykendal (1983) showed that all plaques 
contained varying amounts of extracellular appendages, 
morphologically identical to bacterial fimbriae, these 
plaque samples contained a group of bacteria and 
A.actinomycetemcomitans was among the group. They 
concluded that bacterial extracellular appendages 
resembling fimbriae are common components of bacteria 
freshly isolated from plaque samples and that they may 
play a significant role in adhesive interactions within 
plaque studied. Freshly isolated strains of 
A.actinomycetemcomitans possess fimbriae and adhere to 
hydroxyapatite, while non fimbriated variants of the 
same strains attach less well Rosan et al., (1988). 
Other workers have also reported that
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A.actinomycetemcomitans can adhere to buccal epithelial 
cells (Sweet, MacFarlane and Samaranayake 1988; Taher 
and MacFarlane, 1991). Okuda et al., (1991) reported
that lipopolysaccharide from A.actinomycetemcomitans 
adhered to both saliva-coated and serum-coated 
hydroxyapatite beads and agglutinated human 
erythrocytes. Recently Meyer and Fives-Taylor (1993) 
reported that extracellular microvesicles together with 
a highly proteinaceous material associated with a 
leukotoxic strain of A.actinomycetemcomitans enhanced 
the adherence of a weakly adherent strain. The authors 
hypothesised that both extracellular vesicles and an 
extracellular amorphous material play an important role 
in the bacterial adhesion to epithelial cells. In 
addition the surface material is also important in the 
complex interactions that occur between Gram-positive 
and Gram-negative oral species during the formation of 
dental plaque (Meyer and Fives-Taylor, 1993). Mintz and 
Fives-Taylor (1994) reported that A. actinomyceytemcomi- 
tans has been shown to adhere to a cultured human oral 
epithelial cell line (KB cells) , as detected by an 
enzyme-linked immunosorbent assay and (3H)thymidine 
labelled bacteria. Adhesion was shown to be time and 
bacterial-concentration dependent and inhibited by
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saliva or by the pre-treatment of
A.actinomycetemcomitans with a protease (Mintz and 
Fives-Taylor, 1994) . It has also been reported that
A.actinomycetemcomitans can invade gingival tissue 
(Christersson et al., 1987 A; Christersson et al. ,
1987; Zambon; 1985). This finding was further confirmed 
by Meyer, Sreenivasan and Fives-Taylor (1991) who 
showed that A. actinomycetemcomitans could invade human 
oral epithelial cell lines (KB cell line) as determined 
by the recovery of viable organisms from gentamicin 
treated cultured KB cells and by electronic and light 
microscopy examination. They also showed a correlation 
between the invasiveness of A.actinomycetemcomitans and 
its colonial morphology, as smooth variants were shown 
to invade more proficiently than rough variants (Meyer, 
Sreenivasan and Fives-Taylor, 1991).
Adhesion of H .aphrophilus
There are very few studies that have investigated the 
adhesion of H.aphrophilus strains to host tissues. In a 
study reported by Sweet, MacFarlane and Samaranayake 
(1988) a single strain of H.aphrophilus was reported as 
adhering to human buccal epithelial cells.
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Adhesion of Capnocytophaga species
The characteristics which aid Capnocytophaga species to 
colonize the oral cavity and survive in the periodontal 
pocket were reviewed in detail by Slots and Genco 
(1984). C.sputigena strains possess surface components 
which consists of thick amorphous material, long 
fibrils and vesicles on the external surface of the 
outer membrane. This surface material appears to make 
this organism more adherent than other Capnocytophaga 
species as they possess less extracellular material 
(Slots and Genco, 1984). In an electron microscopic 
examination of the interbacterial matrix of subgingival 
plaque samples from periodontal disease patients, 
Capnocyt ophaga species have been shown to possess 
extracellular appendages resembling fimbriae and it was 
concluded by the authors that these components may play 
a role in the adhesive interactions within plaque 
(Scannapie, Korman and Coykendal, 1983). Sweet, 
MacFarlane and Samaranayake (1988) showed that certain 
Capnocytophaga species were able to adhere to human 
buccal epithelial cells though in lower numbers than 
other species present in the periodontium such as 
P.gingivalis or Veillonella freshly isolated strains.
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1.14.2 Interactions with human polymorphonuclear 
leukocytes (PMNLs)
Human PMNLs represent an early line of defence against 
microbial attack, and individuals with defective PMNLs 
are predisposed to acute infections. PMNLs are 
recognized as important in the protection of the 
periodontium and the interactions between 
periodontopathogens and PMNLs are an important factor 
in periodontitis. In this section both the basic 
principles of phagocytosis and the leukotoxin produced 
by A.actinomycetemcomitans will be discussed 
separately.
Phagocytos is
Phagocytosis is the name given to the process by which 
a specialist group of white blood cells capture and 
digest particulate matter, bacteria and viruses. These 
cells are of myeloid origin and are produced initially 
from haemopoietic stem cells in the bone marrow. They 
are of two types, granulocytes and monocytes 
(macrophages). The granulocytes are classified as 
neutrophils (these constitute more than 90% of the 
total leukocytes), eosinophils or basophils. The 
mononuclear phagocytes occur as nearly spherical
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monocytes in the blood and as irregularly shaped, non­
circulating macrophages in organs such as the liver 
and spleen. The neutrophils and monocytes play an 
important role in removing foreign matter which may 
gain access to the body. The macrophages play an 
important role in filtering the blood as it passes 
through the organs in which they are present and this 
is a major line of defence against invading bacteria 
(Roitt, 1994). The bactericidal activity of the 
phagocytic cells depends on two different mechanisms, 
degranulation and the generation of highly toxic 
radicals. The steps of phagocytosis are illustrated in 
Figure 1.1. Phagocytosis consists of an attachment and 
ingestion phase, the ingestion of particles (including 
bacteria) is dependent on surface properties of the 
particle and the presence on the surface of the 
specific serum ligands, antibody and complement. These 
then will interact with receptors on the phagocyte 
surface and mediate ingestion (Horwitz, 1982). After 
particles are ingested, they become enveloped within 
the white cell membrane and an intracellular vesicle 
called a phagosome is formed. Lysosomes present in 
white blood cell then migrate to the phagosomes and 
fuse with it to form a phagolysosome. The lysosome
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contents (cytoplasmic granules which include enzymes 
and other substances capable of killing bacteria are 
released into the phagolysosome (degranulation). 
Highly reactive oxygen radicals namely superoxide 
anion, singlet oxygen, hydrogen peroxide and hydroxyl 
radicals are produced. The latter process is termed 
the respiratory burst (Babior, 1978). The killing of 
bacteria subsequently occurs. The production of these 
compounds is associated with the production of light 
and was first reported by Allen, Stjernholm and Steele 
(1972). The amount of light produced is very small and 
difficult to measure but can be enhanced and thus 
measured by the use of luminol (5-amino-2,3-dihydrol,4 
phthalazinedione), (Allen and Loose 1976). Allen and 
Loose (1976) demonstrated that chemiluminescence was 
produced following the phagocytosis of bacteria. Other 
studies using luminol-enhanced chemiluminescence have 
directly correlated the bactericidal ability of 
neutrophils with chemiluminescence production (Easmon 
et al., 1980; Welch, 1980; Seymour, Whyte and Powell, 
1985).
Periodontal disease is an inflammatory disease in 
which human PMNLs play an important role, as they 
accumulate in the affected sites (Attstrom 1971;
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Schroeder, 1973) . Interactions of bacteria with human 
PMNLs at the disease site will activate the latter and 
result in the formation of highly toxic oxygen 
products within lysozomes which are powerful 
bactericidal agents. However, if the factors 
responsible for intracellular killing are released 
extracellularly damage to the host tissue may result, 
and the role of PMNLs in periodontal disease has 
therefore, been considered to be both protective and 
destructive (Miller, Lamster and Chasens, 1984). 
Robinson et al. , (1984) examined the chemiluminescence
response of normal human PMNLs to a number of 
different pathogenic microorganisms and they reported 
that each microorganism caused a reproducible response 
pattern. The factors influencing the normal 
chemiluminescence response to these microorganisms 
were also studied and defined. Passo et al. , (1982)
examined a number of Gram-negative bacteria isolated 
from plaque samples including Capnocytophaga species 
and found that only Fusobacterium nucleatum initiated 
a chemiluminescence response in the absence of serum. 
Holm and Kalfas (1993) examined a group of 
A.actinomycetemcomitans and H.aphrophilus strains for 
their ability to produce a chemiluminescence response
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in human PMNLs and activate the oxygen dependent 
bactericidal mechanism in these cells. They reported 
that there were strain-dependent differences among 
A.actinomycetemcomitans in their ability to induce the 
oxygen-dependent bactericidal mechanisms of human 
PMNLs whereas the chemiluminescence response patterns 
of H.aphrophilus strains were all the same. They 
further reported that several environmental factors 
such as salivary compounds and activated complement 
affected the interactions between these two organisms 
and human PMNLs (Holm and Kalfas, 1993)
Leukotoxin
PMNLs are present in periodontal sites and they 
represent a very important defence against 
periodontitis. The ability of a periodontopathogen to 
interfere with or inhibit the bactericidal activity of 
PMNLs will subsequently enhance the virulence of the 
microorganism (Van Dyke, Levine and Genco, 1982) . 
Baehni et al., (1979) reported that a strain of 
A.actinomycetemcomitans isolated from a patient with 
juvenile periodontitis (strain Y4) produced a
leukotoxin capable of killing human PMNLs and
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monocytes. Subsequently these workers examined several 
strains of A.actinomycetemcomitans for their ability 
to produce leukotoxin (Baehni et al., 1981). The study 
included both Type strains and fresh oral isolates, 
and demonstrated that 7 out of 10 fresh isolates, in 
addition to 3 Type strains (ATCC 29522, ATCC 29524 and 
Y4) , were able to produce a leukotoxin capable of 
killing human PMNLs. They also reported that the 
addition of autologous human serum, either fresh or 
heat-inactivated, enhanced the killing by the 
leukotoxic stains. However, it had no effects on the 
non-leukotoxic A.actinomycetemcomitans strains (Baehni 
et al., 1981). It has also been shown that the
addition of serum from juvenile periodontitis patients 
to the assay system inhibited leukotoxicity. 
Similarly, rabbit antiserum against PMNL-membrane 
binding components of strain Y4 neutralized 
leukotoxicity, while antisera raised against a non- 
leukotoxic strain (ATCC 29523) failed to do so (Baehni 
et al., 1981). Serum from normal individuals or those 
with other types of periodontal disease enhanced 
leukotoxicity in assays while sera from individuals 
with juvenile periodontitis inhibited leukotoxicity 
(Tsai et al. , 1981; McArthur et al. , 1981). However,
Zambon et al., (1983) reported that human serum
derived from healthy individuals did not enhance 
leukotoxicity against the tissue culture cell line 
HL60 in contrast to the findings for human PMNLs. 
Several other studies have shown that 
A.actinomycetemcomitans can produce a leukotoxin 
(Taichman, Dean and Sanderson, 1980; Taichman and 
Wilton, 1981; Tsai et al., 1979; Zambon et al., 1983). 
The latter examined the susceptibility of the 
promyelocytic HL60 cell line to leukotoxin from 
A.actinomycetemcomitans. They reported that HL60 cells 
were susceptible to lysis by A.actinomycetemcomitans 
leukotoxin and that the HL60 cells were slightly more 
sensitive to the toxin than were human PMNLs. 
Leukotoxic activity against HL60 cells was shown to be 
dose-and temperature-dependent, reaching a maximum 
after 45 minutes at 37°C. Another study using PMNLs as 
targets has indicated that the maximum was reached 
after 60 minutes exposure to A.actinomycetemcomitans 
sonicates (Tsai et al., 1979) whereas a longer 
exposure (12 0 minutes) was needed when monocytes were 
the targets (Taichman, Dean and Sanderson, 1980).
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The prevalence of leukotoxic A.actinomycetemcomitans 
was shown to be higher in periodontal disease patients 
especially in juvenile periodontitis patients and, 
therefore, Zambon et al., (1983) correlated the 
leukotoxin production with virulence. A few
H .aphrophilus strains were tested in this study but 
proved to be together with non-leukotoxic 
A.actinomycetemcomitans strains, unable to damage 
either HL60 or human PMNL target cells. Tsai et al. ,
(1981) and Taichman and Wilton (1981) have reported 
that the majority of juvenile periodontitis patients 
have a high serum titre of anti-leukotoxin antibodies 
produced against A.actinomycetemcomitans. Tsai et al. ,
(1982) also reported that younger patients (less than 
12 years of age) were more frequently infected with 
leukotoxic A. actinomycetemcomitans than were older 
patients.
Tsai et al., (1984) reported that A.actinomycetemcomi­
tans leukotoxin had a molecular weight of 115,000 
dal tons as determined by the SDS-PAGE and was 
susceptible to heat, since incubation of leukotoxin at 
56°C for 3 0 minutes caused more than 90% inactivation 
and heating for 3 0 minutes at 70°C or 100°C resulted in
complete inactivation. They also showed that 
leukotoxin was trypsin-sensitive. Purified leukotoxin 
killed human but not rat or guinea pig PMNLs and it 
was inactive against human erythrocytes. Leukotoxic 
activity was inhibited by pooled serum from juvenile 
periodontitis patients (Tsai et al., 1984).
Thus several studies have indicated that leukotoxin 
from A.actinomycetemcomitans was capable of killing 
human PMNLs, monocytes and certain human 
myelomonocytic leukaemia cell lines (HL60 and U937). 
PMNLs and monocytes from the great apes and old world 
monkeys are also susceptible to leukotoxin produced by 
A.actinomycetemcomitans (Baehni et al. , 1981; Taichman 
et al., 1984). Epithelial and endothelial cells,
fibroblasts, erythrocytes and platelets proved to be 
non-susceptible (Taichman, Dean and Sanderson, 1980; 
Taichman and Wilton, 1981). Rabie, Lally and Shenker
(1988) reported that A.actinomycetemcomitans
leukotoxin was able to exert a non-lethal effect on 
human lymphocytes, which could compromise the ability 
of the host defences to cope with infection in the 
gingival crevice. In addition it is known that 
A.actinomycetemcomitans leukotoxin kills mature human 
T and B lymphocyte cell lines (Simpson, Berthold, and
Taichman 1988), and Taichman et al., (1991) have
reported that leukotoxin purified from
A.actinomycetemcomitans destroyed a subpopulation of 
human lymphocytes. The authors indicated that Rabie, 
Lally and Shenker (1988) were unable to detect lethal 
activity by the A. actinomycetemcomitans leukotoxin 
against human lymphocytes may be related to the fact 
that the killing of lymphocytes does not involve
decimation of the entire population as it appears that 
only a subpopulation is susceptible.
The A.actinomycetemcomitans leukotoxin gene has been 
cloned in E. coli and it has been shown that 
A.actinomycetemcomitans leukotoxin is similar to
E.,CQli a-haemolysin and to Pasteurella haemolytica 
leukotoxin (Lally et al., 1989). Furthermore, when the 
complete nucleotide sequence of the A.actinomycetemco­
mitans leukotoxin gene was determined it was found to 
be closer to the a-haemolysin of E.coli than to 
P.haemolytica leukotoxin (Kraig, Lally and 
Kolodrubetz, 1990). This group of cytotoxins is 
referred to as the RTX group (Repeats in Toxin) as 
they are characterized by a series of glycine-rich 
repeat units at the C-terminal end of each protein, in
addition to other features (Coote, 1992) . However, 
they differ in their target specificity and the 
A.actinomycetemcomitans leukotoxin tends to remain 
cell-associated and is not secreted into culture 
supernatant as has been reported for other RTX toxins 
(Coote, 1992) . However, it can be released into the 
culture supernatant by polymyxin B treatment (Tsai et 
al., 1984; Ohta et al., 1993). Most of the leukotoxic 
activity of A.actinomycetemcomitans has been detected 
on the cell surface when it is cultured under 
controlled conditions in a chemostat (Ohta et al. , 
1993), and Berthold et al., (1992) reported that it
was localized either in the cell envelope or in 
membranous vesicles on the outer surface of the 
bacterial cell by an experiments using monospecific 
poly-clonal antibody against A.actinomycetemcomitans 
leukotoxin combined with electron immunocytochemical 
techniques. Ohta et al., (1991) reported that the 
leukotoxin could be extracted from whole cells by 
nuclease digestion. Furthermore, Ohta et al. , (1993)
reported that the association of A.actinomycetemcomit­
ans leukotoxin with the cell surface is mediated by 
nucleic acids and that the extracellular secretion of
leukotoxin occurs in growing cultures with an 
increased ionic strength of buffers or media.
Mode of action of leukotoxin
Four genes are required for the synthesis, activation 
and secretion of the RTX toxins, and they are 
designated C, A, B and D in the order of the genetic 
organization. In the case of A.actinomycetemcomitans 
leukotoxin, these are lktC, lktA, lktB and lktD (Coote 
1992) . The A gene is the structural toxin gene, the C 
gene is involved in activation, and the B and D genes 
are required for secretion (Coote, 1992) . Calcium has 
been shown to have an important role in the activity 
of RTX toxins. Lally et al., (1991) showed that
A.actinomycetemcomitans leukotoxin binds Ca2+ in a 
dose-dependent pattern. The leukotoxin of 
A.actinomycetemcomitans binds to cell surface 
receptors and injures the plasma membrane, although 
certain mono-and di-saccharides with mannose and 
galactose configuration provided some protection to 
target cells from toxins (Simpson, Berthold and 
Taichman, 1988). They further reported that cellular 
resistance to the toxin in non-susceptible target
cells may be due to a lack of or decrease in the 
number of leukotoxin receptors or alternatively due to 
impairment of cytopathic events that occur after the 
initial binding between toxin and receptor. Iwase et 
al., (1990) studied different aspects of the 
mechanisms of action of A.actinomycetemcomitans 
leukotoxin and reported that it altered the
permeability of HL60 target cells leading to colloid
osmotic lysis. They further suggested that the toxin
acts as a membranolytic agent producing pores in the 
target cells which could be protected by certain
saccharides. In a similar study Taichman et al.,
(1991) reported that the leukotoxin isolated from
A.actinomycetemcomitans rapidly binds to susceptible 
target cells and alters membrane permeability.
Resistant target cells either fail to bind to the 
toxin or resist permeability after binding. Similar 
events have been shown to occur in the lysis of 
mammalian erythrocytes and leukocytes by other RTX 
toxins derived from Gram-negative bacteria (eg
Pasteurella haemolytica leukotoxin).
It has been shown that substantial differences in the 
level of leukotoxin expression among A. actinomycetemc-
omitans strains exist, though all strains carry the 
complete toxin gene operon (Poulsen et al., 1994).
It is evident from the reviewed literature that the 
ability of certain A.actinomycetemcomitans strains to 
produce leukotoxin and suppress lymphocyte function 
may well contribute to the pathogenesis of juvenile 
periodontitis and possibly other forms of 
periodontitis. However, the production of leukotoxin 
is not the only factor required for pathogenesis, 
since leukotoxic and non-leukotoxic A.actinomycetemco­
mitans strains were isolated from patients with 
juvenile periodontal disease (Slots et al., 1982).
1.14.3 Chemotaxis inhibition by periodontopathic 
bacteria
As mentioned in the Section (1.13.2), human PMNLs play 
a major role in defending the gingival site against 
potential pathogenic bacteria. The ability of any 
putative periodontopathogen to interfere with the 
bactericidal function of PMNLs will contribute to the 
pathogenicity of that species. Several bacterial 
species produce substances that are toxic for 
neutrophils (ie leukotoxin; leucocidin) (Baehni et 
al. , 1979; Scharmann, Jacob and Portendorfen, 1976),
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and can inhibit specific neutrophil functions such as 
chemotaxis and phagocytosis (Church and Nye, 1979; 
Shurin et al., 1979; Ingham et al., 1977).
Chemotaxis is the movement of PMNLs towards the site 
of infection in response to specific chemical agents. 
Van Dyke et al. , (1982) examined the ability of sonic
extracts of A.actinomycetemcomitans to inhibit 
peripheral blood neutrophil chemotaxis, and reported 
that it specifically inhibited chemotaxis. The authors 
concluded that such an ability to inhibit neutrophil 
function may be an important determinant in virulence. 
Cutler et al., (1991) in a study of PMNL functions in
adult insulin-dependent diabetic patients with severe 
recurrent periodontitis, reported that the chemotactic 
ability of PMNLs was depressed and that the 
subgingival microflora had significant numbers of 
several periodontopathic bacteria including
A.actinomycetemcomitans. However, Kinane et al.,
(1989) reported that PMNLs isolated from patients with 
juvenile periodontitis and rapidly progressive 
periodontitis did not show any defective chemotaxis 
and further concluded that the variation which exists 
in the literature with respect to PMNL locomotion in 
periodontal disease was due to differences in the
methods used for analysis. A more surprising finding 
has been reported by Holm, Kalfas and Holm (1989) in 
which they showed that certain strains of 
A.actinomycetemcomitans were able to evoke the 
chemotaxis of PMNL in vivo. The authors related this 
contradictory result to the methodology employed such 
as the source and pre-treatment of PMNL, and 
additional biological factors in the in vitro assay. 
In another study A.actinomycetemcomitans was shown to 
inhibit the chemotaxis of neutrophil in vitro and thus 
may contribute to the pathogenesis of localized 
juvenile periodontitis (Ashkenazi, White and Dennison, 
1992). In addition Ochiai et al., (1989) have reported
that sonic extracts from periodontopathic bacteria, 
including strains of A. actinomycetemcomitans. have an 
immunosuppressive effect when tested in vivo with an 
experimental mouse model. They related this 
immunosuppressive activity to a heat-labile protein in 
the extract. Further, they concluded that this 
immunosuppressive activity produced by
A.actinomycetemcomitans could enhance survival not 
only of the initial periodontopathogen but also other 
opportunistic organisms present in the gingival 
crevice.
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There is little information regarding the ability of
H .aphrophilus to interfere with PMNLs, though in a 
study reported by Holm, Kalfas and Holm (1989) it has 
been shown that certain strains of H.aphrophilus 
evoked the chemotaxis of PMNL in vivo. Lindhe and 
Socransky (1979) showed that Capnocytophaga species 
are less chemotactic for human PMNL than some other 
oral bacteria both in vitro and in vivo. Shurin et 
al. , (1979) showed that peripheral PMNL from patients
with Capnocytophaga intra orally exhibit distinctive 
abnormalities in morphology and locomotion, and the 
removal of the organism produced an improvement with 
a restoration of normal function. Finally sonic 
extracts of Capnocytophaga species have produced 
factors that specifically inhibited peripheral blood 
neutrophil chemotaxis, (Van Dyke et al., 1982).
The interactions between A. actinomycetemcomitans and 
human PMNLs has been studied more extensively in 
contrast with both H.aphrophilus and Capnocytophaga 
species and there is not much information regarding 
the latter two organisms.
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1.14.4 Immunoglobulin A protease(IgA protease)
Immunoglobulin A (IgA) is found in human serum in 
concentrations that range from 1.4 to 4 mg /ml. There
are two subclasses of IgA (IgAl and IgA2) of which
IgAl constitutes 80-90% of the total. IgA is the 
predominant immunoglobulin class in secretions and it 
is present in saliva, tears, nasal fluids, sweat, 
colostrum and secretions of the lung, genitourinary 
and gastrointestinal tracts (Roitt, 1994). Serum IgA 
occurs mostly in the form of monomers, composed of two 
heavy and two light chains with molecular weights of 
about 53,000 and 22,500 respectively. A minor portion 
of the IgA in the sera of normal adults is found in a 
polymeric form, in which monomers are connected by 
disulphide bonds and linked to an additional
polypeptide called a J chain (Koshland, 1975). In
external secretions most of the IgA occurs in a 
polymeric form; dimeric IgA predominates, but milk and 
saliva also contain tetramers (Zikan et al., 1972; 
Halpern and Koshland, 1973). IgA in external 
secretions is usually present as a dimer linked to 
secretory component (secretory IgA) . The function of 
this secretory component may be to protect IgA 
molecules from proteases (Roitt, 1994).
IgA is considered to be an important defence against 
invading microorganisms (Kilian, 1981), and acts by 
neutralizing toxins, enzymes and viruses and by 
inhibiting the adherence of bacteria to mucosal 
surfaces, hence preventing them from attaching and 
possible entering host tissues (McNabb and Tomasi 
1981; Tomasi, 1984) .
Plaut, Wistar and Capra (1974) suggested that IgA 
proteases may be an important factor in the 
pathogenesis of mucosal infections. Certain bacteria 
which colonize mucosal surfaces such as Neisseria 
meningitidis. Nesseria gonorrhoeae, and other bacteria 
important in dental plaque formation such as 
Streptococcus sanguis, produce an extracellular enzyme 
which cleaves human serum IgAl (Mulks and Plaut, 1978; 
Plaut, Wistar and Capra, 1974; Nyvad and Kilian, 
1990) . Furthermore, it has been suggested that this 
enzymatic activity may be involved in the pathogenesis 
of infections with Neisseria gonorrhoeae and Neisseria 
meningitidis since it was not produced by non- 
pathogenic strains. Haemophilus influenzae and 
Streptococcus pneumoniae. both cause bacterial 
meningitis, and produce an IgA protease which 
specifically cleaves human IgAl to yield intact Fab
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and Fc fragments (Kilian, Mestecky and Schrohenloher, 
1979; Male, 1979). Several periodontopathogens are 
also capable of producing an IgA protease which 
cleaved IgAl in the hinge region to produce intact Fab 
and Fc fragments (Kilian, 1981) . These included 
Capnocytophaga and Bacteroides strains. Furthermore, 
Kilian suggested that the presence of such organisms 
can cause damage to the immune defence mechanisms 
which will result in the penetration and spread of 
several toxic products released by subgingival 
microflora. As discussed earlier, of the organisms 
under study, only Capnocytophaga species have been 
shown to cleave human IgAl both in vitro and in vivo 
(Frandsen et al. , 1995). There is little information
in the literature regarding the ability of the two 
other species (A. actinomycetemcomitans and
H.aphrophilus) to produce IgAl protease.
I.14.5 Fibroblast inhibition
Periodontal diseases in general, and juvenile 
periodontitis in particular, are inflammatory diseases 
which lead to the destruction of the tooth supporting 
tissues (Manson and Lehner, 1974; Saxen, 1980) . The 
effects of dental plaque or dental plaque extracts on
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mammalian cells have been studied in vitro. For 
example Smalley and Birss (1986) showed that 
P.gingivalis strain W50 possess a surface membrane 
vesicles when examined by electron microscopy, and 
these vesicles were cytotoxic to human gingival 
fibroblasts, the authors concluded that such activity 
may contribute to the pathogenicity of P.gingivalis. 
Gingival fibroblasts maintain connective tissues in 
the periodontium, and may be affected positively or 
negatively by interacting both with inflammatory cells 
and their products and also directly with bacterial 
products (Larjava et al., 1987).
The inhibition of fibroblast proliferation by 
Atactinomygetemgomitang, Capnocytophaga and
H.aphrophilus
The ability of A.actinomycetemcomitans to inhibit the 
proliferation of fibroblasts has been examined in a 
number of studies. Shenker, Kushner and Tsai (1982) 
examined sonic extracts of A.actinomycetemcomitans 
strain Y4 for their ability to interfere with the 
proliferation of human and murine fibroblast cell 
lines. The extracts inhibited the proliferation of 
both cell lines, and it was suggested that this
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activity of A.actinomycetemcomitans may be an 
important pathogenicity factor of the organism. 
Clearly inhibition of fibroblast proliferation could 
extend and depress healing and contribute to the loss 
of supportive collagen fibres associated with certain 
forms of periodontal disease, especially juvenile 
periodontitis. The ability of capsular material and 
lipopolysaccharides isolated from A.actinomycetemcomi­
tans strains to inhibit the proliferation of human 
gingival fibroblasts was examined by Kamin et al., 
(1986). They reported that capsular material inhibited 
the proliferation of human gingival fibroblasts by 
inhibiting the synthesis of DNA and collagen. They 
also reported that lipopolysaccharide from the same 
bacterium caused only modest inhibition of DNA 
synthesis and it had no effect on collagen synthesis. 
Furthermore, Kamin et al., (1986) reported that this
inhibitory activity was not accompanied by cell death 
as there was no lactate dehydrogenase release by 
fibroblasts. Lipopolysaccharides from A.actinomycetem­
comitans has been examined for its ability to 
interfere with cultured fibroblasts and compared with 
lipopolysaccharides prepared from several other 
bacterial species including Salmonella enteritidis and
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Bacteroides (Porphyromonas) gingivalis. (Bartold and 
Millar, 1988) . The lipopolysaccharide preparations 
inhibited the proliferation of human gingival 
fibroblasts, with the lipopolysaccharide from 
A.actinomycetemcomitans proving more potent than 
others. Based on these results Bartold and Miller 
(1988) concluded that the potential virulence of a 
periodontopathogen may vary as a result of the 
variation in the potency of lipopolysaccharides 
preparation and because of the ability of 
lipopolysaccharides.
The ability of A.actinomycetemcomitans to interfere 
with fibroblasts was further tested by Stevens and 
Hammond (1988), who examined the cytotoxicity of sonic 
extracts from A.actinomycetemcomitans and other oral 
bacteria for human gingival fibroblasts. They used 
three different criteria for the assessment of 
cytotoxicity including direct counts, inhibition of 
DNA synthesis and microscopical examination for 
morphological effects. A.actinomycetemcomitans and
F. nucleatum were shown to be the most potent of all 
tested bacteria by all three criteria. Helegeland and 
Nordby (1993) reported the isolation of a toxin from 
the culture medium of A.actinomycetemcomitans and
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showed that the toxin inhibited the proliferation of 
human gingival fibroblasts.
A few studies have investigated the ability of 
Capnocytophaga species to inhibit the proliferation of 
fibroblasts and a fibroblast inhibitory factor has 
been reported (Sasaki, 1979; Stevens and Hammond, 
1982) . In the study reported by Stevens and Hammond 
(1988) sonic extracts from C.sputigena inhibited the 
proliferation of human gingival fibroblasts, although 
the inhibitory activity of C.sputigena was less than 
that expressed by A.actinomycetemcomitans.
The ability of H.aphrophilus strains to inhibit the 
proliferation of fibroblasts, has not previously been 
investigated.
It is evident from the reviewed literature that 
fibroblasts play a fundamental role in maintaining the 
health of the periodontal tissues. The ability of 
periodontopathogenic organisms to interfere with this 
function could indeed contribute to periodontitis with 
A.actinomycetemcomitans being most active followed by 
Capnocytophaga species.
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1.14.6 Collagenolytic activity of
A.actinomycetemcomitans H.aphrophilus and
Capnocytophaga species
As indicated in previous sections a number of 
periodontopathogens have been shown to produce 
collagenase that will cause damage to connective 
tissue by disrupting collagen. Localized juvenile 
periodontitis is characterised by extensive loss of 
collagen from the gingival connective tissue, a 
feature which distinguishes this form of periodontal 
disease from other types (Zambon, 1985) . Several 
studies have demonstrated that the level of 
degradation of extracellular connective tissue which 
occurs in localized juvenile periodontitis is greater 
than that which occurs in adult periodontitis (Gillet 
and Johnson, 1982; Liljenberg and Lindhe, 1980). 
Certain strains of A.actinomycetemcomitans have been 
shown to produce collagenase (Roertson et al., 1982;
Rozanis and Slots, 1982; Rozanis et al., 1983), and
this activity combined with collagenase released from 
neutrophils lysed by leukotoxin may be involved in 
tissue destruction (Zambon, 1985). Furthermore, 
certain A.actinomycetemcomitans strains produce a 
fibroblast inhibitory factor (Shenker, Kushner and
Tsai, 1982; Steven and Hammond, 1982) which results in 
a loss in collagen production. Thus in combination 
with production of collagenase these two factors can 
destroy subgingival connective tissue and affect the 
production of new collagen (Stevens and Hammond, 
1982) .
There is little information available regarding 
collagenase production by H.aphrophilus and 
Capnocytophaga species.
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1.14.7 Miscellaneous virulence factors produced by 
A.actinomycetemcomitans strains and or Capnocytophaga 
species
This section will include a brief presentation of 
various additional factors produced by the group of 
organisms under study, since they may contribute to 
the pathogenesis of periodontitis.
Birkedal-Hansen et al. , (1982) reported that
A.actinomycetemcomitans strains produce an inhibitory 
factor against epithelial cells (epitheliotoxin), and 
Kamen, (1983) described a heat-labile sonic extract 
prepared from a non-leukotoxic A.actinomycetemcomitans 
isolate that inhibited the proliferation of cultured 
keratinocytes in a dose-dependent pattern as measured 
by direct observation of cultures (cell counts) and by 
incorporation of 3H-thymidine. If these effects 
occurred in vivo such depression of epithelial cell 
proliferation could produce a profound effect on the 
integrity and healing of periodontal tissues. 
Capnocytophaga species has been shown to produce a 
similar factor (Kamen, 1982). Taichman et al., (1984 
A) tested soluble extracts of A.actinomycetemcomitans 
and Capnocytophaga for their ability to alter the 
proliferation of cultured endothelial cells. They
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reported that all A.actinomycetemcomitans strains 
tested produced a dose- dependent and heat-labile 
factor that inhibited DNA and RNA synthesis in human 
and bovine endothelial cells. This inhibitory factor 
was not leukotoxin since it was produced by both 
leukotoxic and non-leukotoxic strains. They also 
reported that sera from patients with juvenile 
periodontal disease neutralized this inhibitory 
factor. They concluded that the alteration of the 
endothelial cells which include a decreased 
endothelial cells proliferation as evident by the 
presence of a fewer labelled nuclei compared to 
control cells and also there was no increase in total 
cell numbers though cell viability was unaltered, may 
be of pathologic significance to the development of 
periodontal disease (Taichman et al. , 1984A) . It is
interesting to note that Capnocytophaga sputigena was 
reported as stimulating the proliferation of
endothelial cells (Taichman et al., 1984A).
Both A.actinomycetemcomitans and Capnocytophaga 
species were among a group of Gram-negative bacteria 
isolated from periodontally diseased sites that 
produced B-cell activating factor which activates the 
B-lymphocytes to produce a poly clonal antibody and
91
the release of osteolytic factors. These responses 
would lead to increased inflammation in the disease 
site, activation of bone resorption and loss of 
periodontal support for the teeth (Bick et al., 1981). 
A.actinomycetemcomitans has been shown to possess 
lipopolysaccharide and capsular material that induce a 
bone resorption in vitro (Kiley and Holt, 1980; 
Nishihara et al., 1989). Wilson, Kamin and Harvey,
(1985) also reported that purified capsular material 
isolated from A.actinomycetemcomitans was a potent
bone resorption mediator. Ishihara et al., (1991) 
reported that lipopolysaccharide isolated from
A.actinomycetemcomitans strain Y4 induced bone
resorption in a BALB/c mouse calvarial system, and 
they further added that this activity may be mediated 
by interleukin-1 and prostaglandin. Meghji et al., 
(1994) reported that a saline extracted surface 
associated material from A.actinomycetemcomitans 
induced a bone resorbing activity. Lipopolysaccharide 
of Capnocytophaga species has also been shown to 
induce bone resorption activity (Sasaki, 1979;
Stevens et al., 1980).
Tolo and Helgeland, (1991) reported that 
A.actinomycetemcomitans (strain ATCC 33384) can
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produce and release components capable of binding to 
the Fc part of the immunoglobulin G (IgG) , and that 
the activity was present in whole bacteria, capsular 
material and medium from broth cultures. The authors 
concluded that the Fc-binding components may 
contribute to the pathogenesis of periodontitis, since 
they interfere with the phagocytic activity of the 
granulocytes and with complement. Furthermore, it has 
been shown that A.actinomycetemcomitans produces 
potent endotoxin which augments the survival of the 
organism which kills macrophages (Kily and Holt, 
1980) . It has also been shown that these bacteria can 
produce factors that interfere with the function of 
human blood lymphocytes since it was shown that the 
function of both B and T-lymphocytes were impaired by 
soluble extracts of this organism and immune 
suppression was observed in vitro, by means of 
soluble heat-labile factor (Shenker, McArture and 
Tsai, 1982; Shenker, Tsai and Taichman, 1982). 
A.actinomycetemcomitans strains were shown to produce 
alkaline and acid phosphatase, which can induce bone 
resorption and thus cause damage to the periodontal 
tissue (Slots, 1981). A.actinomycetemcomitans strains 
have been shown to produce a catalase capable of
degrading hydrogen peroxide from the host immune cells 
and therefore, provides protection against oxidative 
bacterial killing (Slots, 1982A).
Capnocytophaga species were shown to possess a high 
aminopeptidase activity as tested by API ZYM AP system 
(Nakamura and Slots, 1982). This activity may 
contribute to collagen breakdown following initial 
splitting of collagen by host or bacterial 
collagenase, and it may also be important for the 
survival of Capnocytophaga species in dental plaque as 
the ability of this bacterium to degrade numerous 
peptides may provide essential energy and cellular 
constituents for continued growth. Such activity may 
play a role in the pathogenesis of periodontitis 
(Nakamura and Slots, 1982).
In the above Sections a number of factors that may 
contribute to the pathogenic potential of the group of 
bacteria under study, were presented. Although both 
A.actinomycetemcomitans and Capnocytophaga species 
have been shown to possess a number of possible 
virulence factors, A.actinomycetemcomitans has been 
studied more extensively than the other two organisms. 
There is substantial evidence to support a role for 
A.actinomycetemcomitans in periodontal disease
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especially the localized form of juvenile 
periodontitis. However, the evidence supporting the 
role of Capnocytophaga species in periodontitis is far 
from complete and it is clear that more studies are 
needed. In contrast there is very little information 
about the possible virulence of H .aphrophilus. in 
periodontal disease, even although it has been 
implicated in other systemic infections (for example 
endocarditis and brain abscess).
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1.15 Aims of this study
As outlined in the review of literature the search for 
aetiologic agents of periodontal disease is complex 
and far from certain. A number of suspected 
periodontal pathogens have been implicated in the 
aetiology of different forms of periodontal disease 
based on defined criteria which include association, 
elimination, induction of immune response, causing 
disease in experimental animals and producing 
virulence factors. Based on evidence obtained by using 
the described criteria, A.actinomycetmcomitans has 
been strongly associated with the juvenile form of 
periodontal disease. Although other Gram-negative 
capnophilic organisms like Capnocytophaga species were 
implicated in the aetiology of periodontal disease in 
some early studies, the evidence supporting this is 
far from complete and additional studies are needed. 
The possible role of H .aphrophilus. another Gram- 
negative capnophilic rod which is frequently isolated 
from the dental plaque is not clear since only a few 
studies have addressed this question. Therefore, this 
study was undertaken to examine a number of Type and 
wild oral isolates of A.actinomycetemcomitans. 
Hi-aphrophilus and Capnocytophaga species for their
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possible role in periodontitis. The virulence factors 
that were studied consisted of leukotoxin production, 
fibroblast inhibitory activity and the production of 
IgA-protease. The ability of the test bacteria to 
cause haemagglutination of human erythrocytes was also 
examined since colonization and adherence to oral 
surfaces is probably an important step for 
colonization and survival in the subgingival area. The 
ability of the test bacteria to trigger a 
chemiluminescence response from human PMNLs was also 
tested.
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Chapter 2 
Material and Methods
2.1 Isolation of Haemophilus aphrophilus.
Actinobacillus actinomycetemcomitans and Capnocytophaga 
species from subgingival plaque samples
Subgingival plaque samples were collected from groups 
of patients with different forms of periodontal 
disease. These included a group of a 23 patients 
diagnosed with chronic periodontitis and a group of 14 
patients with pockets which persisted following hygiene 
phase therapy. However, the clinical diagnosis of the 
latter group was unknown. Nine patients with juvenile 
and rapidly progressive periodontitis and a group of 3 
patients with unknown clinical diagnosis completed a 
the total of 49 patients used for this study. 
Subgingival plaque was removed from multiple sites and 
placed in 1 ml of Anaerobic Blood Broth (ABB) , or 
Fastidious Anaerobic Broth (FAB), and transferred to 
the laboratory immediately after collection. Samples 
were dispersed by vortex mixing for 60 seconds, then 
serially diluted in FAB, and finally 50jil of each 
dilution were inoculated onto the following media: 
Colombia blood agar plates (CBA), Tryptic Soy Serum 
Bacitracin Vancomycin agar (TSBV), a selective medium 
for A.actinomycetemcomitans (Slots, 1982) and Tryptic
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Soy Serum Bacitracin Vancomycin Fluoride agar (TSBVF), 
the selective medium for H .aphrophilus, (Tempro and 
Slots, 1986). Inoculation was performed using a spiral 
plater (Don Whitley, Shipley, England)(Figure 2.1). 
Neat and 10’1 dilutions of plaque were inoculated onto 
TSBV and TSBVF plates and 10 ’2 and 10 "3 dilutions were 
inoculated onto CBA plates. All plates were incubated 
at 37°C in 5% C02 in air, for 3 days. Counts were made 
by using the grid supplied by the manufacturer (Don 
Whitley, Shipley, England) which is divided into 
sections of different sizes in which known volumes of 
the sample were spread. The number of colony forming 
units/ml was then calculated. After incubation, plates 
were processed as follows: CBA plates were used for the 
isolation of Capnocytophaga species. All suspected 
Capnocytophaga colonies (ie large, flat, spreading, 
grey, yellow or pink) were transferred to fresh CBA for 
purity and further identification. TSBV and TSBVF 
plates were used as semi-selective media for the 
isolation of A.actinomycetemcomitans and H.aphrophilus 
respectively. However, colonies of both species on both 
media were very similar and therefore, suspected 
colonies (ie those which were small, convex, entire, 
cream in colour with irregular edges, and sometimes
Figure 2.1 Spiral plater used for inoculating agar 
plates
(• 
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with star-shaped inclusion) were transferred to fresh 
CBA plates for purity before identification.
2.2 Identification of isolated organisms
2.2.1 Identification of A. actinomycetemcomitans and 
H .aphrophilus
After incubation (3days), plates were checked for 
purity and all plates that contained a pure growth were 
used for identification. From pure cultures smears 
were prepared and stained by Gram's stain. Cultures 
that consisted of Gram-negative short rods or 
coccobacilli were tested for catalase production. The 
catalase test was carried out by emulsifying a few 
colonies of test bacteria grown on CBA for 18-24 hours 
in coloured catalase reagent (Bio Merieux, Marcy- 
l'Etoile, France) on a clean glass slide with a 
platinum loop. Positive strains broke down hydrogen 
peroxide and bubbles of oxygen were released within a 
few seconds. All A.actinomycetemcomitans strains are 
known to be catalase positive, while all H .aphrophilus 
strains are catalase negative. This test was, 
therefore, one of the tests used to differentiate 
between these two closely related organisms. However, 
some exceptions were reported in the literature and
they will be discussed in the discussion section of 
this study. Cultures were then retained and identified 
biochemically by using the API 20A system.
API 20 A system
The API 20A system (Bio Merieux, Marcy-1'Etoile, 
France) comprises a strip of 20 different
biochemical tests, that differentiate between 
microorganisms by their abilities to utilize certain 
carbohydrates and produce certain enzymes (Figure 2.2). 
API 20 A identification strips were inoculated as 
recommended by the manufacturer. Briefly, the test 
organism was suspended in sterile broth (API Lab, 
France), to give an initial turbidity of McFarland
opacity scale 3. All microtubes were then filled
carefully with the suspension from a Pasteur pipette
and the strips incubated for 24 to 48 hours at 3 7°C in 
5% C02 in air. The results were then read and
identification made after comparing the biochemical
profile of the test strain to those of well
characterized reference strains. These included
H.aphrophilus NCTC 5886, A.actinomycetemcomitans NCTC 
9710 and A.actinomycetemcomitans Y4.
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Figure 2.2 API 20A strip used for the biochemical 
identification of both A.actinomycetemcomitans and 
H .aphrophilus strains (uninoculated strip).
2.2.2 Identification of Capnocytophaga species
After incubation, plates were checked for purity and 
used for identification. The morphological 
characteristics of Capnocytophaga species are distinct 
and make the preliminary identification possible. 
Smears were prepared from pure growth and stained by 
Gram's stain. All Gram-negative long fusiform rods were 
retained and identified as Capnocytophaga species. A 
biochemical characterization was attempted using the 
Minitek Anaerobe Identification System (Becton 
Dickinson, Cowley, England). The identification to a 
species level was not possible using the Minitek 
system, as it was not possible to reproduce the results 
with all isolates, with the exception of the C.ochracea 
strains which can be identified using the Minitek 
system. Therefore, it was decided not use the system 
and alternatively all colonies with the morphological 
characteristics outlined in section 2.1 were identified 
as Capnocytophaga and the term Capnocytophaga species 
was used in this thesis.
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2.3 Storage of microorganisms
After isolation and identification, bacterial isolates 
were stored on Protect beads (Lab M, Topley House, 
Bury, England). Bacterial suspensions were prepared by 
harvesting the growth on CBA plates with a sterile 
cotton wool swab and suspending the organisms in a vial 
of Protect beads in a cryopreservative fluid 
suspension. The vials were mixed by inverting them 
several times as recommended by the supplier and excess 
liquid was removed with a sterile Pasteur pipette. Each 
isolate was given a number and storage vials were 
numbered accordingly. They were stored in triplicate at 
-70°C in a freezer.
2.4 Retrieval of bacteria
Whenever a fresh culture was required, the relevant 
vial was removed from the freezer, one or two beads 
removed aseptically and inoculated onto fresh CBA 
plates by rolling the beads gently over the plate 
surface. The plates were incubated at 37 °C in 5% C02 
in air for 24 to 48 hours. The identity of each 
organism was confirmed by morphological and biochemical 
examination and subcultured onto fresh CBA plates 
before use.
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2.5 Sensitivity to antibacterial agents (antibiotics)
Isolates of H.aphrophilus. A.actinomycetemcomitans and 
Capnocytophaga species were tested for their 
sensitivity to selected antibiotics by Stokes method 
(Stokes and Waterman, 1972). Microorganisms were grown 
on CBA plates for 48 hours at 3 7°C in 5% C02 in air. A 
loopful of each organism was spread across the middle 
of a CBA plate as a broad band (Figure 2.3) . 
Staphylococcus aureus (Oxford reference strain NCTC 
6571) was used as a control (Figure 2.3). A suspension 
of S.aureus was prepared in peptone water (Oxoid 
Unipath Ltd, Basingstoke, Hampshire, England)by 
suspending five colonies of a 24 hour CBA culture in 3 
ml peptone water then vortex mixing for 10 seconds. A 
sterile cotton swab was used to inoculate the control 
suspension on either side of the test inoculum without 
touching it (Figure 2.3). Antibiotic discs (Table 2.1) 
(Mast Lab, Merseyside, England) were placed, using a 
sterile needle, on the plates on the space between the 
reference strain and test bacteria. All plates were 
incubated at 37°C in 5% C02 in air for 48 hours. After 
incubation, results were recorded either as 
(i) sensitive, where the zone of inhibition was equal
to, greater or not more than 3 mm smaller than the 
control zone, (ii) moderately sensitive where the zone 
of inhibition was more than 3mm but smaller than the 
control by more than 3mm or (iii) resistant if the zone 
of inhibition was less than 3mm. Zones of inhibition 
were measured from the edge of the disc to the edge of 
the zone. Tests were performed in duplicate on a single 
occasion.
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Table 2.1 LIST OF ANTIBIOTICS USED
ANTIBIOTIC CONCENTRATION ABBREVIATION
TETRACYCLINE lOjig T
ERYTHROMYCIN 10ng E
PENICILLIN 1UNIT PG
AMPICILLIN 10|Llg AP
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Figure 2.3 Diagrammatic illustration of 
antimicrobial sensitivity plate using Stokes method
an
2.6 Haemagglutination of human group A and group 0 
erythrocytes by capnophilic bacteria
2.6.1 Bacteria employed
The microorganisms used in this study included both 
National Type Cultures and fresh isolates from 
subgingival plaque samples taken from patients with 
periodontal disease who attended Glasgow Dental 
Hospital and School for treatment (Tables 3.1, 3.2,
3.3). Stock cultures at -70°C were revived by transfer 
to CBA and incubated for 24 hours, at 37°C in 5% C02 in 
air, followed by subculture onto fresh CBA and 
incubation for a further 18-24 hours.
E .coli (NCTC 10418) was used as a positive control in 
the assay and was grown on CBA for 24 hours at 37°C 
under aerobic conditions. Bacterial suspensions were 
prepared according to a method described by Majeed and 
Macrae (1994). Briefly, the growth from a CBA plate was 
harvested on a sterile cotton wool swab and suspended 
in 0.6 ml of PBS pH7.2 and vortexed for 10 seconds. 
Viable counts of these suspensions were determined 
using a spiral plater as described in Section 2.1. The 
bacterial concentration of suspensions prepared in this 
way was determined in preliminary experiments by viable 
culture technique, and regularly a figure of about
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5xl010 organisms/ml was recorded. Subsequently viable 
counts were performed and suspensions with lower counts 
were not considered for the experiments.
2.6.2 Erythrocyte preparation
Human group A and group 0 erythrocytes were supplied by 
the West of Scotland Blood Transfusion Service in 
Alsever solution (sodium chloride 0.42%, trisodium 
citrate (dihydrate) 0.8%, and glucose 2.05%). For use 
in the assays, erythrocytes were diluted 1:10 in PBS pH
7.2 and washed 3 times by centrifugation at 500 g for 
10 minutes. The red cells were resuspended in PBS pH
7.2 to a final concentration of 1% (v/v) before use in
the assay.
2.6.3 Haemagglutination assay
The haemagglutination assay was performed as described 
by Parry and Porter (1978) with slight modification. 
One hundred microlitres of each bacterial suspension 
were added to the wells of the first row of a 96-well 
microtitre plate (Nunc, Intermed, Denmark). Doubling 
dilutions of bacteria in PBS were made by transferring 
50 jllI of each suspension from the first row to 50 |Lil of 
PBS previously added to the wells in the second row;
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after mixing, 50 |il were transferred and added to wells 
in a third row. The previous step was repeated until 
all rows were completed, giving a dilution range from 
neat to 1 : 128. Group A or group 0 red blood cells
(5Opil) were added to all wells. The plate was shaken 
gently to mix the contents, and then incubated
statically at room temperature for 2 hours. The test 
results were compared with the positive and negative 
controls and the highest dilution giving complete 
haemagglutination was recorded as the titre. A negative 
control consisting of 50|il PBS + 50^ il of either group 
A or group O erythrocytes was included in every plate. 
The positive control consisted of E .coli NCTC 10418. 
Three different carbohydrates were tested for their
ability to inhibit the haemagglutination of human red 
blood cells by the tested microorganisms. Stock
solutions (10% w/v) of fucose, galactose and mannose 
all supplied by (Sigma Chemical Company, Fancy Road, 
Poole, Dorset, England) were prepared in sterile 
distilled water and stored at 4°C until needed. 
Working solutions of 1% of the carbohydrates in PBS 
were prepared immediately prior to the experiments. The 
effect of these sugars was tested by including the 
sugar solution in the assay mixture as a diluent
instead of PBS as described above. Once again 
Escherichia coli NCTC 10418 strain was included in the 
assay as a positive control, together with a PBS 
negative control.
2.7 Detection of leukotoxic activity in strains of 
A.actinomycetemcomitans. H.aphrophilus and Capnocytophaga 
species
2.7.1 Bacterial strains and growth conditions
Test strains of A.actinomycetemcomitans. H.aphrophilus 
and Capnocytophaga species are listed in Tables 3.1, 3.2, 
3.3, and include Type strains together with fresh 
isolates from subgingival plaque samples taken from 
patients with periodontal disease who attended Glasgow 
Dental Hospital and School for treatment. Stock cultures 
were revived from Protect beads stored at -70°C by 
inoculation onto CBA for 24-48 hours at 37°C in 5% C02 in 
air. The growth from two blood agar plates was removed 
with sterile cotton wool swabs and transferred to 2 0 ml 
of tryptic soy broth(Gibco BRL Life Technologies Ltd, 
Paisley, Scotland). Cultures were incubated for 18 hours 
at 3 7°C in 5% C02 in air, then the cells harvested by 
centrifugation at 1500g for 10 minutes at room
temperature (MSE centrifuge, Crawley, Sussex, England). 
The cells were washed twice in 10ml ice cold PBS pH 7.2 
and resuspended in PBS to give a concentration of about 
2xl09 organisms/ml. The concentration of bacterial cells 
in the suspensions was determined by viable counts (see 
Section 2.1) in pilot experiments performed to 
standardize the assay conditions. The number of viable 
bacteria present in all the suspensions tested was 
routinely performed and if values were found subsequently 
to be less than 2xl09 organism/ml, the experimental 
results obtained were excluded. Each cell suspension was 
then divided into 1.5ml aliquots; one labelled as whole 
cells and used in the trypan blue exclusion assay and the 
other disrupted with an ultrasonic probe (Heat System 
Inc, New York, USA) (Figure 2.4), at 20% power output for 
2 minutes on ice. Particulate material was pelleted by 
centrifugation in Eppendorf tubes in a microcentrifuge 
(MSE Microcentaur, Crawley, Sussex, England) at 8000 g 
for 5 minutes. The supernatant was transferred to a clean 
Eppendorf tube and stored on ice for about 30-45 minutes 
prior to use in a chemiluminescence assay (Section 
2.7.6) .
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Figure 2.4 Heat systems ultrasonic probe
2.7.2 Isolation of human polymorphonuclear leukocytes 
(PMNLS)
Human peripheral blood PMNLS were isolated from heparinized 
venous blood from 3 normal adult donors, by means of 
density gradient centrifugation using Histopaque (Sigma 
Diagnostics, Fancy Road, Poole, Dorset, England). Equal 
parts (3ml each) of Histopaque solutions 1119 and 1077 were 
layered on top of each other and an equal volume of whole 
blood (6ml) was layered on top of this gradient. All tubes 
were centrifuged at 700 g for 30 minutes at room 
temperature. Granulocytes formed at the lower opaque layer 
on top of the sedimented erythrocytes (Figure 2.5). 
Material on top of the granulocyte layer was removed 
carefully and the granulocytes then aspirated with a 
pasteur pipette to avoid disturbing the sedimented 
erythrocytes. After resuspension in PBS and washing twice 
by centrifugation at 300 g for 10 minutes at room 
temperature, the cells were finally resuspended in 0.5 ml 
PBS. The number of cells was counted as follows in a 
haemocytometer chamber: the glass chamber (The Improved
Neubauer) was cleaned and a clean cover slip pressed down 
over the grooves (counting area). Pelleted cells were 
suspended in 1 0 0 - 2 0 0 jli1 volume, mixed well and then, 20^ il-
Centrifuge 
700 Xg 
3 0minutes
Granulocytes 
(PMNL's)
Histopaque 1077 
Histopaque 1119
Plasma
Mononuclear 
:11s
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Figure 2.5 Diagramatic illustration of the 
separation of human PMNLs by using Histopaque 
gradient
50(J,1 of cells were transferred to the haemocytometer 
chamber. The haemocytometer was placed on the stage of a 
microscope (Olympus Optical Co, Japan) and examined at 400 
times magnification. The haemocytometer consists of grid 
with a side of 1.0mm divided into 400 squares of 0.0025mm2 
each. The number of cells lying within a 1mm2 area (large 
square bounded by three parallel lines) was counted. The 
number of cells per ml of neat sample was calculated by 
using the following formula:
Cells/ml= Number of cells counted x 104.
Some samples were very concentrated and, therefore, they 
were diluted with PBS before counting and thus, the formula 
used was:
Cells/ml= Number of cells counted x Dilution factor xlO4 
Finally the cells were diluted to 2xl05 -2xl06 cells/ml.
2.7.3 Preparation of HL60 cells
The HL60 cells are human myeloid cells that were 
established by Collins, Gallo, and Gallagher (1977) and 
derived from the peripheral blood leukocytes of a patient 
with acute promyelocytic leukaemia. HL6 0 cells express 
surface markers and components which are associated with
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mature granulocytes (Gallagher et al., 1979). The HL60
cells used in this study were obtained from the European 
Collection of Animal Cell Cultures (ECACC) held at the PHLS 
Centre for Applied Microbiology and Research, Porton, 
Salisbury, Wilts, England. The cells were received as a 
suspension in RPMI 164 0 medium supplemented with 10% foetal 
calf serum. Cells were handled as recommended by the 
supplier. Briefly, cells were checked microscopically and 
then incubated overnight at 3 7°C in 5% C02 in air (C02
incubator). After incubation, cells were passaged 
aseptically in a tissue culture cabinet(M.D.H Ltd, Andover, 
Hants, England) by decanting cells into a sterile plastic 
universal container. Cells were pelleted by centrifugation 
at 70 g (MSE Centaur 2 Centrifuge, Crawley, Sussex, 
England), then suspended in l-2ml of freshly prepared RPMI 
1640 growth medium supplemented with 10% foetal calf serum 
(Gibco Life Technologies Ltd, Paisley, Scotland). Cells 
were counted using a haemocytometer as described in Section
2.7.2 and suspended in freshly prepared RPMI 1640 medium at 
l-3xl05 cells/ml. Cells were passaged every 4-5 days. 
Alternatively and when the cells were not required they 
were passaged weekly by decanting most of the medium
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aseptically, leaving the cells suspended in 5-10 ml which 
were then diluted with fresh growth medium and reincubated.
For leucotoxicity assays, HL60 cells were harvested after
4-5 days growth by centrifugation (70 g, for 6 minutes) , 
then washed twice in PBS. Finally, cells were resuspended 
in 0.5 ml PBS, counted in a haemocy tome ter as described in 
Section 2.7.2, and diluted to 5xl06 to lxlO7 /ml. The
viability of cells was determined before they were used in 
the assays by the exclusion of trypan blue. This was
performed by diluting the cells (1:1) with 0.4% trypan 
blue. Dead cells were stained with the trypan blue dye
while live cells excluded the dye. Both viable and dead
cells were easily distinguishable when examined by light
microscopy (Olympus Optical Company, Japan) by using the 
X40 objective. One hundred cells were counted as described 
in Section 2.7.5, in duplicate and the percentage viability 
was calculated using the following formula:
Total cells counted - Dead cells
% Viability = --------------------------------  xlOO
Total cells counted
Cell suspension with viability greater than 80% were used.
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2.7.4 Trypan blue exclusion assay
Trypan blue exclusion was used to detect the leukotoxic 
activity of A.actinomycetemcomitans strains by Brogan et 
al. , (1994). Zambon et al. , (1983) used the promyelocytic
HL60 cell line as targets for the A. actinomycetemcomitans 
leukotoxin. In this study the trypan blue exclusion assay 
was used for the detection of the leukotoxic activity of 
A.actinomycetemcomitans. H .aphrophilus and Capnocytophaga 
species, and HL60 cells were used as targets. HL60 cells 
were prepared for the assay as described in Section 2.7.3. 
Bacterial strains were prepared as described in Section
2.7.1. Two hundred microlitres of each test strain (whole 
cells) were pipetted into a sterile plastic bijou bottle, 
to which 200 i^l of HL60 cells were added. The ratio of 
bacterial cells to target cells was upto 400 bacterial 
cells/target cell. The contents of each bottle were mixed, 
giving a total volume of 400 fil. A negative control ( 200|il 
of HL60 cells + 200 |iil PBS) and a positive control (200 |iil 
HL60 cells + 200 (il of 0.1% Triton X100) were included in 
every assay (see Table 2.2) . The bottles were incubated in 
a shaking water bath at 37°C (Heto Birkod, Denmark) for one 
hour, after which they were placed on ice for 5 minutes, 
before counting.
2.7.5 Counting of HL60 cells
After storage for 5 minutes, 100 fil of each mixture were 
removed and added to an Eppendorf tube containing 100 |il 
of 0.4% (w/v) trypan blue which was prepared in PBS. After
hand mixing several times, 50|il from each tube was placed 
on a clean glass microscope slide and a cover slip 
applied. Counts were made by light microscopy at a 
magnification of 400x (Olympus Optical Company, Japan). The 
microscope stage was moved with a staggered motion, to 
avoid counting the same cells more than once. A minimum of 
100 cells were counted. Cells were counted only if they 
appeared morphologically typical of healthy HL60 control 
cells. Each strain was tested in duplicate and on two 
separate occasions. The final results were expressed as the 
average percentage death of HL60 cells, which was 
calculated using the following formula:
Total dead cells - Negative control
%HL60 death =   xlOO
Total cells counted
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2.7.6 Chemiluminescence assay
A luminol-dependent chemiluminescence assay described for 
the detection of leukotoxin produced by Pasteurella 
haemolytica (Chang et al., 1986), was used to detect the 
leukotoxic activity of A.actinomycetemcomitans.
H .aphrophilus and Capnocytophaga strains, with a slight 
modification.
In this assay the leukotoxic activity was measured as the 
percentage reduction of chemiluminescence emission
by phorbol myristate acetate (PMA)-stimulated human PMNLs. 
It was necessary to perform a series of preliminary 
investigations in order to optimize the experimental
conditions. The assay finally employed was as follows. The 
reaction mixtures had a final volume of 1.0ml and the 
constituents of the test, PMA control and blank tubes are 
shown in Table 2.3. Luminol (5-amino-2,3dihydro-1,4- 
phthlazindione) (BDH Laboratory Supplies, Poole, England) 
was prepared by dissolving 1.77mg in 1ml dimethyl
sulphoxide (DMSO) (BDH Laboratories Supplies, Poole,
England) , to give a concentration of 10"2 M. This stock 
solution was further diluted to give a working
concentration of 10’4 M. Phorbol 12-myristate-13-acetate 
(PMA) (Sigma Chemical Company, Fancy Road, Poole, Dorset,
England) was prepared by dissolving 2mg PMA in 1 ml of 
DMSO. This stock solution was diluted further to a working 
strength solution by adding 50|il to 10ml of PBS. 
Leukocytes were used at concentrations sufficient to 
produce high measurable chemiluminescence after 
stimulation, and this was normally between 2xl05 to 2xl06 
cells/ml. Leukocytes at the appropriate concentrations were 
mixed with PBS, luminol and test microorganisms (at about 
2xl09 organism/ml) in cuvettes. All cuvettes were incubated 
at 37°C for a period of 40 minutes, after which the PMA 
stimulus was added to all cuvettes, except the blanks. The 
responses were recorded before and after the addition of 
PMA in an LKB Wallac Luminometer connected to an IBM PC 
computer. The assay results were printed out in a graphical 
and tabulated form, and chemiluminescence emission was 
measured in millivolts (mv) . Each sample was measured in 
duplicate and on two separate occasions.
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2.8 Phagocytosis of A .actinomycetemcomitans.
H .aphrophilus and Capnocytophaga strains by human PMNLs
2.8.1 Bacterial strains and growth conditions
Leukotoxic and non-leukotoxic Type and freshly isolated 
strains of A.actinomyctemcomitans, H.aphrophilus and
Capnocytophaga species were selected for use in this part 
of the study (Table 2.4). Bacterial suspensions were 
prepared as described in Section 2.7.1, and final 
suspensions were diluted to an absorbance of 1.0 at 550nm.
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Table 2.2 Trypan blue assay-tube contents
TEST NEGATIVE
CONTROL
POSITIVE
CONTROL
HL60(5x 10° - 1 
x 107 /ml)
200(ll 200|il 200JU1
Organisms(2x109 
- 2xl010 /ml)
200(ll 0 . 00JLL1 0 . 00|Lll
Triton X100 
(0.1%)
0 . OOfil 0 . OOfll 200|Xl
PBS 0 . OOjLll 200)111 0 . 00|ll
Table 2.3 Chemiluminescence assay-tube
contents
BLANK PMA CONTROL TEST
Luminol (10~4 M 
in DMSO)
200|ll 200(11 200(11
PMA (lOmg /ml) 0 . 00|ll 200|ll 200|ll
PMNLs (2xl05- 2x 
106 /ml)
100(ll 100|ll 100|ll
Organisms(2x10 
o- 2xl09 /ml)
0.00(ll 0 . 00|ll 100(ll
PBS 700(ll 500(11 400|ll
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2.8.2 Sera for opsonization
Blood was collected from 2 healthy donors, allowed to 
clot at room temperature for 90 minutes and then 
centrifuged at 500 g for 10 minutes. The serum was 
removed carefully and added in 1ml amounts to sterile 
plastic bijou bottles, after which part of the serum 
was heat inactivated for 30 minutes at 56°C using a 
heating module (Reacti-Therm heating module, Pierce and 
Warriner UK Limited, Chester), and other parts remained 
unheated. Tubes were labelled then stored at -2 0°C 
until required.
122
Table 2.4 List of H.aphrophilus. A.actinomvcetemcomitans and 
Capnocytophaga strains used for the phagocytosis experiments
STRAIN SOURCE STRAIN SOURCE
Ha 40 GDH Aa 115 GDH
Ha 44 GDH Aa 120 GDH
Ha 46 GDH Aa E24 GDH
Ha 79 GDH Aa E79 ATCC29523
Ha 80 GDH Aa E80 ATCC29524
Ha 82 GDH Aa E81 Y 4
Ha 83 GDH Aa E83 NCTC9710
Ha 97 GDH Aa E88 JP2
Ha 104 GDH Cap 13 GDH
Ha 5886 NCTC Cap 52 GDH
AalOO GDH Cap 90 NCTC11153
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2.8.3 Opsonization of bacterial suspensions
In order to opsonize the bacteria, 0.9ml of the cell 
suspension was mixed with 0.1ml of human serum. Tubes 
were incubated at 37°C for 3 0 minutes in an incubator, 
placed on ice and then immediately used in experiments. 
To examine whether the opsonization was essential in 
the phagocytosis process, both opsonized and 
unopsonized bacterial suspensions were tested at the 
same time.
2.8.4 Phagocytosis assay
The constituent parts of the phagocytosis assay are 
listed in Table 2.5. Two hundred microlitres of 
opsonized or non-opsonized bacteria and 200(il of human 
polymorphonuclear leukocytes (PMNLs) at lxlO6 cells/ml 
were mixed together in polystyrene cuvettes (Clinicon). 
An equal volume of luminol (200|il) ( 10’4 M in DMSO) was 
then added and the reaction mixtures were made up to 
1000|j,l by adding appropriate volumes of PBS. After 40 
minutes aerobic incubation at 3 7°C, 200p,l PMA (lOmg
/ml) was added.
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The cuvettes, were placed in a LKB Wallac Luminometer, 
at 3 7°C, and the initial chemiluminescence was measured. 
Almost immediately PMA was added to all tubes except 
for the blanks to measure the residual activity of the 
PMNLs. The responses were recorded in an LKB Wallac 
Luminometer connected to an IBM PC computer. Results 
were printed out in a graphical and tabulated form, 
chemiluminescence was measured in millivolts (mv), and 
each sample was measured in duplicate and on two 
separate occasions.
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Table 2.5 Tube contents (phagocytosis study)
BLANK PMA
CONTROL
TEST
LUMINOL 10 "4M 200|ll 200(ll 200(11
PMA 10 mg/ ML 0 . 00|ll 200(ll 200|ll*
Human PMNLs 
1x10 6
200|ll 200(11 200|ll
Opsonized or 
unopsonized OD 
1.0
0 . 00|ll 0 . 00|ll 200(ll
PBS 600|ll 400(ll 200|ll
PMA was added after the initial incubation
period as described in the text.
2.9 The cytotoxicity of A.actinomycetemcomitans. 
H .aphrophilus and Capnocytophaga strains for a human 
skin fibroblast cell line(IBR3)
2.9.1 Human skin fibroblast cell line-IBR3
Cells of the IBR3 human skin fibroblast cell line were 
obtained from the European Collection of Animal Cell 
Cultures (ECACC). Cells were derived originally from a 
skin biopsy from a normal adult male. Cells were 
received as a monolayer in a tissue culture flask with 
Eagle's Minimum Essential Medium with Earl's balanced 
salts (EMEM-EBSS). Cells were handled as recommended by 
the supplier. Briefly, the flask was checked under an 
inverted microscope upon arrival and incubated 
overnight at 37°C in 5% C02 in air (C02 Incubator, Leec 
Ltd, Nottingham, England). After incubation, the medium 
was decanted, and cells were trypsinized by adding 
0.25% trypsin in EDTA (Gibco Life Technologies Ltd, 
Paisley, Scotland). Trypsin was added in volumes 
sufficient to wet the monolayer (1.5-2. 0ml) , and the 
flask was incubated at 37°C in 5% C02 in air, for 5-15 
minutes. When the cells became detached they were 
dispersed by pipetting and placed in a centrifuge tube 
containing about 1ml of foetal calf serum. The tubes
were centrifuged at 90 g for 8 minutes (MSE Minor S 
Centrifuge, Crawley, Sussex, England), the supernatant 
discarded and the pelleted cells resuspended in fresh 
tissue culture medium (EMEM-EBSS)(Gibco Life 
Technologies Ltd, Paisley, Scotland). The medium was 
supplemented with 1% penicillin/ streptomycin mixture 
and 1% non-essential amino acids (Gibco Life 
Technologies Ltd, Paisley, Scotland). Cells were 
counted using a haemocytometer as described in Section
2.7.2, and seeded at about 1. 5x 105 cells/ml. Flasks 
were incubated at 3 7°C in 5% C02 in air (C02 incubator) , 
and were initially passaged every 3-4 days. However, 
when the cells were not required they were passaged 
weekly. Stock cultures were prepared after the second
passage of cells, and stored at -80°C in a freezing
medium containing the cryoprotective agent dimethyl 
sulphoxide (90% growth medium + 10% dimethyl
sulphoxide).
For the cytotoxicity experiments, cells were used
between passages 6 and 18. The growth medium was 
changed every second day, and flasks were checked for 
contamination and deterioration on an almost daily 
basis. Single cell suspensions of trypsinized
fibroblasts were seeded into wells of 96 well flat 
bottomed microtitre plates (Nunc, Intermed, Denmark) at 
a concentration of 5-6 xlO3 cells/lOOjul.
2.9.2 Bacterial strains and growth conditions
The microorganisms used in this part of the study are 
listed in Tables 3.1, 3.2 and 3.3. Stock cultures were
revived from Protect beads stored at -70°C by 
inoculation onto CBA plates. They were subcultured onto 
fresh CBA and incubated at 37°C, in 5% C02 in air for two 
days before use in assays.
2.9.3 Preparation of whole bacterial cells
In preliminary experiments the growth on blood agar 
plates was harvested on sterile cotton wool swabs and 
transferred into 20 ml of tryptic soy broth (Gibco Life 
Technologies Ltd, Paisley, Scotland). Following 
incubation for 18 hours at 37°C in 5% C02 in air, the 
cells were sedimented by centrifugation (1500 g for 10 
minutes) then resuspended and washed twice with PBS. 
Six ml of PBS were added to the pellet to produce the 
final bacterial cell suspension. Viable counts were
determined by serially diluting the bacterial 
suspensions, and plating out with a spiral plater 
(Figure 2.1). Plates were incubated at 37°C in 5% C02 in 
air for 3 days (C02 incubator) . Determination of viable 
counts was undertaken as described in Section 2.1. The 
number of viable bacteria present in all the suspensions 
was routinely performed and if the cell numbers were 
found to be less than 4xl09 to lxlO10 cells/ml, the 
experimental results obtained were excluded.
2.9.4 Preparation of cell free extracts from bacteria
Bacteria were cultured on CBA, as described in Section
2.9.2, and harvested from two CBA plates with sterile 
cotton wool swabs into 2ml of sterile distilled water, 
followed by vortex mixing for 20 seconds. Ballotini 
beads, size 12 (Jencons Scientific Ltd, Leighton 
Buzzard, England) (0.3 g) were placed in glass 
containers and the bacterial suspension added. The 
containers were fitted in a Mickle High Speed Vibratory 
Tissue Disintegrator (The Mickle Laboratory Engineering 
Co Ltd, Surrey, England) (Figure 2.6) for 1 hour, after 
which the containers were centrifuged at 1500 g for 10 
minutes to separate beads and debris. Cleared
Figure 2.6 The Mickle high speed vibratory tissue 
disintegrator
supernatants were filtered through Minisart filters of 
0.2p,m pore diameter (Minisart NML, Sartorius, Sartorius 
AG, Gottingen, Germany). The filtrates were designated 
cell-free extracts and were used in the cytotoxicity 
assays.
2.9.5 The Bioassay
Mosmann (1983) described a rapid colourimetric assay for 
mammalian cell survival and proliferation, using a 
tetrazolium salt. The basis of the same method was used 
to test the cytotoxicity of A.actinomycetemcomitans. 
H.aphrophilus and Capnoctytophaga species on a cultured 
human skin fibroblast cell line (IBR3) . The experimental 
work for this section of the thesis was carried out in 
two parts. The first part was carried out with whole 
viable bacterial cells, and was basically a pilot study. 
The second part contained the main experimental study 
and was performed using bacterial cell-free extracts. 
Plates for the assay were prepared as described in 
Section 2.9.1. The plates were incubated at 37°C in 5% 
C02 in air(C02 incubator) for two days and the medium 
changed daily. After 48 hours, three different volumes 
of whole bacterial cells (50, 100,150|il) were added in
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triplicate and then all volumes were made up to 200p,l by- 
adding appropriate volumes of growth medium. Plates were 
then incubated for 24 hours at 3 7°C in 5% C02 in air. 
After incubation the contents of the plate were decanted 
aseptically and 100|il of fresh growth medium were added 
to all wells, followed by 10(0.1 of freshly prepared 3- 
[4,5-methylthiazol-2-yl]-2,5-diphenyl tetrazolium
bromide (MTT) (Sigma Chemical Company, Fancy Road, 
Dorset, England). MTT was prepared by dissolving powder 
at a concentration of 5mg/ml in PBS and then filtering 
to remove all undissolved materials.
The plates were incubated for a further 4 hours, after 
which their contents were decanted and 100|il of dimethyl 
sulphoxide (DMSO) were added to all wells to solubilize 
any formazan crystals that may have formed. The plates 
were mixed by gentle agitation on an orbital shaker for
5-10 minutes and plates were read as described at the 
end of this section. During the course of these 
experiments using whole bacterial cells, organisms were 
observed microscopically to adhere to the cultured 
fibroblasts.
In the second part of these experiments, cell-free 
extracts were used instead of whole bacterial cells.
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The same procedures were followed as with the whole 
cells except that a washing step using PBS (pH 7.2) was 
introduced after the fibroblasts had been incubated with 
the bacterial extracts for 24 hours. This was performed 
by decanting the plate's contents then washing by adding 
100(J,1 of PBS to all wells and decanting the contents of 
the plates. This step was repeated 3 times. The 
cytotoxicity or interference with fibroblast 
proliferation was expressed as percentage reduction in 
the optical density obtained with control wells 
containing cultured fibroblasts only. The optical 
density of the plates was measured at 570 nm by using a 
Dynatech MR5000. The percentage reduction in the 
metabolic activity of fibroblasts was calculated by 
using the following formula:
Optical density of test 
%inhibition = 100- ------------------------  xlOO
Optical density of control
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2.10 Human Immunoglobulin A (IgA) protease production 
by A.actinomycetemcomitans. H.aphrophilus and 
Capnocytophaga species.
2.10.1 Bacterial strains and culture conditions
The microorganisms tested are listed in Tables 3.1,
3.2, 3.3. They were revived as described in Section
2.4, then cultured on CBA plates for 3 days at 3 7 °C in 
5% C02 in air. H.influenzae (NCTC 12194) was included in 
these experiments as a positive control since it is 
known to produce a protease that specifically cleaves 
human IgAl to Fab and Fc fragments (Kilian et al. , 
1980) . H .influenzae (NCTC 12194) was revived from a 
lyophilized culture by hydration with FAB, then 
inoculation onto chocolate agar plates. The plates were 
incubated at 3 7°C in 5% C02 in air (C02 incubator) for 
48 hours, then subcultured onto fresh media and 
prepared for storage as described in Section 2.3. When 
required H.influenzae was revived as described in 
Section 2.4, except that chocolate agar plates were 
used in place of CBA plates. H.influenzae cultures 
were discarded after they had been subcultured on more 
than 3-4 occasions.
2.10.2 Detection of cleavage of human Immunoglobulin A 
(IgA)
The screening of bacterial IgA protease activity was 
performed according to methods described by Kilian 
(1981) and Cole and Hale (1991) with slight 
modifications. Briefly, human myeloma serum was 
obtained from Dr I. Franklyn of the Glasgow Royal 
Infirmary and used as the substrate in IgA protease 
assays for screening A.actinomycetemcomitans. 
H.aphrophilus and Capnocytophaga. However, commercial 
human secretory IgA (SIgA)(Cappel Organon Teknika 
Corporation, 100 AKZO Avenue, Durham, NC 27704) was 
also used as the substrate when Capnocytophaga isolates 
were tested. Human myeloma serum was diluted 1:300 in 
PBS (pH 7.2) and then two loopfuls of each test 
organism grown on either CBA or chocolate agar 
(H. influenzae) were emulsified in 70|J,1 of diluted serum 
in an Eppendorf tube. All assay tubes were incubated at 
37°C for 48 hours, after which bacteria were sedimented 
by centrifugation. The cleared supernatants were 
separated and stored at -20°C, until further analysis. 
Cleavage products of IgA and SIgA by bacterial 
proteases were detected by using sodium dodecyl
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sulphate polyacrylamide gel electrophoresis (SDS-PAGE), 
and immunoblotting techniques.
2.10.3 Sodium dodecyl sulphate polyacrylamide gel 
electrophoresis (SDS-PAGE)
Sodium dodecyl sulphate polyacrylamide gel 
electrophoresis (SDS-PAGE), was performed according to 
Laemmli (1970). Slab gels were prepared by mixing 12.5 
ml of 30% acrylamide/0.8% bis-acrylamide(w/v), 7.5ml of 
(1.5 M) Tris buffer (pH 8.8) and 10 ml of distilled 
water. Dissolved oxygen was removed under vacuum, after 
which 0.3ml of 10% SDS (w/v) , 15 |xl of N/N,N'(N'-
tetramethyl-ethylenediamine (TEMED) , and 150jil of 10% 
(w/v) ammonium persulphate in distilled water(freshly 
prepared) were added to initiate polymerization. The 
mixtures were poured as 1.5 mm x 12.5 cm x 14.5 cm slab 
gels. A layer of 1.5ml isopropanol was pipetted onto 
the gel and removed after polymerization. A 5% 
polyacrylamide stacking gel was prepared by mixing 1.5 
ml of 30% acrylamide/0.8% bis-acrylamide(w/v), 2.5 ml
of stacking gel buffer (0.5 M) Tris pH 6.8, and 6.0 ml 
of distilled water. Dissolved oxygen was removed under 
vacuum, after which 100jj,1 of 10% SDS, 10 \il of TEMED, 
and 50jal of 10% ammonium persulphate were added. The
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mixtures were layered onto the 12.5% gels and the 
sample comb was inserted. After polymerization, the 
comb was removed carefully. Samples were prepared as 
follows. Cleared supernatants prepared as described in 
Section 2.10.2, were diluted (1:1) with sample buffer 
containing 0.125 M Tris buffer (pH 6.8), 2% SDS (w/v), 
5% 2 mercaptoethanol(v/v) , 10% glycerol (v/v), and
0.05% bromophenol blue (w/v), and heated at 100°C for 
4 minutes. Molecular weight markers (BDH Laboratory 
Supplies, Poole, England) which included cytochrome C 
(12300 daltons), myoglobin (17200 daltons), carbonic 
anhydrase (3 0000 daltons) , ovalbumin (42700 daltons), 
albumin (66200 daltons) and ovotransferrin (78000 
daltons), were dissolved in the sample buffer and 
included as an track in all experiments. Each 
sample (40-50 |^1) was loaded into the appropriate well, 
and the gel was placed in a vertical electrophoresis 
tank (Hoefer Scientific Instruments, San Francisco, 
California, USA). Both lower and upper tanks were 
filled with tank buffer (25 mM Tris (Sigma Chemical 
Co), 192 mM glycine and 0.1% SDS w/v). Electrophoresis 
was carried out at 30 milliampere (mA) per gel at 10°C, 
and took about 4-4.5 hours to complete.
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Completed gels were then removed carefully and stained 
by soaking overnight in a staining solution composed of 
0.1% Coomassie brilliant blue R250(BDH Laboratory 
Supplies, Poole, England) in 50% methanol (v/v) (Fisons 
Scientific Equipment, Bishop Meadow Road, Loughborough, 
England) and 10% acetic acid (Prolabo, Rue Pelee, 
Paris, France) in water. After staining, gels were 
rinsed with water and soaked in destaining solution 
composed of 50% methanol and 10% acetic acid in water. 
Gels were then dried or stored in sealed bags until 
photographed.
2.10.4 Immunoblotting
Polyacrylamide gels were run as described previously 
(Section 2.10.3), then removed and soaked in distilled 
water for a few minutes. Filter paper (Whatman 3MM) and 
a sheet of nitrocellulose membrane were cut to the size 
of the gel (12.5 cm x 14.5 cm) . Six sheets of filter 
paper and one sheet of nitrocellulose membrane were 
used per gel. The nitrocellulose membrane was soaked in 
water for a few minutes and the absorbent sheets were 
wetted by soaking in blotting buffer composed of Tris 
48 mM, glycine 39 mM, SDS 0.037% (v/v), and 20%
methanol in distilled water. Three sheets of absorbent
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paper soaked in transfer buffer were placed on the 
bottom plate of the blotting apparatus (anode)(LKB 
Produkter AB, Bromma, Sweden) followed by one 
nitrocellulose membrane (Whatman Ltd,) wetted in 
distilled water. The polyacrylamide gel, slightly 
wetted in water, was placed carefully on top of the 
nitrocellulose membrane and the remaining 3 absorbent 
sheets were placed on top of the polyacrylamide gel. 
Air bubbles were removed from the assembled sandwich by 
rolling a pipette over the sandwich. Excess buffer and 
water on the plate surrounding the sandwich were 
removed, and the upper electrode (the cathode) was 
placed carefully on top of the stack. The electrodes 
were connected and transfer undertaken at 0.8 mA per cm2 
(140 mA per gel), which took between 45-60 minutes to 
complete. After transfer the nitrocellulose membrane 
was removed and processed as described below.
2.10.5 Staining of blots
Blots on the nitrocellulose membrane were removed after 
transfer was completed and stained for several minutes 
with 0.5% (w/v) Ponceau S stain (Hopkin and Williams
Ltd, Chadwell Heath, Essex, England) in 1% acetic acid 
to reveal molecular weight markers. The blots were
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washed with distilled water and blocked for one hour 
using a blocking buffer composed of phosphate buffered 
saline (PBS), 0.15% Tween 20 (T20), and 10% dried milk.
After blocking, blots were incubated for one hour in 
blotting buffer (PBS, 0.15% T20, 10% dried milk)
containing primary antibody diluted 1:200 (goat anti 
human SIgA, a chain specific) (Cappel Laboratories). 
After incubation, blots were washed three times for 10- 
15 minutes with PBS containing 0.15% T20 and 1% dried 
milk. After the final wash, blots were incubated in 
blotting buffer containing the secondary antibody 
diluted 1:2000, which was a peroxidase-conjugated 
rabbit anti goat immunoglobulin (Dako, DK-2600 
Glostrup, Denmark) for one hour at room temperature. 
After incubation with the secondary antibody, blots 
were washed three times for 10-15 minutes with PBS 
containing 0.15% T20 and 1% dried milk. Finally, blots 
were developed using a fresh solution of 98 ml PBS 
containing 3 0 mg diaminobenzidine (Sigma Chemical 
Company, Fancy Road, Poole, Dorset, England), 2ml of 
1% aqueous solution of cobalt chloride and 100 fil of 
hydrogen peroxide (Sigma Chemical Company), for several 
minutes, until the bands became clear. Blots were then
washed with distilled 
unt i1 photographed.
water and stored in the dark
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Chapter 3 
Results
3.1 Isolation of H .aphrophilus. A.actinomycetemcomita­
ns . and Capnocytophaga species from subgingival plaque 
samples
A total of 170 subgingival plaque samples from 4 9 
patients with different forms of periodontal disease 
were received and analysed as described in section 2.1. 
H . aphrophilus was isolated from 59 (35%) of the 170
test sites. A.actinomycetemcomitans was isolated from 
only 11 samples (6%). Of the 170 sites tested, 90 sites 
(53%) were positive for Capnocytophaga species. All 
isolated organisms were stored as described in section 
2.3. A selection of these clinical isolates together 
with isolates from the Glasgow Dental Hospital (GDH) 
collections and Type strains were used for the 
different experiments described in the following 
sections. Tables 3.1, 3.2 and 3.3 contain a list of all 
isolates used.
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Table 3.1 List of Actinobacillus actinomvcetemcomitans strains used in this
study
STRAIN
Number
SOURCE STRAIN
Number
SOURCE
Aa 33 GDH AaE 35 GDH
Aa 34 GDH AaE 54 GDH
Aa 94 GDH AaE 56 GDH
Aa 96 GDH AaE 57 GDH
AalOO GDH Aa E74 GDH
Aa 112 GDH Aa E75 GDH
Aa 113 GDH Aa E76 GDH
Aa 115 GDH Aa E79 ATCC29523
Aa 120 GDH Aa E80 ATCC29524
AaEl GDH Aa E81 Y 4
Aa E8 GDH Aa E83 NCTC9710
Aa E24 GDH Aa E88 JP2
Aa E33 GDH
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Table 3.2 List of H.aphrophilus strains used in this study
STRAIN
NUMBER
SOURCE STRAIN
NUMBER
SOURCE
Ha 40 GDH Ha 76 GDH
Ha 41 GDH Ha 77 GDH
Ha 42 GDH Ha 78 GDH
Ha 43 GDH Ha 79 GDH
Ha 44 GDH Ha 80 GDH
Ha 46 GDH Ha 82 GDH
Ha 58 GDH Ha 83 GDH
Ha 59 GDH Ha 86 GDH
Ha 60 GDH Ha 92 GDH
Ha 61 GDH Ha 97 GDH
Ha 62 GDH Ha 99 GDH
Ha 63 GDH Ha 104 GDH
Ha 67 GDH Ha 109 GDH
Ha 68 GDH Ha 110 GDH
Ha 75 GDH Ha 5886 NCTC
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Table 3.3 List of Capnocytophaga species used in this study
STRAIN NO SOURCE STRAIN NO SOURCE
Cap 52 GDH Cap 174 DH
Cap 53 GDH Cap 176 DH
Cap 72 GDH Cap 179 DH
Cap 81 GDH Cap 183 DH
Cap 84 GDH Cap 90 CTC11153
Cap 170 GDH
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3.2 Biochemical characteristics of the freshly isolated
strains of H .aphrophilus and A.actinomycetemcomitans
3.2.1 Biochemical characteristics of the freshly 
isolated A.actinomycetemcomitans strains
The biochemical characteristics were obtained using the 
API 20 A System, which provided a simple, and 
reproducible way of identification.
All A.actinomycetemcomitans strains fermented glucose, 
maltose and mannose. Variable results were obtained 
with mannitol and xylose. No strains of 
A.actinomycetemcomitans fermented lactose, saccharose, 
salicin, arabinose, glycerol, cellobiose, melezitose, 
raffinose, sorbitol, rhamnose or trehalose. 
A.actinomycetemcomitans strains did not produce 
indole or urease, and were unable to hydrolyse gelatine 
and aesculin. Catalase was produced by all strains. A 
summary of the results obtained with a representative 
number of fresh isolates of A.actinomycetemcomitans 
strains is presented in table 3.4. Type strains of 
A.actinomycetemcomitans yielded very similar results 
compared to the fresh isolates in all biochemical 
tests. A typical API 20A profiles obtained with
A.actinomycetemcomitans type strains are summarised in 
Table 3.4A.
3.2.2 Biochemical characteristics of H .aphrophilus 
strains
The biochemical characteristics were obtained using the 
API 2 0 A System which provided a simple and 
reproducible way of identification. All H .aphrophilus 
strains fermented glucose, lactose, saccharose and 
maltose. A number of H .aphrophilus strains fermented 
mannitol, salicin, xylose, arabinose, glycerol, 
cellobiose, rhamnose, sorbitol, and melezitose. None of 
the strains produced urease, formed indole, or 
hydrolysed gelatine or aesculin. Of 24 strains, 21 
(87%) fermented mannose, 20 (83%) fermented raffinose
and 19 (79%) fermented trehalose. All strains were
catalase negative.
The biochemical characteristics of H .aphrophilus 
strains are listed in Table 3.5.
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Table 3.4 Biochemical characteristics of A.actinomvcetemcomitans
Test Reaction Result % positive
Indole Indole formation Negative 0%
Urea Urease production Negative 0%
Glucose Fermentation Positive 100%
Mannitol Fermentation Variable 20%
Lactose Fermentation Negative 0%
Saccharose Fermentation Negative 0%
Maltose Fermentation Positive 100%
Salicin Fermentation Negative 0%
Xylose Fermentation Variable 80%
Arabinose Fermentation Negative 0%
Gelatine Hydrolysis Negative 0%
Aesculin Hydrolysis Negative 0%
Glycerol Fermentation Negative 0%
Cellobiose Fermentation Negative 0%
Mannose Fermentation Positive 100%
Melezitose Fermentation Negative 0%
Raffinose Fermentation Negative 0%
Sorbitol Fermentation Negative 0%
Rhamnose Fermentation Negative 0%
Trehalose Fermentation Negative 0%
Catalase Catalase production Positive 100%
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Table 3.4 A Biochemical characteristics of A.actinomvcetemcomitans Type strains
Test Reaction Result % positive
Indole Indole formation Negative 0%
Urea Urease production Negative 0%
Glucose Fermentation Positive 100%
Mannitol Fermentation Variable 60%
Lactose Fermentation Negative 0%
Saccharose Fermentation Negative 0%
Maltose Fermentation Positive 100%
Salicin Fermentation Negative 0%
Xylose Fermentation Variable 60%
Arabinose Fermentation Negative 0%
Gelatine Hydrolysis Negative 0%
Aesculin Hydrolysis Negative 0%
Glycerol Fermentation Negative 0%
Cellobiose Fermentation Negative 0%
Mannose Fermentation Positive 100%
Melezitose Fermentation Negative 0%
Raffmose Fermentation Negative 0%
Sorbitol Fermentation Negative 0%
Rhamnose Fermentation Variable 60%
Trehalose Fermentation Negative 0%
Catalase Catalase production Positive 100%
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Table 3.5 Biochemical characteristics of H.aphrophilus
Test Reaction/enzyme result % positive
Indole Indole formation Negative 0%
Urea Production of urease Negative 0%
Glucose Fermentation Positive 100%
Mannitol Fermentation Negative 0%
Lactose Fermentation Positive 100%
Saccharose Fermentation Positive 100%
Maltose Fermentation Positive 100%
Salicin Fermentation Negative 0%
Xylose Fermentation Negative 0%
Arabinose Fermentation Negative 0%
Gelatine Hydrolysis Negative 0%
Esculin Hydrolysis Negative 0%
Glycerol Fermentation Negative 0%
Cellobiose Fermentation Negative 0%
Mannose Fermentation Variable 87%
Melezitose Fermentation Negative 0%
Raffmose Fermentation Variable 83%
Sorbitol Fermentation Negative 0%
Rhamnose Fermentation Negative 0%
Trehalose Fermentation Variable 79%
Catalase Catalase production Negative 0%
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3.3 Sensitivity to antibacterial agents
All A.actinomycetemcomitans strains were sensitive to 
tetracycline, 92% were sensitive to ampicillin (8% 
being moderately sensitive) 12% of strains were 
sensitive to penicillin, (8% moderately sensitive) and 
80% were sensitive to erythromycin (20% being 
moderately sensitive) (Table 3.6 ).
All H .aphrophilus strains tested were sensitive to 
tetracycline and ampicillin, 87% were fully sensitive 
to penicillin (with 13% being moderately sensitive) 
while 73% were fully sensitive to erythromycin (27% 
moderately sensitive) (Table 3.7).
All Capnocytophaga species were sensitive to 
tetracycline, ampicillin and erythromycin; 50% were 
sensitive to penicillin and 50% were moderately 
sensitive to penicillin (Table 3.8).
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Table 3.6 Antimicrobial sensitivity results for 25 strains of 
A.actinomycetemcomitans
Antibiotic* % sensitive 
strains
% moderately 
sensitive strains
% resistant 
strains
Tetracycline 100% 0% 0%
Ampicillin 92% 8% 0%
Penicillin 12% 8% 80%
Erythromycin 80% 20% 0%
Table 3.7 Antimicrobial sensitivity results for 30 strains of H.aphrophilus
Antibiotic* % sensitive 
strains
% moderately 
sensitive strains
% resistant 
strains
Tetracycline 100% 0% 0%
Ampicillin 100% 0% 0%
Penicillin 87 % 13% 0%
Erythromycin 73% 27% 0%
* Supplied by Mast Laboratory, Merseyside, England.
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Table 3.8 Antimicrobial sensitivity results for 10 strains of
Capnocytophaga species
Antibiotic* %  sensitive 
strains
% moderately 
sensitive strains
% resistant 
strains
Tetracycline 100% 0% 0%
Ampicillin 100% 0% 0%
Penicillin 50% 50% 0%
Erythromycin 100% 0% 0%
* Supplied by Mast Laboratory, Merseyside, England
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3.4 Haemagglutination activity of H .aphrophilus. 
A.actinomycetemcomitans and Capnocytophaga species
3.4.1 Haemagglutination by A.actinomycetemcomitans
Of the 25 A.actinomycetemcomitans strains tested, 18 
(72%) showed positive haemagglutination. Most of the 
strains tested gave low titres. However, about 30% of 
the tested strains had a titre of 8 ( Table 3.9).
3.4.2 Haemagglutination by H.aphrophilus
Of the 30 H .aphrophilus strains tested for their 
ability to agglutinate group A and group 0 human 
erythrocytes, 28 (93%) showed positive
haemagglutination. However, the titres (calculated as 
the reciprocal of the highest dilution giving positive 
haemagglutination) were low (Table 3.10). There was no 
difference in the pattern of haemagglutination for type 
A and type O red cells. All strains were tested on at 
least 4 occasions and even though some titres varied in 
different assays (for example a certain strain may give 
a titre of 2 in one assay and a titre of 4 in a second 
assay), the results obtained were consistent in terms 
of positives and negatives. The majority of tested
strains (16 strains) gave a titre of 4, 10 strains gave 
a titre of 2, while, only 2 strains gave a titre of 8. 
The positive control yielded a consistent titre of 64.
3.4.3 Haemagglutination by Capnocytophaga species
Ten strains of Capnocytophaga species were tested for 
their ability to haemagglutinate group A and group O 
human erythrocytes. Of the 10 strains tested, 3 strains 
had a titre of 64 with both blood groups, 2 strains had 
a titre of 32, 1 strain of 16 and 4 strains of 8.
Generally the titres obtained with most of the 
Capnocytophaga strains were higher than those obtained 
with other bacteria (H .aphrophilus and
A.actinomycetemcomitans) included in this study. The 
results obtained with Capnocytophaga strains are listed 
in Table 3.11.
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Table 3.9 Haemagglutination activity of 25 strains of
A.actinomycetemcomitans with human groupA and groupO cells
STRAIN Haemagglutination
titre*
STRAIN Haemagglutination
titre*
Group A Group O Group A Group O
Aa 33 8 8 Aa E35 4 4
Aa 34 2 2 Aa E54 4 4
Aa 94 8 8 Aa E56 8 8
Aa 96 4 4 AaE57 4 4
Aa 100 8 8 AaE74 2 2
Aa 112 8 8 Aa E75 0 0
Aa 113 8 8 Aa E76 0 0
Aa 115 8 8 Aa E79 0 0
Aa 120 8 8 Aa E80 0 0
AaEl 4 4 Aa E81 0 0
Aa E8 4 4 Aa E83 0 0
Aa E24 0 0 Aa E88 0 0
Aa E33 8 8 Negative
control
0 0
E.coli 64 64
re was calculated as the reciprocal of the highest dilution that gave positive
haemagglutination.
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Table 3.10 Haemagglutination activity of 30 strains of H.aphrophilus
with human groupA and O cells
STRAIN Haemagglutination
titre*
STRAIN Haemagglutination
titre*
Group A Group O GroupA Group 0
Ha 40 4 4 Ha 75 4 4
Ha 41 4 4 Ha 76 2 2
Ha 42 4 4 Ha 77 2 2
Ha 43 4 4 Ha 78 2 2
Ha 44 4 4 Ha 79 2 2
Ha 46 4 4 Ha 80 2 2
Ha 58 4 4 Ha 82 4 4
Ha 59 4 4 Ha 83 4 4
Ha 60 4 4 Ha 86 4 4
Ha 61 2 2 Ha 92 0 0
Ha 62 2 2 Ha 97 4 4
Ha 63 0 0 Ha 99 4 4
Ha 67 8 8 Ha 104 4 4
Ha 68 8 8 Ha 109 2 2
Ha 5886 2 2 Ha 110 2 2
E.coli 64 64 Negative
control
0 0
* Titre was calculated as the reciprocal of the highest dilution that gave positive 
haemagglutination.
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Table 3.11 Haemagglutination activity of 10 strains of Capnocytophaga
species with human group A and group O cells
STRAIN Haemagglutination
titre*
STRAIN Haemagglutination
titre*
Group A Group O Group A Group O
Cap 52 32 32 Cap 174 8 8
Cap 53 64 64 Cap 176 8 8
Cap 72 64 64 Cap 179 8 8
Cap 81 16 16 Cap 183 64 64
Cap 170 8 8 Cap 90 32 32
E.coli 64 64 Negative
control
0 0
* The titre was calculated as the reciprocal of the highest dilution that gave positive 
haemagglutination
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3.4.4 Haemagglutination inhibition of Capnocytophaga
species
The ability of carbohydrates to inhibit 
haemagglutination was tested with some
haemagglutination-positive strains from each group of 
bacteria. A number of H.aphrophilus and A.actinomycete­
mcomitans strains were tested in preliminary 
experiments and because of the low titres of 
haemagglutination obtained with these strains the 
results of these experiments were not conclusive. 
Therefore, the experiment was restricted to the use of 
mannose only and it was tested with the 3 strongly 
positive Capnocytophaga strains only. Of the 3 strains 
tested, all were mannose-sensitive as compared with 
E.coli positive control, since the titres of all 3 
strains were reduced from 64 to 4 (Table 3.12).
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Table 3.12 Inhibition of haemagglutination activity of three strains of
Capnocytophaga by mannose
STRAIN Haemagglutination
titre*
Haemagglutination inhibition 
by mannose (titre)
GroupA Group O Group A Group O
Cap 53 64 64 4 4
Cap 72 64 64 4 4
Cap 183 64 64 4 4
E.coli 64 2 64 2
Negative
control
0 0 0 0
* The titre was calculated as the reciprocal of the highest dilution that gave positive 
haemagglutination.
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3.5 Leukotoxic activity in H .aphrophilus, 
A.actinomycetetcomitans and Capnocytophaga species as 
measured by the Trypan blue exclusion and 
chemiluminescence assays
3.5.1 Leukotoxic activity of A.actinomycetemcomitans as 
measured by trypan blue exclusion assay
The results showing the leukotoxic activity of 25 
strains of A.actinomycetemcomitans are presented in 
Table 3.13. Five strains (20%) were leukotoxic to HL60 
cells and these included 2 (10%) out of 20 fresh oral
A.actinomycetemcomitans isolates (strains E24 and 34) 
and 3 Type strains, (strains Y4, ATCC 29524 and JP2) . 
Cell killing was in the range of 37% to 64%, with the 
Type strain JP2 being the most toxic (64% killing) and 
strain 34 the least toxic strain (37% killing) (Table 
3.13) .
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Table 3.13 Leukotoxicity of A.actinomvcetemcomitans strains as measured by 
trypan blue exclusion assay with HL60 cells
Strain Number of HL 60 cells 
Dead (+ SEM) Live ( ± SEM) % Death
Aa 33 20.25(1.90) 79.75(1.90) 0.00
Aa 94 26.25 (3.14) 73.75 (3.14) 6.25
Aa 96 38.50 (2.76) 61.50 (2.76) 18.50
AalOO 35.00 (5.18) 65.00 (5.18) 15.00
Aa 112 44.00 (4.89) 56.00 (4.89) 24.00
Aa 113 45.50 (4.55) 54.50 (4.55) 25.50
Aa 115 28.00 (6.27) 72.00 (6.27) 8.00
Aa 120 36.50 (6.04) 63.50 (6.04) 16.50
AaEl 36.00 (2.16) 64.00 (2.16) 16.00
Aa E8 34.75 (4.65) 65.25(4.65) 14.75
Aa E33 28.75 (4.30) 71.25 (4.30) 8.75
AaE35 36.50 (6.22) 63.50 (6.22) 16.50
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Table 3.13 continued
Strain Number of HL60 cells
Dead (± SEM) Live (± SEM) %Death
Aa E54 33.25 (3.10) 66.75 (3.10) 13.25
Aa E56 33.25 (3.69) 66.75 (3.69) 13.25
Aa E57 38.00 (5.65) 62.00 (5.65) 18.00
Aa E74 37.75 (8.58) 62.25 (8.58) 17.75
Aa E75 37.50 (7.31) 62.50 (7.31) 17.50
Aa E76 33.50 (4.55) 66.50 (4.55) 13.50
Aa E79 26.75 ( 0.98) 73.25 ( 0.98) 6.75
Aa E83 41.25 (7.96) 58.75 (7.96) 21.25
Aa E80 74.00(2.00) 26.00(2.00) 54.00
Aa E81 70.00(3.60) 30.00(3.60) 50.00
Aa E88 84.00(9.34) 16.00(9.34) 64.00
AaE24 81.00(3.85) 19.00(3.85) 61.00
Aa34 57.00(6.72) 43.00(6.72) 37.00
PBS control 20.00(2.47) 80.00(2.47) 20.00
3.5.2 Leukotoxic activity of H .aphrophilus as measured 
by the trypan blue exclusion assay
The leukotoxic activity of 3 0 H .aphrophilus strains for 
HL60 cells was measured by using the trypan blue 
exclusion assay. Results obtained are shown in Table 
3.14. None of the H .aphrophilus strains tested were
leukotoxic to HL60 cells based on the criteria used in 
this study (ie death of 30% or more of the target 
cells), even at the highest bacteria/target cell ratio 
employed (400 bacteria/HL60 cell). The range of 
percentage death of target cells ranged from 0% to 18%, 
and results obtained with these experiments were 
consistent and reproducible. All tested strains were
examined on two separate occasions and in duplicate. It
is also important to indicate that a random selection 
of strains from the 3 test groups of bacteria
(H,aphrophilus/ A. actinomycetemcomitans and
Capnocytophaga) were examined together in a single 
experiment by using the same population of target cell.
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Table 3.14 Leukotoxicity of H.aphrophilus strains as measured by the 
trypan blue exclusion assay with HL60 cells
Strain Number of HL60 cells 
Dead (± SEM) Live(± SEM ) % Death
Ha 40 29.25(5.21) 70.75 (5.21) 9.25
Ha 41 31.25 (0.70) 69.00 (0.70) 11.25
Ha 42 30.50 (5.28) 69.50 (5.28) 10.50
Ha 43 27.00 (2.94) 73.00 (2.94) 7.00
Ha 44 32.75 (3.50) 76.25 (3.50) 12.75
Ha 46 29.25 (7.26) 70.75 (7.26) 9.25
Ha 58 28.50 (3.78) 71.50 (3.78) 8.50
Ha 59 29.50 (5.50) 70.50 (5.50) 9.50
Ha 60 19.00(1.56) 81.00(1.56) 0.00
Ha 61 16.00 (2.98) 84.00 (2.98) 0.00
Ha 62 19.25 (4.75) 80.75 (4.75) 0.00
Ha 63 22.25 (3.81) 77.75 (3.81) 2.25
Ha 67 29.25 (5.21) 70.75 (5.21) 9.25
Ha 68 35.00 (2.40) 65.00 (2.40) 15.00
Ha 75 32.75(4.14) 67.25 (4.14) 12.75
PBS control 20.00(2.47) 80.00(2.47) 20.00
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Table 3.14 Continued
Strain Number of HL 60 cells 
Dead(± SEM) Live ( ± SEM) % Death
Ha 76 35.50 (2.42) 64.50 (2.42) 15.50
Ha 77 36.75 (5.93) 63.25 (5.93) 16.75
Ha 78 31.25 (4.43) 68.75 (4.43) 11.25
Ha 79 21.25 (2.42) 78.75 (2.42) 1.25
Ha 80 19.00(1.56) 81.00 (1.56) 0.00
Ha 82 32.75 (3.17) 67.25 (3.17) 12.75
Ha 83 27.50 (2.42) 72.50 (2.42) 7.50
Ha 86 35.50 (8.43) 64.50 (8.43) 15.50
Ha 92 34.50 (5.00) 65.50 (5.00) 14.50
Ha 97 38.0 (2.00) 62.00 (2.00) 18.00
Ha 99 22.00 (2.53) 78.00(2.53) 2.00
Ha 104 28.25 (6.93) 71.75 (6.93) 8.25
Ha 109 29.25 (3.41) 70.75 (3.41) 9.25
Ha 110 33.50 (6.11) 66.50 (6.11) 13.50
Ha 5886 19.75 (5.38) 80.25 (5.38) 0.00
PBS control 20.00(2.47) 80.00(2.47) 20.00
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3.5.3 Leukotoxic activity of Capnocytophaga species as 
measured by the trypan blue exclusion assay
None of the Capnocytophaga species were leukotoxic to 
HL60 cells ( Table 3.15).
The results outlined in this section have indicated 
substantial differences between these group of 
organisms with respect to their leukotoxicity. 
A.actinomycetemcomitans were the most toxic and 
Capnocytophaga strains the least leukotoxic.
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Table 3.15 Leukotoxicity of Capnocytophaga species as measured by the 
trypan blue exclusion assay with HL60 cels
Strain Number of HL 60 cells
Dead (± SEM) Live ( ± SEM) % Death
Cap 15 28.50 (3.34) 71.50(3.34) 8.50
Cap 30 17.75(2.20) 82.25 ( 2.20) 0.00
Cap 45 17.00(2.74) 83.00(2.74) 0.00
Cap 52 23.50(2.84) 76.50 (2.84) 3.50
Cap 53 19.50(2.60) 80.50 (2.60) 0.00
Cap 65 21.00 ( 1.56) 79.00 (1.56) 1.00
Cap 81 29.75(3.35) 70.25 (3.35) 9.00
Cap 90 19.50 ( 1.45) 80.50 ( 1.45) 0.00
PBS control 20.00(2.47) 80..00(2.47) 20.00
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3.5.4 Leukotoxic activity of A.actinomycetemcomitans as 
measured by the inhibition of chemiluminescence 
produced by human PMNLs
Of the 25 A.actinomycetemcomitans strains tested, 5 
were leukotoxic to human PMNLs as indicated by their 
ability to inhibit the chemiluminescence produced by 
PMA- stimulated human PMNLs (Figure 3.1; Table 3.16). 
These strains were A.actinomycetemcomitans E80, E81,
E88, E24 and 34. It is clear from figures 3.1 and 3.2
that the A.actinomycetemcomitans E88 strain caused the 
greatest inhibition of luminol-dependent
chemiluminescence compared with the positive control 
(from 3 50mv to 15mv) while A.actinomycetemcomitans 
strain 34 reduced the chemiluminescence response from 
350 to 105 mv. The results obtained with this assay 
were concordant with the trypan blue exclusion assay, 
since the same 5 leukotoxic strains were found to be 
leukotoxic. The reduction in chemiluminescence ranged 
from 65% (strain 34) to over 95%
(A.actinomycetemcomitans E88). Figure 3.2 shows the 
results obtained with the positive control (PMA- 
stimulated human PMNLs) and the negative control (human 
PMNLs without PMA) . Representative non-leukotoxic
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Figure 3.1 Detection of leukotoxic 
activity among strains of Aa as
measured by the inhibition of 
luminol-dependent chemiluminescence. 
The five leukotoxic strains are 
shown with strain JP2 being the
most toxic and strain 34 the
least toxic.
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Figure 3.2 A positive and negative control 
for the lumino1 -dependent chemiluminescence
inhibition assay used for the detection of
leukotoxic activity among Aa, Ha and
Capnocytophaga strains.
A.actinomycetemcomitans strains as measured by 
chemiluminescence are shown in Figure 3.3.
3.5.5 Leukotoxic activity of H .aphrophilus as measured 
by the inhibition of chemiluminescence produced by 
human PMNLs
None of the tested H .aphrophilus strains were 
leukotoxic as indicated by their failure to inhibit the 
level of chemiluminescence produced by PMA-stimulated 
control PMNLs. Representative non-leukotoxic
H .aphrophilus strains are shown in Figure 3.4, and it 
is clear that no strains inhibited the 
chemiluminescence response of the positive control. It 
is also clear from Figure 3.4 that certain non- 
leukotoxic H .aphrophilus strains caused an increase in 
the level of chemiluminescence response produced by the 
positive control. A similar observation was recorded 
with the non-leukotoxic A. actinomycetemcomitans strains 
and may represent a response to lipopolysaccharide.
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Figure 3.3 Detection of leukotoxic activity 
among strains of Aa as measured by the
inhibition of lumino1 -dependent
chemiluminescence. Two representative
non -1eukotoxic strains (E83 and 120) are
shown.
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Figure 3.4 Detection of leukotoxic 
among strains of Ha as measured by the
inhibition of lumino1 -dependent
chemiluminescence. Three representative 
non -1eukotoxic strains (GDH 40, 44,86) are
shown.
Table 3.16 Leukotoxic activity of toxic A.actinomvcetemcomitans strains as 
measured by the reduction in chemiluminescence (CL) of human PMNLs
Strain Chemiluminescence
(mv)
% Reduction in
Chemiluminescence
(mv)
AaE 80 78 74.00
Aa E88 15 95.00
Aa 34 105 65.00
Aa E81 45 85.00
Aa E24 30 90.00
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3.5.6 Leukotoxic activity of Capnocytophaga species 
as measured by the inhibition of chemiluminescence 
produced by human PMNLs
None of Capnocytophaga species tested with the 
chemiluminescence assay were leukotoxic.
Representative non-leukotoxic Capnocytophaga strains 
are shown in Figure 3.5.
3.6 Results of the phagocytosis of A .actinomycetemcomi- 
tans. H.aphrophilus and Capnocytophaga species by human 
PMNLs using the luminol-dependent chemiluminescence 
assay
3.6.1 Phagocytosis of A.actinomycetemcomitans strains
Two patterns of chemiluminescence responses were
observed when opsonized A.actinomycetemcomitans strains 
were incubated with human PMNLs. The first pattern was 
produced by the majority of strains of 
A.actinomycetemcomitans. that is an immediate,
exponential, fast, well-defined chemiluminescence peak 
and was exhibited by eight of the nine strains (90%) 
(A.actinomycetemcomitans strain E24, E79, E80, E81,
E83, 100, 115 and 120). A representative strain
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Figure 3.5 Detection of leukotoxic activity 
among strains of Capnocytophaga species by 
the inhibition of lumino1-dependent 
chemiluminescence. Representative non -1eukotoxic 
strain (90).
producing this pattern is shown in Figure 3.6 and 
chemiluminescence values obtained with all tested 
strains are listed in Table 3.17. Unopsonized cells of 
the same strains did not stimulate human PMNLs and no 
chemiluminescence response was recorded. The second 
pattern of chemiluminescence response was observed with 
only one strain (E88) and it was recorded when an 
opsonized A.actinomycetemcomitans strain E88 was 
incubated with human PMNLs under the same conditions. 
This strain produced a relatively fast and small 
chemiluminescence peak, but no further response was 
recorded when PMA was added. This indicated that the 
PMNLs were not functioning properly, perhaps due to 
leukotoxic activity (Figure 3.7). However, other 
leukotoxic strains were different, since the 
chemiluminescence response produced by these strains 
(E24, E81, E80) indicated that they were phagocytosed
by human PMNLs. The reason for this difference is not 
clear but it could be due to differences in the surface 
components expressed by these different strains. All 
non-leukotoxic A.actinomycetemcomitans strains were 
able to trigger a chemiluminescence response, though it 
was strain-dependent, since certain strains produced 
higher chemiluminescence responses than others. For
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Figure 3.6 Representative opsonized Aa strain
(E83) used for the phagocytosis experiments.
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Figure 3.7 The chemiluminescence response 
triggered by the opsonized Aa leukotoxic JP2 
strain used for the phagocytosis experiments.
example, the A. actinomycetemcomitans strain E83 
triggered a chemiluminescence response about 3 times 
greater than that produced by A.actinomycetemcomitans 
strain 100. Unopsonized cells of the same strains 
failed to initiate similar responses which indicates 
the opsonic activity of serum.
3.6.2 Phagocytosis of H .aphrophilus
The incubation of ten strains of H .aphrophilus with 
human PMNLs resulted, after serum opsonization, in an 
immediate exponential chemiluminescence response, 
indicating phagocytic activity of human PMNLs (Figure 
3.8). These strains included H .aphrophilus 40, 44, 46,
79, 80, 82, 83, 97,104 and 5886 (NCTC strain),
chemiluminescence values obtained with all tested 
strains are listed in Table 3.17. Unopsonized cells of 
the same strains failed to initiate similar responses 
when incubated under the same conditions. However, 
prolonged incubation times with unopsonized cells 
resulted in very broad and substantially smaller 
chemiluminescence peaks (Figure 3.9).
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Figure 3.8 Representative opsonized Ha strain 
(44) used for the phagocytosis experiments
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Figure 3.9 Representative unopsonized Ha
strain (44) used for the phagocytosis 
experiments.
3.6.3 Phagocytosis of Capnocytophaga species
Incubation of opsonized Capnocytophaga species with 
human PMNLs resulted in fast, exponential 
chemiluminescence responses similar to those observed 
with H .aphrophilus strains (Figure 3.10). These strains 
included Capnocytophaga strain 13, 52 and 90 (NCTC
strain). These results indicate the ability of 
Capnocytophaga species to activate the respiratory 
burst by human PMNLs, list of chemiluminescence values 
recorded for Capnocytophaga strains are shown in Table 
3 .17.
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Figur 3.10 Representative opsonized 
Capnocytophaga strain (90) used for the 
phagocytosis experiments
Table 3.17 Chemiluminescence values recorded with 
strains of A.actinomycetemcomitans. H .aphrophilus and 
Capnocytophaga species
Strain Chemiluminescence Strain Chemiluminescence
opsonized unopsonized opsonized unopsonized
Ha 40 280mv* 0.00 Aa 115 3 75mv 0.00
Ha 44 3oomv 0.00 Aa 12 0 260mv 0.00
Ha 46 3 600mv 0.00 Aa E24 518mv 0.00
Ha 79 23 0mv 0.00 Aa E79 44 0mv 0.00
Ha 80 290mv 0.00 Aa E80 280mv 0.00
Ha 82 32 0mv 0.00 Aa E81 175mv 0.00
Ha 83 32 0mv 0.00 Aa E83 600mv 0.00
Ha 97 3 80mv 0.00 Aa E88 65 mv 0.00
Ha 104 4 00mv 0 . 00 Cap 13 42 0mv 0.00
Ha5886 2 90mv 0.00 Cap 52 350mv 0.00
Aa 100 120mv 0.00 Cap 90 295mv 0.00
* millivolts
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3.7 The cytotoxicity of H .aphrophilus. A.actinomycete­
mcomitans and Capnocytophaga species for cultured 
human skin fibroblasts
3.7.1 The cytotoxicity of H .aphrophilus. A.actinomyce- 
mcomitans and Capnocytophaga species for cultured human 
skin fibroblasts (Whole live cells)
In the first part of the cytotoxicity experiments, 
the ability of whole cells of some H .aphrophilus. 
A.actinomycetemcomitans and Capnocytophaga strains to 
interfere with the growth of the cultured human skin 
fibroblast cell line IBR3 was examined. Results 
obtained from these preliminary experiments indicated 
that some strains from all species were able to 
interfere with and reduce the metabolic activity of 
cultured fibroblasts. This reduction occurred in a 
dose-dependent manner. However, a major technical 
problem arose especially in wells with higher ratios of 
fibroblast growth medium to bacteria (50pl bacterial 
cells/150|il growth medium) . The problem involved the 
formation of a dark coloured precipitate, which 
interfered with the final optical density measurements. 
The results of a representative A.actinomycetemcomitans 
strain illustrating this problem are shown in Figure
177
3.11. A number of experiments were performed to resolve 
the problem. These included dilution of the medium 
with PBS, medium modification (ie removal of serum) and 
medium replacement with RPMI 1640 medium. The results 
of these preliminary experiments indicated that the 
precipitation occurred as a result of an interaction 
between bacterial cell components and the fibroblast 
growth medium. An attempt to use cell-free bacterial 
extracts was therefore made. Cell-free extracts were 
prepared either by sonication or disintegration of 
bacteria for 20 minutes. The results of these 
experiments indicated the suitability of the 
preparation obtained by disintegration, though some 
viable cells were detected by viable counts. The time 
of disintegration was increased to 1 hour and the 
system was kept cool for the period of 1 hour by 
placing an ice box on top of the disintegrator. The 
resultant cell-free extracts were tested in an 
additional group of experiments. Satisfactory 
cytotoxicity results were achieved and, therefore, 
cell-free extracts were used in the second part of the 
study.
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3.7.2 The cytotoxicity of A.actinmycetemcomitans cell- 
free extracts for cultured human skin fibroblasts
Twenty five A.actinomycetemcomitans strains were tested 
for their ability to depress the growth of human skin 
fibroblasts. Of those tested, 24/25 were cytotoxic and 
reduced the optical density of cultured fibroblasts by 
more than 50% (Table 3.18). The optical density 
reduction by these cytotoxic strains ranged from 64% to 
83%, which suggests different degrees of cytotoxic 
activity among A.actinomycetemcomitans strains. The 
group of A.actinomycetemcomitans strains tested in the 
present study included a number of leukotoxic and non- 
leukotoxic strains. There was no correlation between 
the leukotoxicity and fibroblast inhibition, as certain 
non-leukotoxic strains were more cytotoxic to the 
cultured fibroblast cell line. The non-cytotoxic strain 
was A.actinomycetemcomitans E79 (Table 3.18). 
Furthermore, before the termination of the cytotoxicity 
cultures the plates were examined microscopically for 
any morphological changes. It was observed that most 
cytotoxic strains caused some morphological changes, 
which included gross changes in the appearance of cells 
and a clear reduction of cell density (Figure 3.12).
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Figure 3.12 (A and B) Morphological changes in cultured 
human skin fibroblasts caused by a strain of 
A .actinomycetemcomitans (115). Photograph A shows 
cultured fibroblasts not exposed to bacteria (control 
culture) . Photograph B shows cultured fibroblasts 
exposed to a strain of A.actinomycetemcomitans (115)
Table 3.18 List of all A.actinomvcetemcomitans strains used for the
cytotoxicity assay and their effects on the fibroblast cell line
Strain OD 570nm
(± SEM)
% Reduction* Strain OD570 nm
(± SEM)
% Reduction*
Aa 33 0.166(0.0235) 76% Aa E35 0.123(0.0030) 69%
Aa34 0.331(0.0794) 66% Aa E54 0.128(0.0014) 68%
Aa 94 0.185(0.0016) 79% Aa E56 0.189(0.0230) 75%
Aa 96 0.191(0.0059) 77% Aa E57 0.175(0.0104) 76%
AalOO 0.183(0.0057) 79% Aa E74 0.211(0.0225) 71%
Aa 112 0.166(0.0076) 78% Aa E75 0.196(0.0312) 77%
Aa 113 0.159(0.0125) 64% Aa E76 0.180(0.047) 70%
Aa 115 0.156(0.0047) 83% Aa E79 0.523(0.0140) 46%
Aa 120 0.324(0.0223) 70% AaE80 0.230(0.0606) 63%
AaEl 0.230(0.0399) 77% Aa E81 0.256(0.0013) 67%
Aa E8 0.143(0.0104) 81% Aa E83 0.211(0.0272) 71%
Aa E24 0.151(0.0087) 80% Aa E88 0.177(0.0138) 75%
Aa E33 0.178(0.0180) 81%
* Reduction in optical density proportionate to degree of cytotoxicity
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3.7.3 The cytotoxicity of H . aphrophilus cell free 
extracts for cultured human skin fibroblasts
Of the 30 H .aphrophilus strains tested for their
ability to depress the growth of a human skin
fibroblast cell line IBR3, 26 (87%) were recorded as
cytotoxic since they reduced the optical density of 
cultured fibroblasts by more than 50% (Table 3.19) . The 
remaining four strains (13%) reduced the optical 
density of cultured fibroblasts by less than 50% and 
were, therefore, considered non-cytotoxic. These 
strains were H .aphrophilus strains 58, 59, 5886 (NCTC
strain) and 42.
3.7.4 The cytotoxicity of Capnocytophaga cell free 
extracts for cultured human skin fibroblasts
Of the 9 Capnocytophaga strains, 5 (55%) were
cytotoxic to cultured human skin fibroblasts (strain 
52,53,72,183 and 90) (Table 3.20). Capnocytophaga 
strains 170, 174, 176 and 179 were non-cytotoxic.
Morphological changes were evident though to a lesser 
extent than those caused by A.actinomycetemcomitans 
cell-free extracts.
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Table 3.19 List of H.aphrophilus strains used for the cytotoxicity assay and
their effects on the fibroblast cell line
Strain OD 570 nm 
(± SEM)
% Reduction* Strain OD 570nm 
(± SEM)
%Reduction*
Ha 40 0.194(0.0406) 75% Ha 76 0.145(0.0075) 76%
Ha 41 0.130(0.0050) 84% Ha 77 0.146(0.015) 73%
Ha 42 0.211(0.0063) 47% Ha 78 0.120(0.0015) 83%
Ha 43 0.134(0.0064) 66% Ha 79 0.238(0.0199) 71%
Ha 44 0.140(0.0150) 88% Ha 80 0.203(0.0332) 73%
Ha 46 0.120(0.0015) 85% Ha 82 0.164(0.0052) 78%
Ha 58 0.527(0.043) 46% Ha 83 0.132(0.0124) 85%
Ha 59 0.329(0.035) 45% Ha 86 0.195(0.0023) 67%
Ha 60 0.149(0.0126) 79% Ha 92 0.139(0.0018) 66%
Ha 61 0.182(0.047) 71% Ha 97 0.157(0.0024) 61%
Ha 62 0.303(0.074) 55% Ha 99 0.109(0.0043) 87%
Ha 63 0.290(0.068) 58% Ha 104 0.203(0.011) 79%
Ha 67 0.178(0.0172) 73% Ha 109 0.112(0.0025) 86%
Ha 68 0.155(0.0115) 76% Ha 110 0.135(0.0115) 85%
Ha 75 0.175(0.0054) 70% Ha 5886 0.525(0.030) 24%
* Reduction in optical density proportionate to degree of cytotoxicity
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Table 3.20 List of all Capnocytophaga strains used for the cytotoxicity study
and their effects on the fibroblast cell line
Strain OD570 nm 
(± SEM)
%
reduction*
Strain OD 570 nm 
(± SEM)
%
reduction*
Cap 52 0.201(0.0238) 61% Cap 176 0.129(0.0156) 13%
Cap53 0.126(0.0009) 68% Cap 179 0.375(0.0190) 8.5%
Cap 72 0.202(0.0169) 55% Cap 183 0.262(0.045) 57%
Cap 170 0.323(0.0120) 22% Cap 90 0.197(0.0039) 65%
Cap 174 0.299(0.0192) 33%
* Reduction in optical density proportionate to degree of cytotoxicity
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3.7.5 Adherence of certain A. actinomycetemcomitans. 
H .aphrophilus and Capnocytophaga strains to cultured 
human skin fibroblast cell line
In the first part of the cytotoxicity study and during 
the course of the preliminary experiments with the 
whole live cells, it was observed that certain 
A.actinomycetemcomitans and H.aphrophilus strains 
adhered to the surface of the cultured fibroblast 
monolayer. Figure 3.13 shows the results obtained with 
a representative positive and negative strains. The 
adherent cells formed clumps on the top of the
monolayer. An attempt to remove the attached cells from 
the monolayers by washing with PBS did not remove the 
attached cells. This further confirms this observation, 
since the non-adherent cells were removed very easily 
from the plates even without washing, simply by 
inverting the plates. Although it was not possible to
quantify the number of attached bacteria, it was
possible to distinguish between adherent and non­
adherent strains visually when examined
microscopically, as the non-adherent cells formed a 
homogenous layer on top of the monolayer, while the 
adherent cells formed clumps. Results obtained with
representative strains of all 3 species under study are
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Figute 3.13 (A and B): A representative strain (115) of 
A. actinomycetemcomitans adhering to cultured human skin 
fibroblasts. Photograph A shows a negative control 
culture. Photograph B A .actinomycetemcomitans adhering 
to cultured fibroblasts.
Figure 3.13 A : A representative non-adherent
A^aotlnoiiiy_cetemcomitans strain (E88) to cultured human 
skin fibroblast
presented in Table 3.21. There was a correlation with 
the colonial morphology of the strain, since the cells 
of the rough type colonial morphology adhered more than 
those with smooth colonies. The ability of strains to 
adhere was variable, as certain strains adhered almost 
immediately or after several hours, while others did 
not adhere even after 24 hours.
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3.21 A comparison of the colonial morphology and adherence of 
A.actinomvcetemcomitans. H.aphrophilus and Capnocytophaga strains to cultured 
human skin fibroblasts
Strain colonial type Adherence
Ha 42 Smooth -
Ha 43 Smooth -
Ha 44 Smooth +
Ha 82 Rough ++
Ha 83 Smooth +
Ha 67 Rough ++
Ha 68 Rough ++
AaE35 Rough +++
Aa E54 Rough +++
Aa E76 Smooth -
Aa E88 Smooth -
Aa 112 Rough +++
Aa 113 Rough +++
Aa 115 Rough +++
Cap 81 Smooth -
Cap 90 Smooth -
* +++ = adherence occurred almost immediately; ++
adherence occurred after 4 hours; + = weak adherence
occurred within 24 hours; - = no adherence even after
24 hours
3.8 Human Immunoglobulin A protease production by 
A.actinomycetemcomitans, H.aphrophilus and
Capnocytophaga species
3.8.1 Cleavage of human myeloma IgA by 
A.actinomycetemcomitans strains
Twenty five strains of A.actinomycetemcomitans were 
examined for their ability to cleave human IgA myeloma 
serum. SDS-PAGE and immunoblotting analysis revealed 
that none of the strains tested cleaved IgA even after 
48 hours of incubation (Figure 3.14)
3.8.2 Cleavage of human myeloma IgA by H.aphrophilus 
strains
SDS-PAGE and immunoblotting analysis of IgA myeloma 
serum incubated with 3 0 H .aphrophilus strains revealed 
that none of the strains tested cleaved IgA even after 
48 hours incubation (Figures 3.15)
3.8.3 Cleavage of human myeloma IgA by Capnocytophaga 
species.
The incubation of all 10 Capnocytophaga strains with 
human IgA myeloma serum under the same experimental 
conditions resulted in the cleavage of IgA as revealed
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Figure 3.14 Western blot of human myeloma IgA before 
and after incubation with strains of
A. actinomycetemcomitans. Lane 1 IgA incubated in PBS. 
Lane 2 IgA after incubation with the positive control 
H .influenzae IgA band was cleaved to two smaller 
fragments (arrows). Lanes 3-12 IgA after incubation 
with strains of A.actinomycetemcomitans. no cleavage 
as the IgA band (arrow) still present.
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Figure 3.15 Western blot of human myeloma IgA before 
and after incubation with strains of H .aphrophilus. 
Lane 1 IgA incubated in PBS. Lane 2 IgA after 
incubation with the positive control H .influenzae IgA 
band was cleaved to two smaller fragments (arrows). 
Lanes 3-12 IgA after incubation with strains of 
H .aphrophilus. no cleavage occured as the IgA band 
(arrow) still present.
by immunoblotting (Figure 3.16). Capnocytophaga strains 
cleaved IgA to yield 2 smaller fragments, similar to 
the pattern obtained with H .influenzae (NCTC 12194), 
the positive control (Figure 3.17). However, in some 
experiments there was non-specific reactivity between 
the commercial antisera used for blotting and some 
bacterial proteins, as evident by the presence of 
unknown bands in some blots. This reactivity was 
stronger with the Capnocytophaga strains than with the 
H .influenzae positive control. Furthermore,
H .influenzae cleaved a commercially purified human 
secretory IgA (SIgA) in a similar pattern. All 
Capnocytophaga strains cleaved human SIgA in the same 
pattern (Figure 3.17). Furthermore, the incubation of 
certain Capnocytophaga strains with SIgA, resulted in 
the cleavage of the secretory component. However, 
whether this is due to the action of IgA protease or 
another proteolytic enzyme is not clear (Figure3.18).
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Figure 3.16 Western blot of human myeloma IgA before 
and after incubation with Capnocytophaga strains. 
Lane 1 IgA incubated in PBS. Lane 2 IgA after 
incubation with H .influenzae (positive control). 
Lanes 3-11 IgA after incubation with Capnocytophaga 
strains, all strains cleaved IgA as the major IgA 
band (arrow) was cleaved to two smaller fragments.
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Figure 3.17 Western blot of human myeloma IgA and 
human SIgA before and after incubation with a strain 
of H .influenzae (positive control) and Capnocytophaga 
strain (52) . Lane 1 IgA in PBS. Lane 2 human SIgA in 
PBS. Lane 3 IgA cleaved by H . influenzae, IgA band 
removed (arrows).Lane 4 SIgA incubated with 
H .influenzae. Lane 5 H .influenzae incubated in PBS. 
Lane 6 IgA after incubation with Capnocytophaga 
strain 52 (IgA band removed). Lane 7 SIgA after 
incubation with Capnocytophaga strain. Lane 8 
Capnocytophaga incubated in PBS.
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Figure 3.18 SDS-PAGE of human S-IgA before and after 
incubation with strains of Capnocytophaga species. 
Lane 1 molecular weight markers. Lane 2 S-IgA in PBS. 
Lane 3 SIgA after incubation with Capnocytophaga 
strain 52. Lane 4 strain 52 in PBS. Lane 5 strain 
SIgA after incubation with Capnocytophaga strain 53. 
Lane 6 strain 53 in PBS. Lane 7 SIgA after incubation 
with Capnocytophaga strain 54. Lane 8 strain 54 in 
PBS. Lane 9 SIgA after incubation with H .aphrophilus 
strain 44. Lane 10 strain 44 in PBS. Lane '11 SIgA 
after incubation with H .aphropilus strain 40. Lane 12 
strain 40 in PBS. Secretory component (SC) arrows, is 
cleaved by all 3 Capnocytophaga strains
3.9 Summary of virulence factors produced by
A.actinomycetemcomitans # H.aphrophilus and
Capnocytophaga species
Twenty five A .actinomycetemcomitans, 3 0 H .aphrophilus
and Capnocytophaga species were examined in the current 
study for their ability to produce a number of 
virulence factors. These included the ability of the 
strains to haemagglutinate human erythrocytes, 
possession of leukotoxic activity, the ability to 
resist phagocytosis, the ability to cleave human IgA by 
means of IgA-protease and finally the ability to exert 
cytotoxic effects on cultured human skin fibroblasts.
I
| 3.9.1 A.actinomycetemcomitans
j
! The results obtained in the current study showed that
68% of tested strains possessed a haemagglutinating 
factor since they were able to haemagglutinate both 
human group A and group 0 erythrocytes. Five (20%) of 
tested strains killed both HL60 cells and human PMNLs 
as measured by the trypan blue and the inhibition of 
luminol-dependent chemiluminescence assays. All tested 
strains but one triggered a chemiluminescence response, 
these strains including both leukotoxic and non- 
leukotoxic strains. The single A .actinomycetemcomitans
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strain that failed to elicit a chemiluminescent 
response and which would therefore escape phagocytosis 
was the highly toxic JP2 strain. All tested strains but 
one inhibited the proliferation of cultured human skin 
fibroblasts, though none of the tested strains produced 
IgA protease. A summary of all results obtained with 
the tested strains is shown in Table 3.22.
3.9.2 Capnocytophaga species
; All tested Capnocytophaga strains were able to
I
I haemagglutinate human erythrocytes and to cleave human
|
| myeloma IgA. Three strains were tested for their
i
I susceptibility to phagocytosis by human PMNLs, and all
I
i
j 3 strains triggered a chemiluminescence response
j
indicative of phagocytic activity. Fifty five percent 
of tested Capnocytophaga strains were able to interfere 
with the proliferation of cultured human skin 
fibroblasts. None of the tested Capnocytophaga strains 
possessed leukotoxic activity. A summary of all 
results obtained with Capnocytophaga species are shown 
in Table 3.23.
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3.9.3 H .aphrophilus
The majority of H .aphrophilus strains agglutinated 
human erythrocytes. None of the tested strains 
possessed leukotoxic activity as measured by both 
assays employed in the current study, though all tested 
strains triggered a chemiluminescence response and 
appeared sensitive to phagocytosis. The majority of 
strains exerted cytotoxic effects against cultured 
human skin fibroblasts. None of the tested strains 
produced IgA-protease. A summary of all results
! obtained with H .aphrophilus strains is shown in Table
i
| 3.24.
! It is clear from the summarised results that
j  A.actinomycetemcomitans is capable of producing a range
i
i
! of virulence factors that may contribute to the
! pathogenesis of periodontitis. The results obtained in
the present investigation suggest that A.actinomycetem­
comitans possesses the highest potential of the three 
bacterial species studied to cause infection. 
Capnocytophaga species also produced an array of potent 
virulence factors that may damage the host tissues (for 
example the IgA-protease) . The results obtained with 
H .aphrophilus strains indicate that the potential of 
this bacterium to cause damage to the host is less than
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for A.actinomycetemcomitans or Capnocytophaga species. 
However, the majority of tested H.aphrophilus strains 
were able to produce a fibroblast inhibitory factor and 
possessed haemagglutination activity, in keeping with 
their ability to cause infection under certain 
circumstances. Additional studies are needed to define 
the true role of these capnophilic organisms in the 
aetiology of periodontitis.
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Table 3.22 Summary of the virulence factors produced by
A.actinomvcetemcomitans strains tested in the current study
Strain Haemagglutination Leukotoxicity Phagocytosis Cytotoxicity IgA-
protease
Aa 33 + - ND + -
Aa 34 + + ND + -
Aa 94 + - ND + -
Aa 96 + - ND + -
AalOO + - + + -
Aa 112 + - ND + -
Aa 113 + - ND + -
Aa 115 + - + + -
Aa 120 + - + + -
AaEl + - ND + -
Aa E8 + - ND + -
Aa E24 - + + + -
Aa E33 + - ND + -
ND not determined
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Table3.22 Continued
Strain Haemagglutination Leukotoxicity Phagocytosis Cytotoxicity IgA-
protease
Aa E35 + - ND + -
Aa E54 + - ND + -
Aa E56 + - ND + -
Aa E57 + - ND + -
Aa E74 + - ND + -
Aa E75 - - ND + -
Aa E76 - - ND + -
AaE79 - - + - -
Aa E80 - + + + -
Aa E81 - + + + -
Aa E83 - - + + -
Aa E88 - + - + -
ND not determined
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Table 3.23 Summary of virulence factors produced by Capnocvtophaga species
tested in the current study
Strain Haemagglutination Leukotoxicity Phagocytosis Cytotoxicity IgA-
protease
Cap 52 + - + + +
Cap 53 + - ND + +
Cap72 + ND ND + +
Cap 81 + - ND ND +
Cap 170 + ND ND - +
Cap 174 + ND ND - +
Cap 176 + ND ND - +
Cap 179 + ND ND - +
Cap183 + ND ND + +
Cap 90 + - + + +
Cap 15 ND - + ND ND
Cap 30 ND - ND ND ND
Cap 45 ND - ND ND ND
Cap 65 ND - ND ND ND
ND not determined
195
Table 3.24 Summary of the virulence factors produced by
H .aphrophilus strains tested in the current study
Strains Haemagglutination Leukotoxicity Phagocytosis cytotoxicity IgA-
protease
Ha 40 + - + + -
Ha 41 + - ND + -
Ha 42 + - ND + -
Ha 43 + - ND + -
Ha 44 + - + + -
Ha 46 + - + + -
Ha 58 + - ND - -
Ha 59 + - ND - -
Ha 60 + - ND + -
Ha 61 + - ND + -
Ha 62 + - ND + -
Ha 63 - - ND + -
Ha 67 + - ND + -
Ha 68 + - ND + -
ND not determined
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Table 3.24 continued
Strain Haemagglutination Leukotoxicity Phagocytosis Cytotoxicity IgA-
protease
Ha 75 + - ND + -
Ha 76 + - ND + -
Ha 77 + - ND + -
Ha 78 + - ND + -
Ha 79 + - + + -
Ha 80 + - + + -
Ha 82 + - + + -
Ha 83 + - + + -
Ha 86 + - ND + -
Ha 92 - - ND + -
Ha 97 + - + + -
Ha 99 + - ND + -
Ha 104 + - + + -
Ha 109 + - ND + -
Ha 110 + - ND + -
Ha5886 + - + - -
ND not determined
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Chapter 4 
Discussion
4.1 The Isolation of A . actinomycetemcomitans. 
H .aphrophilus and Capnocytophaga species from 
subgingival plaque samples
4.1.1 The isolation of A.actinomycetemcomitans
The fresh A.actinomycetemcomitans strains used in this 
study were either freshly isolated from subgingival 
plaque samples from patients with different forms of 
periodontal disease or were previously isolated strains 
stored at -70°C at Glasgow Dental Hospital and School. 
A.actinomycetemcomitans was isolated from only 11 (6%)
of 170 sites from 49 subjects with different forms of 
periodontal disease and even though, the initial 
diagnosis was available and of the 4 9 subjects, 23 were 
diagnosed initially with chronic periodontitis, 9 
patients with rapidly progressive periodontitis, 14 
patients having persisting pockets following a hygiene 
phase therapy and their clinical diagnosis was unknown 
and 3 patients with unknown clinical diagnosis, the 
complete clinical diagnoses of the subjects 
investigated in the present study were not completely 
known. The prevalence of A.actinomycetemcomitans in 
these patients was lower than expected and 
substantially lower than what has been reported
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previously in the literature (Slots et a l ., 1982;
Zambon, 1985). Slots et al., (1982) reported that
A. actinomycetemcomitans was isolated from 26 of 27 
patients with juvenile periodontitis compared to only 
24 of 142 healthy individuals. Petit et al. , (1993)
reported the isolation of A.actinomycetemcomitans from 
16 subjects with adult periodontitis patients out of 13 
families participated in a study regarding the 
transmission of A.actinomycetemcomitans in families 
with adult periodontitis, though 5 subjects were 
children and the total number of subjects consisted of 
13 couples and 26 children. The reason for this lower 
prevalence of A. actinomycetemcomitans among the 
subjects used in the present study was not clear. One 
explanation is the frequent isolation of Streptococcus 
species from the subgingival plaque samples used in the 
present study, since it was observed that in all 
samples where A.actinomycetemcomitans was isolated it 
was isolated in almost pure culture. It has been shown 
that certain Streptococcus species can suppress the 
growth of A.actinomycetemcomitans (Slots, 1982; Hillman 
and Socransky, 1989; Socransky and Haffajee, 1992). 
Streptococcus species were present in virtually all
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other samples, suggesting that bacterial antagonism 
against A.actinomycetemcomitans may have occurred.
The selective medium TSBV was employed for the recovery 
of A.actinomycetemcomitans from the subgingival plaque 
samples. This medium has been used by a number of 
workers for the isolation of A.actinomycetemcomitans 
(Taher, 1990; Asikainen, Alaluusua and Saxen, 1991; 
Papapanou et al. , 1993), since it has been shown that
the TSBV medium resolved a number of problems 
encountered when other media, for example Chocolate 
agar medium or Malachite green medium, were used for 
the isolation of this organism. Chocolate agar medium 
is not sufficiently selective and supports the growth 
of a number of organisms like Haemophilus species, 
Streptococcus species and Neisseria species, which 
hamper the isolation of A.actinomycetemcomitans. 
Malachite green inhibits the growth of 
A.actinomycetemcomitans strains even at low 
concentrations (Slots, 1982). An additional advantage 
of the TSBV medium is that it contains no haem and, 
therefore, the catalase test, which is an important 
test used to distinguish A.actinomycetemcomitans from 
the closely related H .aphrophilus. can be performed 
directly on colonies on the plate. Taher (1990) also
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found that the TSBV medium was substantially better 
than the malachite green medium for the isolation of 
A.actinomycetemcomitans from subgingival plaque 
samples. Although the use of TSBV medium reduced the 
number of contaminating bacteria present in the 
samples, in the present study it still supported the 
growth of Streptococcus species, in spite of the 
presence of vancomycin. This was contrary to a report 
by Slots (1982).
4.1.2 The identification of A.actinomycetemcomitans
In the present study A.actinomycetemcomitans isolates 
were identified on the basis of their colonial 
morphology, catalase production and biochemical 
characteristics.
Colonial morphology of A.actinomycetemcomitans
The colonial morphology of A.actinomycetemcomitans is 
an important feature used for the isolation of this 
organism from primary cultures. The colonial morphology 
of A.actinomycetemcomitans on TSBV medium in primary 
cultures is distinct. The colonies are adherent to the 
agar surface and are star-shaped. In a number of 
reported studies, this was the only colonial type
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recognised as A.actinomycetemcomitans (Slots, 1982; 
Kaplan et al. , 1989) though, in the present study and
in previously conducted studies in this laboratory 
(Taher, 1990) both star-shaped and non star-shaped 
colonies were produced by A.actinomycetemcomitans on 
primary isolation. Furthermore, Taher (1990) showed 
that more A.actinomycetemcomitans isolates produced 
non star-shaped colonies than those produced the star­
shaped colonies. It was also observed in this study 
that organisms other than A.actinomycetemcomitans and 
H .aphrophilus were capable of producing a star-shaped 
colony including some Gram-positive cocci. Therefore, 
the selection of only star-shaped colonies may result 
in under reporting of samples which are positive for 
A.actinomycetemcomitans. Representative star-shaped 
colonies of A .actinomycetemcomitans. H.aphrophilus and 
one unknown Gram-positive organism are shown in Figure 
4.1. The star-shaped colonies usually lost this 
characteristic after subculturing an observation 
already reported in the literature (Slots, 1982).
Catalase test
Catalase production is an important characteristic in 
identifying A.actinomycetemcomitans isolates on primary
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Figure 4.1 (A and B) A representative 
A. actinomycetemcomitans star-shaped colony (photopraph 
a) and representative H ,aphrophilus star-shaped colony 
(photograph b).

cultures. The test is used to distinguish between the 
very similar colonies produced by A.actinomycetemcomit- 
ans and H .aphrophilus. It is generally accepted that 
A.actinomycetemcomitans strains are catalase producers. 
(Zambon, 1985; Kaplan, 1989; Papapanou et al. , 1993).
This was in agreement with the results obtained in the 
present study, as all A.actinomycetemcomitans strains 
isolated were catalase positive. However, it is 
important to mention that catalase negative 
A.actinomycetemcomitans strains have been isolated 
infrequently from subgingival plaque samples (Tanner et 
al. , 1982; Miyasaki, Wilson and Genco, 1986) . Baehni
et al., (1979) reported that the
A.actinomycetemcomitans strain Y4 was catalase negative 
which is very surprising as other studies, including 
the present study, found the strain Y4 to be a catalase 
producer. Tanner et al. , (1982) reported that 3 of 15
A.actinomycetemcomitans strains were catalase negative, 
though no information was given about the test and how 
it was performed. Miyasaki, Wilson and Genco (1986) 
also reported the variability of A.actinomycetemc­
omitans strains with respect to catalase activity. If 
the catalase production is not a consistent feature of 
A. actinomycetemcomitans. then a large number of the
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reported A.actinomycetemcomitans prevalence studies are 
questionable in their findings, since most workers have 
used catalase production as a key test for 
identification of the organism. Indeed, some studies 
have used the colonial morphology and catalase 
production only for the identification of 
A.actinomycetemcomitans strains isolated from 
subgingival plaque samples (Papapanou et al., 1993). 
Biochemical tests are essential for the formal 
identification of these bacteria.
Biochemical characteristics of A.actinomycetemcomitans
In the present study the commercial system API 20A was 
used for the biochemical characterization of the 
isolated A.actinomycetemcomitans strains. The system 
contains 20 different biochemical tests that can be 
inoculated with a standard suspension of the organism. 
The system is a very convenient and rapid way of 
testing large numbers of strains. The biochemical 
characteristics of A. actinomycetemcomitans are listed 
in Table 3.4. Results obtained with the system were in 
agreement with some of the reported studies. Tanner et 
al. , (1982) reported similar results for carbohydrate
fermentation, though they reported negative catalase
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results for some strains. The results obtained in the 
present study were in agreement with those reported by 
King and Tatum (1962) and Kaplan et al., (1989) .
It is clear from the ongoing discussion that there are 
some differences in certain biochemical characteristics 
of A.actinomycetemcomitans. These differences are more 
evident with the reported variable tests rather than 
the confirmed positive or negative tests. This may be 
related to differences in the experimental methods, the 
type and source of the basic chemicals and media used 
for these tests. The API 2 0A system resolved a number 
of these problems and it provided a very reliable, 
rapid way of identifying this organism.
4.1.3 The sensitivity of A.actinomycetemcomitans 
strains to antibiotics
The susceptibility of A. actinomycetemcomitans strains 
to four antibiotics was tested in vitro. The results 
obtained in the present study showed that all tested 
strains were sensitive to tetracycline, the majority of 
the strains were sensitive to ampicillin and 
erythromycin but a large number of strains were 
resistant to penicillin. The results of the present 
study are in agreement with those reported by Slots et
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al. , (1980) for tetracycline sensitivity, as they
showed that all tested strains (59) were susceptible to 
tetracycline at small concentrations (2(j,g/ml) . However, 
there were differences with regard to other 
antibiotics. For example, in the present study 92% of 
strains were sensitive to ampicillin while in a study 
by Slots et al., (1980) 83% of the strains were
sensitive to ampicillin but at a much higher 
concentration (about 3 times the concentration used in 
the present study). Similarly, in the current study 80% 
of the strains were highly susceptible to erythromycin 
while Slots et al. , (1980) reported that only 53% of
the strains were sensitive to the same antibiotic at a 
comparable concentration. However, the results of the 
present study were substantially different from those 
of Slots et al . , (1980) with regard to penicillin
sensitivity. Thus the results of this study showed that 
only 12% of the test strains were sensitive 
to 1 unit (0.6 |4,g/ml) of penicillin whereas Slots et 
al., (1980) found that about 54% of strains were
sensitive to penicillin at 4|j,g/ml. The differences in 
the susceptibility is probably due to the difference in 
the concentration of antibiotic used, although 
differences in the assay methods employed and the
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number of strains tested in each of the studies may 
also be involved. Kaplan et al. , (1989) in a review of
the literature reported that A.actinomycetemcomitans 
strains were highly susceptible to tetracycline, which 
is in agreement with the results of the present study. 
However, they reported that about 50-80% of 145 
A.actinomycetemcomitans strains in the reviewed studies 
were susceptible to ampicillin and about 50-80% of 100 
A.actinomycetemcomitans tested strains were susceptible 
to penicillin. In the present study 92% and 12% of the 
25 A.actinomycetemcomitans strains tested were 
sensitive to ampicillin and penicillin respectively. 
Furthermore, Kaplan et al. , (1989) reported that less
than 3 0% of A.actinomycetemcomitans strains were 
sensitive to erythromycin a finding which was not 
supported by the results of the present study, in which 
about 80% of the tested strains were sensitive. The 
reasons for these differences were not clear, though 
they may be related to methodology, concentrations of 
antibiotic, or natural changes in the antibiotic 
susceptibility of this organism as a result of the 
clinical use of antibacterial agents.
207
4.1.4 The isolation of H.aphrophilus from subgingival 
plague samples
The H .aphrophilus strains used in this study were 
isolated from subgingival plaque samples taken from 
patients with different forms of periodontal disease. A 
total of 170 sites from 49 subjects were sampled and 
processed; 59 (35%) proved to be positive for
H .aphrophilus. most of the sites positive for this 
bacterium showed heavy growth.
There is very little information about the prevalence 
of H .aphrophilus strains in periodontal disease or 
about their clinical significance. Only a few studies 
have addressed the role of H.aphrophilus and this was 
merely for reasons of comparison, since it is very 
closely related to A.actinomycetemcomitans. In the 
present study, H .aphrophilus was initially isolated by 
using the selective medium TSBVF (Tempro and Slots,
1986) . A.actinomycetemcomitans was reported as 
sensitive to sodium fluoride and inhibited on TSBVF 
medium (Tempro and Slots, 1986) . This medium is very 
similar to the TSBV medium, but in addition contains 
sodium fluoride. In the present study the TSBVF medium 
was used initially together with the TSBV medium, to 
selectively isolate H .aphrophilus and
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A.actinomycetemcomitans respectively. However, it was 
observed during the early stages of the study that 
there was not much difference between the organisms 
cultured on both media, contrary to what Tempro and 
Slots (1986) had reported. For this reason it was 
decided that only the TSBV medium would be used, since 
it supported the growth of both organisms equally well. 
Tempro and Slots (198 6) reported the isolation of 
H.aphrophilus from 52% of subgingival plaque samples 
collected from 11 out of a group of 14 subjects. Its 
contribution to the total subgingival microflora at 
diseased sites was lower than at healthy sites and the 
authors concluded that H .aphrophilus plays no role in 
advanced periodontal disease (Tempro and Slots, 1986). 
In the present study no attempt was made to calculate 
the proportion of H .aphrophilus in the total microflora 
of the subgingival plaque samples, though the overall 
prevalence of H.aphrophilus in the subgingival sites
35% was slightly lower than the 52% reported by Tempro
and Slots (1986). Liljemark et al. , (1984) in a study
to demonstrate the distribution of oral Haemophilus 
species in dental plaque reported the isolation of 
H . aphrophilus from 7 (50%) of the subgingival sites
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sampled among 14 subjects and from 4 (29%)
supragingival sites from the same 14 subjects.
4.1.5 Identification of H .aphrophilus
H.aphrophilus was isolated and identified on the basis 
of colonial morphology, negative catalase reaction and 
biochemical characterization.
The colonial morphology of H .aphrophilus is very 
similar to the colonial morphology of 
A.actinomycetemcomitans on primary culture. Cultures 
were examined for both star-shaped and non star-shaped 
colonies which were purified by culture; after a few 
subcultures all colonies lost the star-shaped 
characteristic. Tempro and Slots (1986) in their 
characterization of H .aphrophilus oral isolates did not 
mention the ability of H .aphrophilus colonies to form 
the star-shape on primary culture. Their description of 
the smooth type colonies, however, is in agreement with 
the appearance of these colonies in the current study. 
The catalase test was used to differentiate between the 
colonies of both H.aphrophilus and A.actinomycetemcom­
itans . In the present study all H.aphrophilus isolates 
were catalase negative, in agreement with all reported 
studies in the literature (Tempro and Slots, 1986) .
210
Biochemical characterization of H .aphrophilus strains
In the present study the identification of 
H .aphrophilus was performed by using the API 2 0A 
system. The identification of H .aphrophilus was based 
on the fermentation of glucose, lactose, saccharose and 
maltose together with a negative catalase test. The 
results obtained with the API 2 0A system for
H .aphrophilus oral isolates were in agreement with all 
reported studies (King and Tatum, 1962; Liljemark et
al. , 1984; Tempro and Slots, 1986) .
4.1.6 The sensitivity of H .aphrophilus to antibiotics 
in vitro
In the present study, 4 antibiotics were tested against 
H .aphrophilus strains isolated from subgingival plaque 
samples. The results showed that the H.aphrophilus
strains were susceptible to all the antibiotics tested. 
Though, larger number of strains were sensitive to
tetracycline and ampicillin and the remaining strains 
were moderately sensitive. Results obtained in the 
present study were in agreement with the findings of 
Baker et al. , (1985). This group (Baker et al. , 1985)
studied 17 antibiotics, three of which (tetracycline,
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erythromycin and penicillin) were used in the current 
study. H.aphrophilus strains were found to be highly 
sensitive to tetracycline and erythromycin, though a 
higher concentration of penicillin was required 
according to Baker et al., (1985). Similar results were
obtained in the current study.
4.1.7 The isolation of Capnocytophaga species from 
subgingival plaque samples
The identification of Capnocytophaga species was based 
on colonial morphology and Gram stain reaction only. 
Colonies of Capnocytophaga species on CBA plates were 
distinct and easily distinguishable from other colonies 
on the plate. Biochemical characterization was 
attempted by using the Minitek Anaerobe Identification 
System but it was unsuccessful with poor 
reproducibility. The identification of the 
Capnocytophaga isolates to the species level was not, 
therefore, possible by using the Minitek system. The 
isolation of Capnocytophaga species was based on the 
distinct colonial and morphological characterization. 
Similar identification procedures were used by 
Papapanou et al. , (1993) as these authors used only
cultural and morphological characteristics and a
motility test for the isolation of Capnocytophaga
species. It has to be mentioned though that the Minitek
system can be used for the identification of certain 
Capnocytophaga species (for example C.ochracea) though 
not other Capnocytophaga species. In the current study 
Capnocytophaga species were isolated from a large 
proportion (53%) of the 170 subgingival plaque samples. 
Some early reports in the literature suggested that 
Capnocytophaga species might be important in the
aetiology of periodontal disease (Newman et al. , 1976;
Slots and Genco, 1984) but the evidence supporting this 
claim is contradictory and not conclusive. Furthermore, 
in a recent review of the currently suspected
periodontal pathogens (Socransky and Haffajee, 1994) 
Capnocytophaga species were not included. In fact it 
has been shown that some Capnocytophaga species, for 
example C. ochracea. may be beneficial to the host in 
some cases (Socransky and Haffajee, 1992) . Papapanou et 
al. , (1993) reported that Capnocytophaga species were
isolated from subgingival plaque samples of 32% of 171 
randomly selected individuals, though there was no 
correlation between the isolation of Capnocytophaga 
species and the periodontal conditions of the subjects.
213
In the present study the prevalence of Capnocytophaga 
species was slightly higher than that reported by
Papapanou et al. , (1993) . Mashimo et al. , (1983) also
reported the isolation of Capnocytophaga species from
15 subgingival plaque samples from 5 patients with 
advanced periodontitis, a higher prevalence than that 
obtained in the present study. However, Mashimo et al., 
(1983) used a selective medium for the recovery of 
Capnocytophaga species as opposed to the non-selective 
medium (CBA) used in the current study. This may 
account for the differences observed between the two 
studies. A number of studies have reported the 
isolation of Capnocytophaga species from subgingival 
plaque samples taken from patients with different 
periodontal conditions and from healthy individuals.
For example, Moore et al. , (1983) reported the
isolation of Capnocytophaga species from subgingival 
plaque samples from patients with moderately sever 
chronic periodontitis. However, they were considered 
unimportant as direct causative agents since they were 
isolated in equal or greater numbers from healthy 
individuals (Moore et al, 1983).
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4.1.8 The sensitivity of Capnocytophaga species to 
antibiotics
The Capnocytophaga species isolated in the present 
study were tested for their susceptibility to four 
antibiotics. The results showed that all tested 
Capnocytophaga strains (34) were highly susceptible to 
tetracycline, erythromycin and ampicillin.
Susceptibility to penicillin varied among strains, as 
some strains were sensitive and others were only 
moderately sensitive. Mashimo et al. , (1983) reported
that Capnocytophaga strains were highly sensitive to 
tetracycline, ampicillin, erythromycin and penicillin, 
in agreement with the results obtained in the current 
study. Baker et al. , (1985) also tested a number of
Capnocytophaga strains for their susceptibility to a 
range of antibiotics. They demonstrated the sensitivity 
of this organism to tetracycline, penicillin and 
erythromycin, though a higher concentrations of 
tetracycline relative to the other two antibiotics was 
required, since Baker et al., (1985) reported that 25|aM 
of tetracycline were required to inhibit 90% of the 
tested strains, compared to only 1.6|iM/ml and 3.2|iM/ml 
for penicillin and erythromycin respectively. This 
result is in agreement with that obtained in the
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present study. Recently Garces et al . , (1994) reported
the isolation of a C.sputigena strain which was 
resistant to a number of p-lactam antibiotics, 
including ampicillin. The authors concluded that 
sensitivity testing should be performed on isolates 
from all patients with infections caused by 
Capnocytophaga species or any other capnophilic 
organisms present in their oral microflora.
4.1.9 Conclusions
H .aphrophilus was isolated from 35% of 170 subgingival 
plaque samples from 49 subjects with different 
periodontal conditions.
A.actinomycetemcomitans was isolated from only 6% of 
170 subgingival plaque samples by using the selective 
medium TSBV.
Capnocytophaga species were isolated from the larger 
proportion (53%) of 170 subgingival plaque samples.
All three organisms, which form the subject of this 
thesis, were sensitive to tetracycline, erythromycin 
and ampicillin, though the susceptibility to penicillin 
was variable.
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4.2 Haemagglutination of human erythrocytes of blood 
groups A and 0 by A . actinomycetemcomitans. 
H .aphrophilus and Capnocytophaga strains
The adherence of pathogenic bacteria to host surfaces 
is an essential step for colonization, invasion and 
subsequent production of disease. In the present study 
the ability of A. actinomycetemcomitans. H .aphrophilus 
and Capnocytophaga strains to adhere to oral surfaces 
was addressed by testing the ability of these groups of 
organisms to haemagglutinate human group A and group 0 
erythrocytes. Others have already shown that the 
ability of microorganisms to haemagglutinate 
erythrocytes from different sources can be used as a 
model to study the interaction between bacterial cells 
and other cell types, for example epithelial cells 
(Duguid, Clegg and Wilson, 1979) . The results obtained 
in the current study for the A.actinomycetemcomitans 
strains showed that 18 (72%) of the 25 tested strains
were able to haemagglutinate both group A and 0 human 
erythrocytes. About 30% of the positive strains had a 
titre of 8, while the remaining 42% of positive strains 
had a titre of 2 or 4. Haemagglutination titres of 2 or 
4 are extremely low and some would suggest that they be 
viewed as negative. However, in other reported studies
the ability of certain organisms to haemagglutinate 
erythrocytes has been measured visually without
calculating titres (Majeed and Macrae, 1994). There are 
a number of studies in the literature which indicate 
the ability of A.actinomycetemcomitans to adhere to 
host tissues. Rosan et al. , (1988) illustrated the
ability of A.actinomycetemcomitans to adhere to
hydroxyapatite by using fimbriated and non-fimbriated 
variants. Taher and MacFarlane (1991) reported the 
ability of A.actinomycetemcomitans strains to adhere to 
human buccal epithelial cells in vitro. Mintz and
Fives-Taylor (1994) also reported the ability of
A.actinomycetemcomitans to adhere to the cultured human 
oral cell line KB as measured by an enzyme linked 
immunosorbent assay or (H3)thymidine labelled adhesion 
assay. Okuda and Kato (1987) demonstrated the ability 
of certain lipopolysaccharides prepared from a number 
of subgingival plaque bacteria, including
A.actinomycetemcomitans to haemagglutinate human and 
animal erythrocytes. They reported that
lipopolysaccharide from the strain Y4 agglutinated 
human erythrocytes of groups A and 0 (Okuda and Kato, 
1987). Several mechanisms have been suggested for 
adherence of A. actinomycetemcomitans to host tissues.
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For example, fimbriae are believed to play a role in 
some cases (Rosan et al. , 1988), but extracellular
microvesicles derived from some strains of 
A.actinomycetemcomitans have also been shown to 
function in adhesion (Meyer and Fives-Taylor, 1993).
The results of the present study regarding the ability 
of A.actinomycetemcomitans to haemagglutinate human 
erythrocytes also indicate ability of some strains to 
bind to host tissue.
Of the 3 0 H .aphrophilus strains tested in the present 
study, 28 (93%) were recorded as haemagglutination
positive though only 7% had a titre of greater than 4, 
and overall the haemagglutination activity was lower 
than for A.actinomycetemcomitans. There are few studies 
in which the question of H .aphrophilus adherence has 
been addressed. Sweet, MacFarlane and Samaranayake 
(1988) examined a number of oral bacteria for their 
ability to adhere to human buccal epithelial cells in 
vitro, and H.aphrophilus was among the test group. They 
reported that H .aphrophilus adhered to buccal 
epithelial cells, though not strongly. Furthermore, it 
was shown that freshly isolated strains of
A.actinomycetemcomitans were more hydrophobic than the 
freshly isolated strains of H.aphrophilus (Holm and
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Kalfas (1991) and a correlation between hydrophobicity 
and the ability of oral bacteria to adhere is well 
recognised (Taher, 1990). The haemagglutination results 
for H .aphrophilus may, therefore, reflect the ability 
to adhere.
Ten Capnocytophaga species were tested for their 
ability to haemagglutinate human erythrocytes. All 
tested strains were able to haemagglutinate both group 
A and group O human erythrocytes, producing very high 
titres, as 50% of the strains had a titre of 32 or 
more, while the remaining 50% had a titre of 8 or 16. 
These results may reflect the ability of this organism 
to adhere and colonize the host tissues, since it has 
been shown that certain Capnocytophaga strains were 
able to adhere to human buccal epithelial cells in 
vitro (Sweet, MacFarlane and Samaranayake, 1988) . There 
are no similar studies regarding the ability of 
Capnocytophaga species to haemagglutinate human 
erythrocytes, though the lipopolysaccharide isolated 
from C.gingivalis strain ATCC 33624 has been shown to 
haemagglutinate human erythrocytes. No haemagglutinati­
on was observed when the lipopolysaccharide from 
C.ochracea strain ATCC 33596 was tested.
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The results obtained in the present study regarding the 
ability of these groups of organisms to haemagglutinate 
human erythrocytes were variable, with Capnocytophaga 
species being the strongest and H .aphrophilus the 
weakest.
Various sugars can inhibit the attachment of certain 
oral bacteria to surfaces. For example binding of 
E .corrodens to human buccal epithelial cells is 
inhibited by sugars containing D-galactose and N- 
acetyl-D galactoseamine. Mannose inhibited the binding 
of E .corrodens only moderately (Yamazaki, Ebisu and 
Okada, 1981), which suggests that carbohydrate 
receptors on either the bacterial surface or the target 
cells to which they adhere are important determinants 
of adherence. Haemagglutination inhibition by certain 
sugars was attempted in this study, though the results 
obtained with both A.actinomycetemcomitans and 
H .aphrophilus were not conclusive, perhaps because of 
the lower titres in the absence of sugars. However, not 
all such interactions involve carbohydrate receptors. 
For example the attachment of the oral pathogen
B.gingivalis to erythrocytes was resistant to sugars 
(Okuda et al. , 1986). The authors related this result
to the fact that the haemagglutinin of B . gingivalis
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could bind specifically to proteinaceous material 
associated with amino acid residues, and similar 
ability may also exist among strains of the 
A.actinomycetyemcomitans and H.aphrophilus.
The ability of mannose to inhibit the haemagglutination 
of three Capnocytophaga strains with very strong 
haemagglutination activity was tested in the present 
study. The results indicated that all 3 strains were 
sensitive to mannose suggesting that the bacterial 
lectin-like surface components are important 
determinants of adherence and the attachment of 
Capnocytophaga species to erythrocytes.
4.2.1 Conclusions
Of the 25 A.actinomycetemcomitans strains tested 18 
(72%) were able to haemagglutinate human erythrocytes 
of groups A and 0.
Of the 30 H.aphrophilus strains tested 28 (93%) were
shown to possess haemagglutination activity against 
human erythrocytes.
All tested Capnocytophaga strains were shown to possess 
strong haemagglutinating activity against human 
erythrocytes.
The haemagglutination activity of 3 Capnocytophaga
strains was sensitive to mannose.
4.3 Leukotoxic activity in A.actinomycetemcomitans. 
H .aphrophilus and Capnocytophaga strains as measured by 
the trypan blue exclusion and chemiluminescence assays
4.3.1 Experimental methods
A number of methods have been used for the detection 
of leukotoxic activity in A.actinomycetemcomitans. 
These include the inhibition of 51Cr release, lactate 
dehydrogenase release, trypan blue exclusion and less 
frequently used electron microscopic examination 
methods (Baehni et al., 1981; Rabie, Lally and Shenker, 
1988; Tsai et al. , 1984). Other techniques have been
employed for the detection of related toxins (eg 
Pasteurella haemolytica leukotoxin), including the 
reduction of the tetrazolium dye MTT (Vega et al., 
1987) and a luminol-dependent chemiluminescence 
inhibition assay (Chang and Renshaw, 1986; Chang et 
al., 1986).
In this study two different assay systems, the trypan 
blue exclusion with HL60 cells and luminol-dependent 
inhibition with human PMNLs assays were used to detect
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leukotoxic activity
A.actinomycetemcomitans. 
Capnocyt ophaga species.
among strains of
H.aphrophilus and
4.3.2 Criteria used to determined the leukocytotoxicity 
by both assay systems 
Trypan blue exclusion assay
In the trypan blue assay, dead cells are stained with 
trypan blue while live cells exclude the dye. The 
percentage of dead target cells was calculated by 
directly counting dead and live cells by light 
microscopy. There are only a few studies where the 
trypan blue exclusion was used as an indicator of 
leukotoxicity to HL60 cells and human PMNLs and no 
criteria have been agreed by which a strain can be 
defined as leukotoxic. Although a number of 
investigators have used trypan blue to measure the 
leukotoxicity of A.acinomycetemcomitans. they have not 
defined clearly the cut-off point employed. For example 
Ohta et al. , reported a value of 30% or more, while 
Tsai et al. , (1979) reported a value of < 95% for human
PMNLs though the cut-off point was not indicated in 
both studies. Furthermore some of these workers did not
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even show any data related to the trypan exclusion 
assay (Baehni et al. , 1981). The percentage of dead 
cells reported for human PMNLs are different: Ohta et 
al. , (1987) reported a value of 30% or more, while Tsai
et al. , (1979) reported a value of more than 95% when
human PMNLs were exposed to A. actinomycetemcomitans 
strain Y4 and more than 90% when human monocytes were 
the targets. Taichman and Wilton (1981) examined the 
ability of sonic extracts prepared from 
A.actinomycetemcomitans strain Y4 to destroy human 
PMNLs by leukotoxin and showed that the strain Y4 was 
leukotoxic to human PMNLs (56% kill) as measured by 
the trypan blue exclusion assay. Zambon et al. , (1983)
reported a value of more than 60% death for HL60 cells 
when they were exposed to the leukotoxic strain Y4, 
compared to 15% for HL60 cells unexposed to leukotoxin. 
Rabie, Lally and Shenker (1988) reported a percentage 
death of 80-85% of the total target cells exposed to 
leukotoxin, using human monocytes as targets.
In this study any strain which killed 30% or more of 
the target cells after subtracting the negative control 
value was considered leukotoxic. Although other workers 
have reported higher values, they failed to mention the 
threshold value for leukotoxicity, and it was
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considered reasonable in this study to accept a kill 
of 3 0% as the lower limit of leukotoxicity. This same 
figure has been reported by other workers (Ohta et al. ,
1987), although, it was obtained with a single 
A.actinomycetemcomitans leukotoxic strain, and it was 
not considered as the cut-off point for deciding 
whether a strain is leukotoxic or non-leukotoxic.
Luminol-’dependent chemi luminescence inhibition assay
Chemiluminescence has not been employed previously to 
distinguish between leukotoxic and non-leukotoxic 
strains of A.actinomycetemcomitans and no figures are 
available to indicate the lower limit of significant 
activity. In the present study the cut-off-point was 
set at about 50% reduction or inhibition of the 
chemiluminescence peak produced by PMA-stimulated human 
PMNLs (control cells) at 37°C for 40 minutes. The 50% 
reduction was chosen to allow for the variability in 
PMNL chemiluminescence responses that may occur, since 
it was observed that PMNLs responses vary from one 
individual to another and also from the same individual 
at different times (Stevens, Winston and Van Dyke, 
1978) . Such variability was also observed during the
course of these experiments and by other workers (Dr. 
M.Saddati, personal communication).
4.3.3 Leukotoxic activity of A.actinomycetemcomitans 
Type strains
In the present study a total of 5 A.actinomycetemcomi­
tans type strains were tested for their leukotoxic 
activity by using the trypan blue exclusion assay. 
Based on the criteria used in this thesis, three 
strains \A .actinomycetemcomitans Y4 (E81), JP2 (E88) 
and ATCC 29524 (E80) ] were leukotoxic. Strain JP2 was
the most toxic of all strains, killing more than 63% of 
HL60 cells, while the two other type strains were non­
toxic [ATCC 29523 (E79) and NCTC 9710 (E83)]. The
leukotoxicity of these type strains have been studied 
by a number of workers and even though some of these 
strains were investigated more frequently than others, 
in several studies similar results have been reported 
(Table4.1). The leukotoxic type strains in this study 
have been shown to be leukotoxic in other studies 
(Baehni et al. , 1981; Simpson, Berthold and Taichman,
1988; Iwase et al., 1990). However, Tsai et al., (1978)
reported that A.actinomycetemcomitans strain Y4 was not
cytotoxic to human PMNLs, but in a later report (Baehni 
et al., 1979) by the same group strain Y4 was 
recorded as leukotoxic to human PMNLs. These workers 
related the discrepancy to the growth medium and
conditions under which the non-cytotoxic strain was 
grown (Baehni et al. , 1979). The significance of this
finding is not clear, since virtually all other studies 
using the same strain (Y4) have indicated that it is 
leukotoxic to both commonly used targets (human PMNLs 
and HL60 cells) under a number of different 
experimental conditions (Baehni et al., 1981; Zambon et 
al., 1983; Taichman et al., 1991)(Table 4.1).
There are several studies where the leukotoxicity of 
these type strains were reported and in spite of the 
fact that the experimental conditions employed in the 
present study were different from those reported in
other studies, (for example the growth medium and
conditions employed, together with the criteria by 
which a leukotoxic strain is defined), the results 
obtained were similar. However, the reported values 
for certain strains varied from one study to another as 
shown in Table 4.1, for example the value reported for 
the strain Y4 was about 96% in a study reported by
Baehni et al. , (1979), while Taichman and Wilton (1981)
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reported a value of 56% though the target cells in both 
studies was human PMNLs. In spite of the different 
conditions used in both studies as in the first study- 
whole cells were used while in the second sonic cell 
extract was used. Ohta et al. , (1987) reported a value
of 30% kill. Furthermore, Zambon et al., (1983)
reported a value of only 60% though the target cells 
were HL60 which were shown to be slightly more 
sensitive than PMNLs. The reasons for this variability 
are not clear, but perhaps it is not surprising due to 
the lack of defined criteria for leukotoxicity and 
consistency in assay methodology in different studies. 
The latter may be especially important since it has 
been shown that the sensitivities of a number of 
commonly used assays for the detection of 
leukotoxicity differ in their sensitivity (Chang and 
Renshaw, 1986) .
There is not much information in the literature 
concerning the trypan blue exclusion assay which was 
used in the present study, especially when HL60 cells 
are employed as the target cells. However, a few 
studies have reported the use of trypan blue exclusion 
as an indicator of leukotoxicity (Table 4.1). Zambon et 
al. , (1983) reported that the trypan blue staining of
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HL60 cells exposed to A.actinomycetemcomitans strain 
Y4, revealed that more than 60% of HL60 cells were 
killed compared to 15% for the unexposed HL60 cells. In 
Zambon et al., (1983) study A.actinomycetemcomitans
strain Y4 was the only type strain stained with trypan 
blue, though 3 other type strains were examined in the 
study. The authors did not refer to or discuss the 
suitability of using trypan blue exclusion with HL60 
cells for the detection of leukotoxic activity of 
A.actinomycetemcomitans. considering the variability 
between the reported values for the same strain Y4 in 
different studies. The results obtained in the present 
study were comparable with those reported by Zambon et 
al. , (1983), since 50% killing of HL60 was the value
obtained for the same Y4 strain.
More recently Brogan et al. , (1994) examined a number
of A.actinomycetemcomitans strains for their leukotoxic 
activity against the HL60 cell line and the trypan blue 
exclusion was used as an indicator for leukotoxic 
activity. A number of type strains were included and 
some of these strains were also tested in the current 
study (JP2, Y4, ATCC 29523, ATCC 29524 and NTCC 9710). 
The leukotoxic activity was measured by calculating the 
LD50 which was defined as the number of bacteria
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required to kill 50% of 2xl05 HL60 cells in 1 hour at 
3 7°C. The results reported indicated that strain JP2 
was the most toxic strain. The remaining strains were 
less toxic, as even the commonly reported leukotoxic Y4 
strain expressed 20-fold lower toxicity to HL60 cells 
while strain ATCC 2 9524 expressed about 10-fold lower 
toxicity than the JP2 strain. This result compares to 
the results obtained in the present study in spite of 
the differences in the experimental conditions 
employed. However, the more surprising result reported 
by Brogan et al. , (1994) was that of the strain NCTC
9710 which was shown to be leukotoxic to HL60 cells and 
also with higher potency than the known leukotoxic 
strain Y4. The results obtained in the present study 
indicated that it is a non-leukotoxic strain as 
measured by the trypan blue exclusion assay.
The reason for this variability is not clear, though it 
may be the criteria used to identify leukotoxicity.
The two type strains used in the present study and 
found to be non-leukotoxic were strain ATCC 29523 and 
NCTC 9710. There was some variability with respect to 
the leukotoxicity of these type strains since most of 
the reported results of the ATCC 2 9523 strain have 
indicated variability of the leukotoxicity of this
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strain. Thus, it was originally reported as leukotoxic 
to human PMNLs (Baehni et al. , 1979; Spitznagel, Kraig
and Kolodrubetz, 1991) though negative results against 
both human PMNLs and HL60 cells have also been 
reported (Zambon et al. , 1983) . More recently Ohta et
al. , (1993) have shown that the strain ATCC 29523 was
leukotoxic when it was grown in a chemostat culture. 
More surprising was the finding that the reported non- 
leukotoxic strain ATCC 33384, the equivalent of NCTC 
9710, was also found to be leukotoxic (Ohta et al. , 
1993). Recently, in a study reported by Haubek et al. , 
(1995) it has been shown that a different 
epidemiological situation may exist between Europe and 
USA regarding the virulence of A.actinomycetemcomitans 
isolates. Particularly virulent clones, with high 
level production of leukotoxin, may be present in the 
USA but not in Northern Europe. This was previously 
reported by Brogan et al. , (1994) as they examined 97
A.actinomycetemcomitans strains originating from both 
Europe and USA and found that only two strains 
expressed high leukotoxic activity, both of which 
originated from the USA.
It is clear from the discussion above that there is 
some variation in the reported leukotoxicity values for
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A.actinomycetemcomitans type strains. This may result 
from the different criteria used to identify 
leukotoxicity when the trypan blue exclusion was used, 
since it varied from 30% (Ohta et al. , (1987) to 96%
(Baehni et al. , 1979), and it may be also due to the
different detection systems and their sensitivities. It 
may also be important to mention that most of the
reported studies have examined only a few strains, and 
sometimes only one strain was used. In spite of the
reported differences between different studies, the 
results obtained in the present study with 
A.actinomycetemcomitans type strains were comparable to 
those reported for the similar type strains in several 
other studies. Unless a standardized method taking into 
consideration all aspects of the assay, is established 
it will be difficult to compare results from different 
studies.
4.3.4 Leukotoxic activity of freshly isolated oral 
A.actinomycetemcomitans strains
Of the 20 fresh A.actinomycetemcomitans isolates, only 
two (10%) were leukotoxic to HL60 cells as measured by 
the trypan blue exclusion assay: strains E24 and 34
produced values of 61% and 3 7% respectively. There are
233
a number of studies where the leukotoxicity of fresh 
A.actinomycetemcomitans isolates has been measured. 
However, only a few of them used the trypan blue 
exclusion assay: Taher, for example, (1990) examined 12 
fresh A.actinomycetemcomitans isolates and showed that 
only one strain was leukotoxic, and killed about 33% of 
the target cells.
The leukotoxic activity among the fresh isolates tested 
in this study was not previously determined. However, 
similar studies using A.actinomycetemcomitans fresh 
isolates were performed by a number of researchers.
The prevalence of leukotoxic and non leukotoxic 
A.actinomycetemcomitans fresh isolates was examined by 
Zambon et al. , (1983) . They reported that 6% of 13
fresh A.actinomycetemcomitans isolates from 11 healthy 
individuals, were toxic to PMNLs, as were 43% of 14 
strains isolated from 13 patients with adult 
periodontitis, 75% of 4 strains isolated from 4 
patients with juvenile diabetic periodontitis, 66% of 3 
strains isolated from 2 patients with generalized 
juvenile periodontitis and 55% of 66 isolates from 25 
patients with localized juvenile periodontitis. 
However, data obtained with these leukotoxic fresh oral 
isolates were not shown as the authors indicated what
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percentage of tested strains were leukotoxic (Zambon et 
al. , 1983) . Furthermore, they have shown that a single
individual harboured both leukotoxic and non-leukotoxic 
A.actinomycetemcomitans strains. These findings of 
Zambon et al. , (1983) clearly indicate that leukotoxic
and non-leukotoxic strains were found within each 
subject group, though leukotoxic strains were found in 
significantly higher proportions in diseased subjects, 
especially among juvenile periodontitis patients. 
Baehni et al., (1981) examined 10 fresh
A.actinomycetemcomitans isolates for leukotoxic 
activity and they reported that the majority (70%) of 
tested strains were leukotoxic to human PMNLs. However, 
the trypan blue exclusion test was not used as an 
indicator for leukotoxicity (Table 4.1). Ohta et al. , 
(1987) reported that 8 (25%) of 32 freshly isolated
A.actinomycetemcomitans strains from 3 patients with 
rapidly progressive periodontitis, gingivitis and 
juvenile periodontitis were leukotoxic to human PMNLs. 
Chung et al. , (1989) reported that 10 (22%) out of 46
A.actinomycetemcomitans oral isolates were leukotoxic 
to human PMNLs. Therefore overall, the majority of 
wild strains of A.actinomycetemcomitans tested for 
leukotoxicity have proved to be negative.
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leukotoxicity is a characteristic not shared by all
A.actinomycetemcomitans strains.
Even though an objective comparison between the current 
study and those available in the literature is 
difficult, since the majority of these studies have 
used different detection systems (for example trypan 
blue was not commonly used) , the prevalence of 
leukotoxicity among the fresh isolates used in this 
study was lower than those reported in the literature, 
since only 2 (10%) of 20 fresh isolates were found
leukotoxic to HL60 cells as measured by the trypan 
blue exclusion assay. There are several possible 
reasons for this disparity. These factors will be 
discussed separately in the following sections.
4.3.5 Leukotoxic activity of H .aphrophilus strains
A total of 30 H.aphrophilus strains were tested for 
their leukotoxic activity against either HL60 cells as 
measured by trypan blue exclusion assay or against 
human PMNLs as measured by the luminol-dependent 
chemiluminescence inhibition assay. None of the strains 
tested were leukotoxic based on the criteria employed 
in this study. The percentage death of the target cells 
as measured by the trypan blue exclusion assay ranged
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from (0% to 18%) though none was considered leukotoxic, 
since the values fell below the 30% cut-off point 
chosen for this study. There are only a few studies 
where H .aphrophilus leukotoxic activity has been 
reported and even then only a small number of strains 
were included for the purpose of comparison with
A.actinomycetemcomitans. Zambon et al. , (1983) included
one strain (H.aphrophilus ATCC 5908) and it was found 
to be non-leukotoxic to HL60 cells as measured by the 
lactate dehydrogenase release assay. To further confirm 
the point about the difficulty in deciding on the 
criteria used to distinguish between leukotoxic and 
non-leukotoxic strains in the absence of a well
standardized one, Zambon et al. , (1983) considered the
3.3% and 3.7% lactate dehydrogenase release by a
H.aphrophilus strain from HL60 cells and human PMNLs 
respectively as non-significant. On the other hand 
Chung et al. , (1989) when testing a group of
A.actinomycetemcomitans strains, considered a 2.5% 
release of lactate dehydrogenase was sufficiently high 
to designate a strain as leukotoxic. Baehni et al. , 
(1981) tested 7 H.aphrophilus plaque isolates for their 
leukotoxic activity and reported that none of the
tested strains were leukotoxic as measured by the
lactate dehydrogenase assay at a ratio of 100 bacteria/ 
PMNL. Sonic extracts of 3 H .aphrophilus strains caused 
the release of 3% of lactate dehydrogenase by human 
PMNLs when used at a concentration of 0.4mg protein/107 
PMNLs. Tsai et a l (1984) tested one H .aphrophilus 
strain for its leukotoxic activity as measured by a 51Cr 
release assay and reported that the tested strain was 
non-leukotoxic. Ohta et al. , (1987) tested two
H.aphrophilus type strains (H .aphrophilus NCTC 5906 and 
NCTC 5908) for their leukotoxic activity and reported 
that both strains were non-leukotoxic.
In this study 30 H .aphrophilus strains were tested for 
their leukotoxic activity as measured by two different 
assays. In the present study the results obtained from 
both assay methods were concordant and indicated that 
all tested strains were non-leukotoxic. This was the 
first time that a large number of H .aphrophilus strains 
were actually tested for their leukotoxic activity, as 
most if not all other studies included a few strains of 
H.aphrophilus for comparison reasons only.
4.3.6 Leukotoxic activity of Capnocytophaga species
Capnocytophaga species have been implicated in some 
forms of periodontal disease in a number of studies and
238
it has been shown that this organism is capable of 
producing a number of virulence factors (for example 
IgAl protease) (Slots and Genco, 1984). Although
leukotoxin is not believed to be produced by 
Capnocytophaga species, few studies have actually been 
reported. One study examined one C.gingivalis strain 
for leukotoxic activity and was shown to be non- 
leukotoxic as determined by observing morphological 
changes on human PMNLs (Ohta et al. , 1987) . In the
present study, 8 Capnocytophaga strains were examined 
for their leukotoxic activity by two different
techniques but none proved to be leukotoxic. Since 
these strains were not identified to species level it 
is still possible that a particular species possesses 
leukotoxic activity, but it was not present in the 8 
strains that we examined.
Luminol-dependent chemiluminescence inhibition assay
The luminol-dependent chemiluminescence inhibition
assay has not been used previously for the detection 
of the leukotoxic activity of A.actinomycetemcomitans 
strains and in order to assess the suitability of the 
assay a number of preliminary experiments were 
performed by using the leukotoxic E88 strain together
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with some representative non-leukotoxic strains of 
A.actinomycetemcomitans and H,aphrophilus.
The incubation time was investigated and the results 
obtained from these experiments indicated that maximum 
inhibition of chemiluminescence was achieved after 
about 3 0 minutes at 37°C with no substantial changes 
for upto 45 minutes. Cells were, therefore, incubated 
for 40 minutes. The stimulation of human PMNLs by using 
opsonized zymosan and PMA, and the possibility of using 
HL60 cells as targets in this assay, were also examined 
in these preliminary experiments since these cells 
express surface markers and components which are 
associated with mature granulocytes (Gallagher et al. ,
1979). The results obtained from these experiments 
indicated that opsonized zymosan was not an effective 
stimulus for human PMNLs, as it produced a broad and 
not very well defined chemiluminescence peak, over a 
longer period of time. By contrast the peak produced by 
the use of PMA was well defined and appeared quickly. 
There was no chemiluminescence produced when HL60 cells 
were used, even when the number of HL60 cells was 
increased substantially. However, the results of these 
experiments were not conclusive as the experiment was 
performed only once and the stage of growth at which
the HL60 cells were used was uncertain. This may be an 
important factor in determining whether the HL60 cells 
produce a chemiluminescent response or not. It would be 
very interesting to see if HL60 cells can produce 
chemiluminescence when exposed to appropriate 
stimulation, as this would enhance the assay 
substantially, because of the lengthy procedures 
needed for the isolation of human PMNLs and the need 
for fresh PMNLs.
Other important parameters that may affect the 
leukotoxicity assay outcome were tested in these 
preliminary experiments. These were the dose-dependency 
and the effect of heat on the leukotoxic activity of 
A. actinomycetemcomitans strains, since a number of 
studies have shown that the activity of 
A.actinomycetemcomitans leukotoxin was dose-dependent 
and inactivated by heat (Zambon et al. , 1983; Ohta et 
al., 1987; Simpson et al. , 1988). For this purpose the
highly toxic A.actinomycetemcomitans JP2 strain and 
representative non-leukotoxic A.actinomycetemcomitans 
and H.aphrophilus strains were used. The results 
obtained from these experiments demonstrated that the 
leukotoxicity of the JP2 strain was dose-dependent, 
since an increase in the number of bacteria added was
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accompanied by an increase in the inhibition of the 
chemiluminescence responses produced by the PMA- 
stimulated human PMNLs. The heated fractions of (JP2) 
strain for 90°C for 20 minutes had no effect on 
chemiluminescence and similar results were obtained 
with suspensions of non-leukotoxic strains of
A.actinomycetemcomitans and H .aphrophilus. treated in 
the same way as the JP2 strain.
Chemiluminescence has been used to investigate the 
functional activity of human PMNLs by a number of 
workers (Robinson et al. , 1984) . The function of PMNLs
in periodontal disease patients was also assessed by 
chemiluminescence (Gomez et al. , 1994), though
chemiluminescence has not been used previously for 
detection of the leukotoxic activity of 
periodontopathic organisms like A.actinomycetemcomitan- 
S. However, a chemiluminescence assay was developed and 
used for the detection of the Pasteurella haemolytica 
leukotoxin (Chang et al. , 1986; Chang and Renshaw,
1986). The assay was also used to investigate different 
factors affecting the leukotoxic activity of
P.haemolytica. The direct comparison of the 
chemiluminescence assay with other commonly used assays 
for the detection of P.haemolytica leukotoxin revealed
that the chemiluminescence assay was the most 
sensitive. It could detect leukotoxic activity at much 
higher dilutions than other assays. For example it was 
not possible to detect leukotoxic activity with the 
trypan blue exclusion assay at a dilution of 1:64, 
while it was still possible to detect (21% inhibition) 
leukotoxicity at a dilution of 1:16384 when the 
chemiluminescence assay was used (Chang and Renshaw, 
1986) . The sensitivity of the assay may relate to the 
fact that it measures the metabolic activity of PMNL 
rather than cell death.
For both assay systems employed in the current study 
there are advantages and disadvantages. The trypan blue 
exclusion assay has been used frequently to examine the 
viability of cells. It is technically easy and does not 
require the use of any expensive equipment or reagents. 
Further, the use of HL60 cells as targets in the assay 
may be advantageous since HL60 cells are probably more 
sensitive to the A.actinomycetemcomitans leukotoxin 
than are human PMNLs (Zambon et al., 1983). The
maintenance and preparation of HL60 cells in the 
laboratory is also simpler and more convenient than the 
isolation and preparation of human PMNLs. In relation 
to disadvantages the visual counting of dead cells
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makes it laborious to perform if a large number of 
samples is to be counted. Variability may occur if 
counting is performed by different individuals. In 
contrast the luminol-dependent chemiluminescence 
inhibition assay was shown to be very sensitive. The 
elimination of visual counting makes it more objective, 
it is rapid to perform as multiple samples can be 
tested simultaneously and a number of factors can be 
examined in a single experiment. It is highly 
reproducible, but it requires the use of relatively 
expensive equipment (Luminometer). Another major 
difference between the two assays is the need for 
freshly isolated human PMNLs with the latter assay, as 
it can be used only as a measurement of the functional 
activation of phagocytic cells (PMNL). Unfortunately 
HL60 cells can not be used in this assay. The fact that 
the results obtained by using both assays for all 
tested organisms were concordant, indicates the 
suitability of chemiluminescence for the detection of 
leukotoxic activity of oral organisms.
4.3.7 Factors affecting leukotoxicity
It is evident from the ongoing discussion that there 
was some variability regarding the prevalence of
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leukotoxic A.actinomycetemcomitans strains. Several 
factors are thought to affect the leukotoxic activity 
of A.actinomycetemcomitans. a number of which will be 
presented and discussed in the following sections.
Growth medium and cultural conditions
A number of workers have correlated the growth medium 
and cultural conditions for A.actinomycetemcomitans to 
be important factors in demonstrating toxicity. Most 
workers have employed thioglycollate broth as the 
medium of choice with anaerobic culture conditions 
(Baehni et al. , 1979; Baehni et al. , 1981; Zambon et
al., 1983; Iwase et al., 1990; Taichman et al. , 1991)
(Table 4.1). These studies reported positive leukotoxic 
activity for the majority of the tested strains though 
only small number of strains were tested and mostly 
type strains in some of these studies. The strains that 
have been studied most frequently are Y4 and JP2. Other 
media used by researchers to grow A.actinomycetemcomit­
ans for the detection of leukotoxic activity have 
included PYG medium, TSA medium and BHIB medium; the 
leukotoxic activity of all leukotoxic strains was 
detected equally well in spite of using different
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growth media (Lally et a l . , 1991; Brogan et a l . , 1994;
Chung et al., 1989).
In this study, for the detection of leukotoxic activity 
of A.actinomycetemcomitans strains by both assays, 
bacteria were initially grown on CBA plates for 4 8 
hours and then in TSB for 18 hours at 37°C in 5% C02 in 
air. As indicated in the results only two fresh 
isolates were leukotoxic as measured by both assays and 
the prevalence of leukotoxicity among these strains was 
lower than that reported by other workers (Baehni et 
al. , 1981; Zambon et al., 1983). It seems unlikely that 
growth medium and assay conditions were the reason for 
the low prevalence of leukotoxicity in the fresh 
isolates since these conditions were suitable for the 
detection of leukotoxic activity in known leukotoxic 
type strains.
Thioglycollate broth (TGB) was not used in the present 
study for a number of reasons. The medium was not 
readily available and TSB combined with C02 culture gave 
satisfactory results in preliminary experiments and 
successfully identified known toxic and non-toxic 
strains. Furthermore, in a previous study from this 
laboratory the TGB medium was used for growing 
A.actinomycetemcomitans for the detection of leukotoxic
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activity, and in spite of the fact that some of the 
tested strains had been shown previously as leukotoxic 
they were found to be non-leukotoxic after growth in 
this medium (Taher, 1990) . Furthermore, other 
researchers have used media other than the 
thyioglycollate broth and have been able to demonstrate 
leukotoxicity of A.actinomycetemcomitans strains (Lally 
et al. , 1991; Brogan et al. , 1994). Therefore, the
importance of growth medium and culture conditions in 
the demonstration of leukotoxin is probably low.
Toxin concentration (dose-dependency)
For the detection of leukotoxic activity among 
A.actinomycetemcomitans strains, whole live cells, 
(bacteria/target cell), soluble sonic extracts (mg 
protein/ml) and purified toxin mg/dry weight) have been 
used. Leukotoxic activity of A.actinomycetemcomitans 
strains has been shown to be dose-dependent in a number 
of studies. However, experiments have been designed 
specifically to compare the suitability of using whole 
cells or soluble sonic extracts in the determination of 
leukotoxic activity of this organism. Tsai et al., 
(1979) showed that sonic extracts prepared from strain 
Y4 (concentration of 109 cells/ml) were toxic to both
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human PMNLs and monocytes in a dose-dependent pattern, 
since the release of lactate dehydrogenase which was 
used as an indicator of leukotoxicity, increased
directly (0-60%) with the increase in the Y4 sonic 
extract concentration from 0-1.5mg [dry weight]/ml 
after 1 hour incubation at 3 7°C. Similarly the 
incubation of sonic extract of Y4 with human PMNLs or 
monocytes for 1 hour at 37°C, resulted in killing of
more than 95% of human PMNLs and more than 90% of human 
monocytes, as measured by trypan blue exclusion. Baehni 
et al. , (1981) examined both fresh clinical isolates
and type strains of A.actinomycetemcomitans for their 
leukotoxic activity and reported that both sonic 
extracts and whole cells prepared from leukotoxic
strains of A.actinomycetemcomitans caused dose-
dependent cytotoxicity to human PMNLs as measured by 
the lactate dehydrogenase assay. Taichman and Wilton 
(1981) also reported that a sonic extract prepared from 
the leukotoxic Y4 strain killed target cells in a dose- 
dependent pattern since an increased concentration of 
sonic extract (0.001-1. 0p,g/ml) resulted in increased 
killing of human PMNLs as measured by the trypan blue 
exclusion assay. Several reports confirmed the finding 
that the leukotoxicity of A.actinomycetemcomitans was a
dose-dependent (Zambon et a l . , 1983; Iwase et a l . ,
1990).
In the current study a ratio of 400 bacterial cells to 
one HL60 cell was used. This ratio was higher than that 
used by some other workers, for example Baehni et al. , 
(1981) who used a maximum ratio of 200 bacteria/PMNL. 
Tsai and Taichman (1986) used a concentration of 5-100 
bacteria/PMNL, while Chung et al. , (1989) used a dose
of 50 bacteria/PMNL. The higher ratio was chosen since 
the leukotoxicity of H .aphrophilus strains and the 
fresh oral A.actinomycetemcomitans strains examined in 
this study was not known and a high bacterial cell 
concentration would ensure the detection of leukotoxic 
activity in any that possessed only low or moderate 
activity. In preliminary experiments the highly toxic 
A. actinomycetemcomitans JP2 strain was examined at 
different concentrations of whole cells, and the number 
of HL60 cells killed increased with higher 
concentrations of A.actinomycetemcomitans JP2 cells. 
Although a high bacteria/target cell ratio was used, 
only 2 out of 2 0 fresh A.actinomycetemcomitans strains 
were leukotoxic as measured by both assays employed in 
this study. It, therefore, seems unlikely that this low 
prevalence of leukotoxic activity among fresh
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A . actinomycetemcomitans isolates was due to the dose of 
toxin available.
From the discussion above it was clear that whole 
cells, sonicates or pure toxin can be used for the 
detection of leukotoxicity and that the leukotoxic
activity is dose-dependent.
Exposure time
The incubation (exposure) time required to achieve
maximum killing of the target cells (human PMNLs or 
HL60 cells) in the leukotoxic activity assays was shown 
to be of great importance. A number of studies have 
demonstrated that the leukotoxic activity of 
A.actinomycetemcomitans is time-dependent. Tsai et 
al. , (1979) reported that the leukotoxicity of strain
Y4 sonic extract was time-dependent, since the 
percentage of lactate dehydrogenase released from human 
PMNLs exposed to one dose (l.Omg/ml) of Y4 leukotoxin 
increased when the time was increased (0-60 minutes). 
This finding was also confirmed by Taichman, Dean and 
Sanderson (1980), who showed that the activity of 
A.actinomycetemcomitans leukotoxin against human 
monocytes was time dependent. Taichman, Dean and
Sanderson (198 0) reported that the maximum lactate
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dehydrogenase release was reached after 120 minutes. 
Zambon et al. , (1983) showed that exposure of whole
A.actinomycetemcomitans strain Y4 to HL60 cells or
human PMNLs resulted in maximum killing after 45
minutes at 3 7°C as measured by the lactate 
dehydrogenase release. Chung et al. , (1989) reported
that the leukotoxic activity of A.actinomycetemcomitans 
reference strains was time-dependent and they used a 60 
minute incubation time in their experiments. The 
exposure time used in the present study was 1 hour when 
the trypan blue exclusion assay was employed, as a 
number of published studies using HL60 cells and human 
PMNLs as targets have reported maximum killing within 
45-60 minutes (Chung et al. , 198 9; Zambon et al. ,
1983) . However, other incubation times have been used. 
It should be mentioned that prolonged preparation times 
for the target cells, extended incubation times or
delays in cell counting after the assay is complete can 
cause damage to the target cells, as observed during 
the course of current experiments.
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Temperature
The temperature of incubation in the leukotoxic 
activity detection assays is a critical factor. It is 
known that the leukotoxic activity of
A. actinomycetemcomitans strains is temperature 
dependent (Tsai et a l 1979; Zambon et al. , 1983),
most indicating that 37°C is the temperature most 
suitable for the detection of leukotoxicity. To 
determine the temperature of incubation for this study 
preliminary experiments were performed using the 
leukotoxic strain A.actinomycetemcomitans JP2 and the 
non-leukotoxic strain 100. The results showed that 
there was no detectable leukotoxic activity with the 
highly toxic JP2 strain when tested at 4°C (ice cold 
cells) and minimal activity was detected at 22°C (room 
temperature). All experiments were therefore, performed 
at 37°C. Similar observations were reported in the 
literature, as Tsai et al. , (1979) reported that there
was no detectable leukotoxic activity at 4°C, but at 
37°C the leukotoxic activity was detectable. 
Furthermore, Zambon et al. , (1983) showed that the
temperature was an influencing factor in the detection 
of leukotoxic activity in A.actinomycetemcomitans.
Target cells (target cell specificity)
Another important factor in the assay is the target 
cell employed. A number of studies have been conducted 
to determine the target cell specificity of 
A.actinomycetemcomitans leukotoxin. The results of 
these studies indicated that human skin fibroblasts, 
erythrocytes, platelets, and a number of non-human 
cells were non-susceptible to leukotoxin, while human 
monocytes and PMNLs were shown to be sensitive (Tsai et 
al. , 1979; Tsai et al. , 1984; Taichman et al. , 1984).
Additional studies revealed that PMNLs and monocytes 
from monkeys were susceptible to
A.actinomycetemcomitans leukotoxin (Taichman et al.,
1984). Taichman et al. , (1987) showed that PMNL from
humans, the great apes, and most Old World monkeys were 
susceptible to A.actinomycetemcomitans leukotoxin. The 
most commonly used target cells for the detection of 
A.actinomycetemcomitans leukotoxin have been human 
PMNLs and the leukaemic cell line HL60 (Zambon et al. , 
1983; Simpson, Berthold and Taichman, 1988; Iwase et 
al., 1990; Taichman et al., 1991; Brogan et al., 1994). 
The target cells employed in this study for the trypan 
blue exclusion assay were the leukaemic cell line HL60,
for the following reasons. HL60 cells have been 
previously used by a number of workers (Zambon et al. , 
1983; Simpson, Berthold and Taichman, 1988). 
Furthermore, the susceptibility of the HL60 cell line 
to A.actinomycetemcomitans leukotoxin and their 
availability provided a very convenient alternative to 
human PMNLs. Human PMNLs were used as targets when the 
luminol-dependent chemiluminescence inhibition assay 
was used since HL60 cells were not suitable for this 
assay. Simpson, Berthold and Taichman, (1988) studied 
the susceptibility of several cell lines to leukotoxin 
purified from A. actinomycetemcomitans strain JP2 and 
reported that a number of human tumour cell lines were 
susceptible to leukotoxin. These included the leukaemic 
cell lines HL60, U937 and KG-1, which can be used as
models to study the mechanism of action of 
A.actinomycetemcomitans leukotoxin.
Other factors that may affect leukotoxicity
Some workers have reported that the age of the donor 
patient is an important factor in the leukotoxicity of 
A.actinomycetemcomitans isolates. Tsai and Taichman 
(1986) reported that 100% of the
A. actinomycetemcomitans strains isolated from young
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patients (6-12 years of age) were leukotoxic, but only 
23% of strains isolated from a group of older patients 
(13-25 years of age) were leukotoxic. However, the 
significance of this finding is doubtful, since a 
number of other studies have indicated that leukotoxic 
strains of A.actinomycetemcomitans can be isolated from 
older patients (Chung et al., 1989).
The serotype of a particular A.actinomycetemcomitans 
strain or even the geographical location of the 
patients from which the strains were isolated were 
thought to be important factors in the determination 
of leukotoxicity of A.actinomycetemcomitans. Some 
studies have associated the A.actinomycetemcomitans 
serotype b with localized juvenile periodontitis in 
North American patients and hence with leukotoxicity, 
as the isolation of leukotoxic strains in these group 
is more common (Slots et al., 1982; Zambon et al., 
1983; Zambon, 1985). However, Chung et al. , (1989)
reported that there was no correlation between serotype 
b and localized juvenile periodontitis nor with 
leukotoxicity in a group of Korean patients.
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4.3.8 Conclusions
In summary, in the present study, three capnophilic 
Gram-negative microorganisms were tested for their 
leukotoxicity by using two assay systems. Results 
obtained indicated substantial differences in the 
leukotoxicity of all three organisms.
Only 2 of the 20 freshly isolated A.actinomycetemcomi­
tans strains and 3 of the 5 type strains were 
leukotoxic to both HL60 cells and human PMNLs as 
measured by the trypan blue exclusion assay and the 
luminol-dependent chemiluminescence inhibition assay 
respectively.
The prevalence of leukotoxic strains among the fresh 
isolates of A.actinomycetemcomitans tested in this 
study was lower than that reported in the literature 
for fresh A.actinomycetemcomitans isolates. However, 
the results obtained with type strains were in 
agreement with those reported.
Dose of toxin, temperature of incubation and exposure 
time were the most important factors influencing the 
outcome of the detection of leukotoxic activity in 
A. actinomycetemcomitans.
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This was the first time the leukotoxic activity of
A. actinomycetemcomitans was detected by using the 
luminol-dependent chemiluminescence inhibition assay. 
Leukotoxin production was not detected in any of 30
strains of H .aphrophilus. However, certain strains of
H .aphrophilus killed small numbers of HL60 cells as
measured by the trypan blue assay but they were
considered as non leukotoxic based on the criteria used 
in the present study.
None of the Capnocytophaga strains was leukotoxic as
measured by both methods.
The comparison of results obtained in different studies 
proved to be very difficult due to the large number of 
variables. A standard method, taking into consideration 
all these variables, is essential to allow comparison 
of results of different studies and secondly to be
certain of the results obtained.
4.4 Phagocytosis of A.actinomycetemcomitans. 
H.aphrophilus and Capnocytophaga species by human PMNLs 
in vitro
In the present study the ability of human PMNLs to
phagocytose selected strains of A.actinomycetemcomitan- 
a, H.aphrophilus and Capnocytophaga was tested by using
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a luminol-dependent chemiluminescence assay. (Allen, 
Stjernholm and Steele, 1972). The initial light 
emission by the phagocytic cells is very small to 
measure, requiring a large number of cells and a very 
sensitive light detector. Luminol has been used to 
enhance the light emission, thus improving the 
sensitivity of the assay (Allen and Loose, 1976; 
Stevens, Winston and Van Dyke, 1978). Furthermore, it 
has been shown also that the chemiluminescence response 
of normal PMNLs is positively correlated to the 
phagocytic ability of the PMNLs (Grebner et al. , 1977; 
Stevens, Winston and Van Dyke, 1978; Easmon et al. ,
1980) . The results obtained in the present study showed 
that two chemiluminescence response patterns were 
produced by human PMNLs. The first pattern was 
initiated by all opsonized H .aphrophilus strains, 9 of 
the 10 opsonized A.actinomycetemcomitans strains and 
all opsonized Capnocytophaga strains. In this pattern, 
a rapid exponential chemiluminescence response was 
observed over a short period of time, indicating the 
ability of these strains to trigger a chemiluminescence 
response when incubated with human PMNLs. This suggests 
that human PMNLs can phagocytose these strains under 
the experimental conditions employed in this study,
though this was not confirmed by any other test. 
However, a positive correlation between
chemiluminescence response and the bactericidal 
activity of human PMNLs against A.actinomycetemcomita­
ns has been shown by Sjostrom et al. , (1992), while
Holm and Kalfas (1993) and Holm, Kalfas and Holm (1993) 
also reported that the chemiluminescence triggered by 
H.aphrophilus strains positively correlated with the 
degree of killing by human PMNLs. Unopsonized cells of 
the same strains failed to trigger similar responses, 
indicating the importance of serum opsonic activity. 
A similar finding was reported by Sjostrom et al. , 
(1992) as they showed that the serum from both rapidly 
progressive periodontitis patients and normal 
individuals enhanced the chemiluminescence response and 
killing by human PMNLs against A.actinomycetemcomitan- 
S. Furthermore, it has been shown by Sjostrom et al. ,
(1992) that complement was an effective opsonin and 
that the removal of complement resulted in 
substantially reduced chemiluminescence with 
A.actinomycetemcomitans. although only one strain 
(A.actinomycetemcomitans strain Y4) was studied. This 
finding was also supported by results obtained from 
preliminary experiments performed in the present study.
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In these experiments the serum used for opsonization 
was heated at 56°C for 3 0 minutes to inactivate 
complement, resulting in a minimal chemiluminescence 
response. Holm and Kalfas (1993) also reported that the 
highest degree of killing and chemiluminescence 
response by H .aphrophilus strains were observed in the 
presence of active serum, and that both parameters were 
reduced when heated serum was present. The opsonic 
activity of human serum IgG from patients with 
localized juvenile periodontitis against A. actinomycet­
emcomitans has also been reported (Baker and Wilson, 
1989).
The second pattern was obtained with one leukotoxic 
A.actinomycetemcomitans strain (JP2). In this pattern, 
a very rapid chemiluminescence peak response and decay 
were observed. The peak was substantially smaller than 
those observed in the first pattern and no residual 
activity of human PMNLs was observed after the addition 
of PMA to the reaction mixture. This may indicate that 
the leukotoxin destroyed the human PMNLs and prevented 
the phagocytosis process, though the viability of the 
human PMNLs was not formally checked. The addition of 
PMA to all other test mixtures resulted in a second 
chemiluminescence peak, indicative of residual PMNL
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activity. In the present study, both leukotoxic and 
non-leukotoxic A.actinomycetemcomitans strains were 
tested. Among the leukotoxic strains tested only the 
JP2 strain appeared to damage the PMNLs in this system. 
This finding was contrary to that reported by Clark, 
Leidal and Taichman (1986) as they showed that 
A. actinomycetemcomitans strain JP2 leukotoxin was 
inactivated by exposure to myeloperoxidase, H202 and a 
halide, the main bactericidal system generated by human 
PMNLs during stimulation (respiratory burst). The 
reason for the discrepancy is not clear though, it may 
be related to the fact that in the current study whole 
bacterial cells were used, while Clark, Leidal and 
Taichman (1986) used pure toxin. Miyasaki et al., 
(1986) showed that human PMNLs were capable of killing 
both leukotoxic and non-leukotoxic
A.actinomycetemcomitans strains but in Miyasaki et al. , 
(1986) study a very small bacteria:PMNL ratio was used 
(10 bacteria:1PMNL), though when an increased ratio to 
a one commonly used for the detection of leukotoxic 
activity (100 bacteria/PMNL), an increase in trypan 
blue uptake was noted by the authors, indicative of 
toxicity. Kalmar, Arnold and Van Dyke, (1987) also 
showed that A.actinomycetemcomitans strain Y4 was
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phagocytosed and killed by human PMNLs in the presence 
of serum, prior to the killing of PMNLs by leukotoxin, 
though in the absence of serum the PMNLs were killed by 
leukotoxin. Sjostrom et al. , (1992) reported that the
viability of human PMNLs was not affected by exposure 
to the nominally leukotoxic A.actinomycetemcomitans Y4 
strain during the course of their experiments. Holm, 
Kalfas and Holm (1993) also reported that leukotoxin 
production by A.actinomycetemcomitans strains was not a 
major factor influencing the susceptibility of these 
bacteria to the phagocytic killing of human PMNLs since 
both leukotoxic and non-leukotoxic strains were killed. 
The results obtained in the current study with regard 
to the leukotoxic A.actinomycetemcomitans strain Y4 
were in agreement with those reported by Miyasaki et 
al. , (1986) and Sjostrom et al. , (1992). The
chemiluminescence response produced by A.actinomycetem­
comitans strains used in the current study was strain- 
dependent, as certain strains produced very large 
chemiluminescence peaks (for example, Strain (E83) and 
others produced smaller chemiluminescence peaks (for 
example, Strain 100) . Similar observations have been 
reported for other species of bacteria, for example 
different responses were observed for three different
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Klebsiella pneumoniae strains, the authors related this 
to differences in membrane or cell wall characteristics 
(Robinson et al., 1984).
Holm and Kalfas (1993) reported the ability of certain 
A.actinomycetemcomitans and H .aphrophilus strains to 
induce a chemiluminescence response from human PMNLs in 
the presence of active serum and saliva. They showed 
that while all H .aphrophilus strains produced a similar 
chemiluminescence response pattern, A. actinomycetemcom­
itans strains produced strain-dependent
chemiluminescence patterns. This was in agreement with 
the results obtained in the current study. Holm, 
Kalfas and Holm (1993) in a separate study tested the 
susceptibility of the same A.actinomycetemcomitans and 
H .aphrophilus strains to phagocytic killing by human 
PMNLs and reported that certain A.actinomycetemcomita- 
strains were resistant to phagocytic killing in 
spite of their ability to trigger a chemiluminescence 
response in the earlier study. In addition, 
A.actinomycetemcomitans strains that triggered a strong 
chemiluminescent response (for example A.actinomycetem­
comitans strain ATCC 29523) showed a degree of killing 
that was comparable to strains which failed to induce a 
chemiluminescence response (for example strain ATCC
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2 9522) . The reverse was observed with H .aphrophilus 
strains as there was a positive correlation between 
chemiluminescence production and the degree of killing 
by human PMNLs (Holm and Kalfas, 1993). Holm and Kalfas
(1993) concluded that while H .aphrophilus strains are 
susceptible to phagocytic killing by oxygen-dependent 
mechanisms, A.actinomycete-mcomitans strains are killed 
mainly by non-oxygen-dependent mechanisms. The 
conclusion of Holm and Kalfas (1993) with regard to the 
susceptibility of A. actinomycetemcomitans strains to 
killing by human PMNLs is different from the findings 
reported by Miyasaki et al. , (1986), who showed that
A.actinomycetemcomitans strains were susceptible to 
both oxygen and non-oxygen-dependent killing mechanisms 
by human PMNLs. Holm, Kalfas and Holm (1993) related 
the discrepancy to differences in the experimental 
methodology employed in the two studies. 
A.actinomycetemcomitans strains were shown to be 
different with regard to their susceptibility to 
oxidative killing by the different oxidants produced by 
the xanthine-xanthine oxidase system, hydrogen peroxide 
proving the most bactericidal against
A.actinomycetemcomitans (Dongari and Miyasaki, 1991). 
H . aphrophilus was also examined and shown to be in­
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sensitive to the oxidant products of the xanthine- 
xanthine oxidase system (Dongari and Miyasaki, 1991). 
Although direct phagocytic killing of H .aphrophilus 
strains was not measured, the results obtained in the 
present study regarding the phagocytosis of 
H .aphrophilus strains were in agreement with a number 
of the reported studies (Holm and Kalfas, 1993; Holm, 
Kalfas and Holm, 1993).
Robinson et al. , (1984) examined the luminol-dependent
chemiluminescent response of human PMNLs to a number of 
pathogenic microorganisms and reported that each test 
organism induced a reproducible chemiluminescence peak 
and pattern. Differences in chemiluminescence response 
between strains of the same organism were related to 
the different cell wall and membrane structures that 
may exist between different strains (Robinson et al. , 
1984) . However, Robinson et al. , (1984) did not
correlate the chemiluminescence response to the 
phagocytic and bactericidal activity of human PMNLs. 
Their findings are similar to those obtained in the 
present study with respect to the ability of 
microorganisms to induce a luminol-dependent 
chemiluminescence response from human PMNLs and to the 
strain-dependent differences. Robinson et al., (1984)
also showed that zymosan was a good activator of PMNLs 
as it produced a well defined peak in a short period of 
time. Results obtained from preliminary experiments 
performed in the present study did not support this 
finding, since the use of zymosan to stimulate human 
PMNLs resulted in a very broad small peak over a long 
period of time (90 minutes) . This was also observed in 
other studies, though opsonized zymosan was used to 
stimulate some non human PMNLs (Dr. M. Saddati, 
personal communication). The reasons for the 
discrepancies observed are not clear, though they may 
relate to the zymosan preparation method, PMNLs 
employed or the assay conditions used.
All Capnocytophaga species tested in the current study 
produced the first described pattern of 
chemiluminescence response. This suggests that human 
PMNLs can phagocytose this organism and also show the 
need for serum opsonization. One previous study has 
examined the ability of Capnocytophaga species to 
trigger a chemiluminescence response in human PMNLs 
(Passo, Syed and Silva, 1982) . Passo, Syed and Silva
(1982) examined a group of Gram-negative microaerophil- 
ic or anaerobic bacteria including Capnocytophaga 
species, isolated from dental plaque, for their ability
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to produce chemiluminescence from human PMNLs. The 
addition of serum enhanced the chemiluminescence 
response to all tested organisms, including 
Capnocytophaga species.
4.4.1 Conclusions
All tested H.aphrophilus strains triggered a 
chemiluminescence response by human PMNLs in vitro. 
Opsonization was shown to be essential for the 
interactions between H .aphrophilus strains and human 
PMNLs in vitro.
A. actinomycetemcomitans triggered chemiluminescence in 
a strain-dependent manner.
Leukotoxin activity was not a major factor in the 
phaogocytosis of A.actinomycetemcomitans strains, since 
both leukotoxic and non-leukotoxic strains triggered a 
chemiluminescent response from human PMNLs.
Opsonization of A.actinomycetemcomitans strains was 
shown to enhance substantially the chemiluminescence 
response by human PMNLs.
All Capnocytophaga strains triggered a
chemiluminescence response from human PMNLs. This 
response was enhanced by opsonization of Capnocytophaga 
strains.
267
4.5 The cytotoxicity of A.actinomycetemcomitans. 
H.aphrophilus and Capnocytophaga species for cultured 
human skin fibroblasts
4.5.1 Experimental methods
The cytotoxicity of A.actinomycetemcomitans.
H.aphrophilus and Capnocytophaga strains for cultured 
human skin fibroblasts was tested by using a 
colorimetric MTT (Tetrazolium salt) cleavage assay. The 
assay, which was based on the cleavage of MTT by the 
mitochondrial enzyme succinyl-dehydrogenase to form 
coloured formazan, was first developed by Mosmann
(1983) . The assay had not been used previously for 
testing the cytotoxicity of any of these groups of 
organisms for cultured fibroblasts. However, it had 
been used in a number of other cytotoxicity studies, 
for example those of Visconti et al. , (1991) who used
the assay for testing the cytotoxic effects of Fusarium 
mycotoxins on cultured human cell lines (K-56 and MIN- 
GL1) . Smith et al. , (1992) also used the assay for
testing the cytotoxicity of fungal spores on cultured 
human embryonic diploid fibroblast lung cells. Scragg, 
Cannon and Williams (1994) used the reduction of the 
tetrazolium salt MTT assay to assess the cytotoxic
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effects of a number of short-chain fatty acids produced 
by some periodontal pathogens such as P.gingivalis on 
two cultured fibroblast cell lines (Vero cells and 
human gingival fibroblasts). They showed that Vero 
cells were more sensitive than human gingival 
fibroblasts to both morphological and metabolic 
changes.
A number of preliminary experiments were performed in 
the current study to determine the final experimental 
conditions and to examine the suitability of this 
assay. In the early experiments, whole live bacterial 
cells were used and the results suggested that 
A.actinomycetemcomitans strains were cytotoxic for 
cultured fibroblasts. However, it became clear that it 
was not possible to use whole, live bacterial cells 
since they caused a very dark coloured precipitate 
which interfered with the final absorbance readings. 
This made the interpretation of the results difficult. 
The results of an additional group of preliminary 
experiments performed to resolve this problem indicated 
that the precipitate was the result of an interaction 
between bacterial components and the fibroblast growth 
medium. However, it is not clear whether the 
interfering factor(s) present in only whole viable
cells or also in dead intact cells. The use of cell- 
free preparations was, therefore, attempted. A group of 
preliminary experiments were performed with sonicated 
cell extracts. In these experiments bacterial cells 
were sonicated by using the Heat systems probe at 20% 
power output for 20 minutes on ice. The results of 
these experiments were not conclusive because there 
were still some live cells in the preparations, as 
evident from viable counts, and this resulted in the 
same problem of precipitation. An attempt to use a cell 
free extract was then made by disintegrating the 
bacterial cells for 20 minutes, which proved to be no 
more successful. The time of disintegration was then 
increased to 1 hour. The preparation obtained from this 
procedure resulted in a cell-free extract that 
contained no live cells and produced satisfactory 
results when used for the cytotoxicity experiments. It 
should be mentioned that the use of whole viable cells 
of H.aphrophilus and Capnocytophaga strains caused the 
same problem.
The bio-assay employed in the present study represented 
a rapid, reproducible, straightforward assay for 
evaluating the cytotoxicity of these groups of 
organisms. The use of the multiwell scanning
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spectrophotometer (ELISA reader) provided the means by 
which a large number of samples could be read 
accurately at the same time.
4.5.2 The criteria used to assess the cytotoxicity of 
A.actinomycetemcomitans. H.aphrophilus and Capnocytoph­
aga strains for cultured human skin fibroblasts
The bio-assay employed in the present study was based 
on the ability of metabolically active cultured 
fibroblasts, but not dead fibroblasts, to cleave the 
MTT. Control fibroblast cultures, unexposed to any test 
organisms, were included in all test plates and their 
optical density measurement was considered as 100%. 
Since there was no precedent for the use of this assay 
with these bacterial species, the cut-off point was 
taken to be a 50% reduction of the optical density
obtained with control cultures. It is not clear,
though, whether the reduction of 50% in the optical
density of control cultures means that 50% of cultured
cells were inhibited by test organism or just an
overall reduction of the metabolic activity of the
whole cultured cells. In a study reported by Smith et
al. , (1992) using the same methodology to measure the
cytotoxicity of fungal spores, the cut off point used
was 10%. The assay requires about 5 days to complete, 
during which time a number of steps are performed 
including media changes, washing the cells and adding 
toxins. These treatments of the cultured cells over 5 
days may affect their activity, thus considering a cut­
off point of 10% reduction as an indicator of toxicity 
appears to be very low. Furthermore, Smith et al. ,
(1992) expressed the cytotoxicity as mortality which is 
not an accurate expression since no direct cell counts 
were performed and the viability of the cells was not 
assessed. Scragg, Cannon and Williams (1994) reported 
different values for different acids. This was in a 
range of 60%-90% though it is not clear whether this 
was a cut-off point or reductions in the metabolic 
activity obtained. In the current study if the 50% cut­
off point used is reduced by only 5% to 45% then all 
A.actinomycetemcomitans strains will become positive, 
while only one H.aphrophilus strain will remain 
negative though the results obtained with 
Capnocytophaga strains will not change.
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4.5.3 The cytotoxicity of A.actinomycetemcomitans to 
cultured human skin fibroblasts
The cytotoxic activity was recorded for almost all of 
the 25 A.actinomycetemcomitans strains tested (96%). 
This was probably the largest number of strains tested 
for their ability to interfere with cultured human 
fibroblasts in a single study. The positive strains 
reduced the optical density of the control cultures in 
a range from 63% to 83%, indicating possible 
differences in potency among the cytototoxic strains. 
Similar findings were reported by Shenker, Kushner and 
Tsai (1982) as they reported the ability of soluble 
sonic extracts of A.actinomycetemcomitans to inhibit 
the proliferation of cultured murine and normal human 
skin fibroblasts as assessed by DNA and RNA synthesis 
assays (incorporation of [3H] thymidine and 
[3H]uridine). They reported that the inhibitory factor 
was heat-labile and independent from other cytotoxic 
factors produced by A.actinomycetemcomitans strains, 
for example leukotoxin. They also reported that this 
inhibition was not accompanied by cell death as 
assessed by direct cell counts, though only four 
strains were tested in their study. The single non- 
cytotoxic strain reduced the control cultures by about
273
46%. The results obtained in the present study were not 
surprising since many studies have shown a high 
proportion of A.actinomycetemcomitans strains to be 
cytotoxic to cultured human fibroblast cell lines, in 
spite of the differences in experimental procedures 
used in different studies. Stevens and Hammond (1982) 
reported that two A.actinomycetemcomitans strains, one 
of which was leukotoxic (strain Y4) and one non- 
leukotoxic (strain 627) were able to inhibit the 
proliferation of human fibroblasts. Stevens and Hammond 
(1988), in a comparative study, tested the cytotoxicity 
of several periodontal bacteria against human gingival 
fibroblasts. A.actinomycetemcomitans strains were among 
the test organisms and the results showed that the 
sonic extracts of A.actinomycetemcomitans and 
F. nucleatum were the most toxic to cultured human 
gingival fibroblasts. This cytotoxicity was dose- 
dependent. Furthermore, Stevens and Hammond (1988), 
showed that sonic extracts of A.actinomycetemcomitans 
were able to cause morphological effects which included 
a reduction in cell density and alteration in cellular 
morphology. These latter observations were in agreement 
with the findings of the present study. Other bacterial 
components, for example lipopolysaccharides and
capsular material, were shown to be cytotoxic to 
cultured human fibroblasts. Kamin et al. , (1986) showed
that the capsular material isolated from 
A.actinomycetemcomitans was toxic to cultured human 
gingival fibroblasts. Lipopolysaccharide isolated from 
the same strain was also tested by Kamin et al. , 
(1986) . They reported that the lipopolysaccharide was 
toxic to cultured human gingival fibroblasts only at a 
high concentration (10-50|ag/ml) compared to much lower 
concentrations (0.1(j.g/ml and above) for the capsular 
material. The cytotoxicity of capsular material also 
behaved in a dose-dependent pattern. Contrary to the 
previous study, Bartold and Millar (1988) reported that 
lipopolysaccharides from A.actinomycetemcomitans and 
other periodontal bacteria exerted cytotoxic effects on 
cultured human gingival fibroblasts and that the 
lipopolysaccharide from A. actinomycetemcomitans was the 
most toxic to cultured human gingival fibroblast at 
concentrations from 0.5-50jig/ml. Bartold and Millar 
(1988) in their discussion indicated that their finding 
was in agreement with most reported studies regarding 
the toxicity of lipopolysaccharides to human 
fibroblasts and failed to refer to the study reported 
by Kamin et al. , (1986). Recently Helgeland and Nordby
(1993) reported the isolation of a toxin from the 
growth medium of A.actinomycetemcomitans and showed 
that this toxin inhibited the growth of human gingival 
fibroblasts, though the cells were not killed. The 
factor responsible for the inhibitory activity among 
the A.actinomycetemcomitans strains tested in the 
current study is not known.
4.5.4 The cytotoxicity of H .aphrophilus strains for 
cultured human skin fibroblasts
The ability of 30 H .aphrophilus strains to interfere 
with the proliferation of cultured human skin
fibroblasts was tested by using the MTT bio-assay. The 
results showed that the majority of tested
H.aphrophilus strains (87%) were cytotoxic. The
positive strains reduced the optical density in a range 
from 55% to 87%. There is no information in the 
literature regarding the cytotoxicity of H .aphrophilus 
strains for cultured human fibroblasts, and this is the 
first report of cytotoxic activity by a collection of 
relatively large number of freshly isolated strains. 
Only one type strain of H . aphrophilus (NCTC 5886) was 
tested in this study and it was shown to be non- 
cytotoxic as it reduced the optical density of control
cultures by only 24% which is low compared with the 
majority of the fresh isolates. Whether this represents 
a fundamental difference between type and fresh 
isolates with regard to their cytotoxicity is not clear 
until more type strains have been tested. In spite of 
the frequent isolation of H .aphrophilus strains from 
subgingival plaque, it is generally accepted that 
H.aphrophilus is a part of the normal oral microflora 
and its role in the aetiology of periodontitis in 
minimal. The findings that H .aphrophilus strains 
exerted a cytotoxic activity against human fibroblasts 
is therefore, very interesting since it clearly shows 
that H .aphrophilus could cause damage to host tissues.
4.5.5 The cytotoxicity of Capnocytophaga species for 
cultured human skin fibroblasts
Nine Capnocytophaga strains were tested for their 
ability to alter the proliferation of cultured human 
skin fibroblasts. The results obtained in the present 
study showed that 5 out of 9 strains were cytotoxic for 
cultured human skin fibroblasts. The positive strains 
reduced the optical density of the control cultures in 
a range from 55% to 68%, while the negative strains 
reduced control cultures in a range from 8.5% to 33%. A
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few previous studies have examined the cytotoxicity of 
this organism for cultured human fibroblasts. Stevens 
and Hammond (1982) showed that filter sterilized sonic 
extracts of certain Capnocytophaga strains inhibited 
the proliferation of human foreskin fibroblasts. This 
included all tested strains of C .sputigena. though they 
reported variable results regarding the cytotoxicity of 
C.gingivalis and C.ochracea (Stevens and Hammond, 
1982) . Stevens and Hammond (1988) tested a number of 
periodontal bacteria for their ability to interfere 
with cultured human gingival fibroblasts, including 
Capnocytophaga sputigena. They showed that C.sputigena 
was cytotoxic for cultured human gingival fibroblasts, 
though the degree of fibroblast inhibition was less 
than that observed with the highly toxic 
A.actinomycetemcomitans (Stevens and Hammond, 1988). 
In the current study only one strain known as 
C.sputigena while other strains as indicated earlier 
were not identified to the species level. The 
C.sputigena tested in the current study is cytotoxic 
for cultured fibroblasts and even though the 
experimental methods in the current study and those in 
the study reported by Stevens and Hammond (1988), the 
results agreed. The extent of cytotoxicity of
C.sputigena obtained in the present study is lower than 
those obtained with A. actinomycetemcomitans strains 
which also in agreement with Stevens and Hammond 
(1988) .
The cytotoxicity results recorded with all tested 
strains from each of the test bacteria indicate that 
A.actinomycetemcomitans strains are the most toxic to 
cultured human skin fibroblast cell line used in this 
study followed by H .aphrophilus strains. Capnocytophaga 
species is the less toxic of the three.
4.5.6 Adhesion of A. actinomycetemcomitans.
H.aphrophilus and Capnocytophaga strains to cultured 
human skin fibroblasts
During the course of the early cytotoxicity experiments 
using whole viable bacterial cells it was observed that 
certain strains of both A.actinomycetemcomitans and 
H.aphrophilus. but not of the Capnocytophaga species, 
were able to attach to the cultured human skin 
fibroblasts employed in the cytotoxicity study. Seven 
A. actinomycetemcomitans. 7 H.aphrophilus and 2
Capnocytophaga strains were tested for their ability to 
adhere to cultured fibroblasts. Capnocytophaga species 
did not adhere, while the ability of both organisms to
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adhere was dependent on the colonial morphology, since 
the colonies that adhered to the agar surface of 
culture plates (rough type) attached more strongly to 
the cultured fibroblasts and attached cells were not 
removed by washing. It was also observed that certain 
A.actinomycetemcomitans strains (for example GDH 115) 
adhered almost immediately, while others adhered only 
after several hours. The smooth type colonies adhere 
weakly or not at all to both agar and fibroblasts. 
Although it was not possible to quantify the number of 
attached bacteria per fibroblast cell, it was possible 
to distinguish visually between adherent, weakly 
adherent and non-adherent cells.
The ability of certain strains of A.actinomycetemcomit­
ans to adhere to the human oral KB cell line 
(epithelial cells) has been shown previously (Meyer and 
Fives-Taylor, 1993). These authors attributed this
ability to extracellular micro-vesicles associated with 
the bacterial surface (Meyer and Fives-Taylor, 1993). 
In addition these extracellular microvesicles,
together with a highly proteinaceous polymer associated 
with a leukotoxic test strain, enhanced the adherence 
of otherwise weakly adherent strains. The results
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obtained in the current study may represent further 
evidence for the ability of A.actinomycetemcomitans to 
adhere to host tissues, though the mechanisms are 
unclear. Mintz and Fives-Taylor (1994) also reported 
that A. actinomycetemcomitans strains were able to 
adhere to a human epithelial cell line as detected by 
enzyme linked immunosorbent assay. The findings of the 
recent study by Mintz and Fives-Taylor (1994) are in 
agreement with the preliminary results obtained in the 
current study and further confirm the suitability of 
using cultured human cell lines for adhesion studies. 
There are a few studies that have investigated the 
adhesion of H .aphrophilus strains to host tissues. In 
a study reported by Sweet, MacFarlane and Samaranayake, 
(1988) a single strain of H .aphrophilus was reported as 
adhering to human buccal epithelial cells in vitro.
4.5.7 Conclusions
Twenty four of the 25 A.actinomycetemcomitans strains 
tested and 26 of the 30 H.aphrophilus strains tested 
were cytotoxic for cultured human skin fibroblasts.
Of the 9 Capnocytophaga strains tested only 5 were 
cytotoxic for cultured human skin fibroblasts.
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The MTT bio-assay was used for the first time to test 
for the cytotoxicity of these organisms and it was 
shown to be both rapid and reproducible.
This is the first study to determine cytotoxic activity 
for H .aphrophilus strains.
Adherence of A.actinomycetemcomitans and H .aphrophilus 
is shown to be dependent on colonial morphology. 
Strains with rough colonies adhered more strongly than 
the smooth colonies strains.
Capnocytophaga species did not adhere to cultured human 
skin fibroblasts.
4.6 Human IgA protease production by Capnocytophaga.
A.actinomycetemcomitans and H.aphrophilus
4.6.1 Experimental methods
There are a number of established methods to 
demonstrate cleavage of human IgA by IgAl protease- 
producing human pathogenic bacteria. These methods 
include SDS-PAGE, immunoelectrophoresis and
immunoblotting (Kilian, 1981). In the present study the 
cleavage of human myeloma IgA and human secretory IgA 
was detected by SDS-PAGE and immunoblotting, since they
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have been frequently used for the detection of cleavage 
products.
To determine the suitability of the methods chosen for 
this study, a number of preliminary experiments were 
performed. Both H .influenzae and selected
Capnocytophaga strains were used as controls, since 
both organisms have been shown previously to cleave 
human IgAl by producing the specific enzyme IgA (IgAl) 
protease (Kilian, Mestecky and Schrohenloher, 1979;
Kilian, 1981). Initially the assay mixtures were 
incubated for 18 hours at 3 7°C and SDS-PAGE used to 
detect cleavage products. The results obtained from 
these experiments were not conclusive, since it was 
extremely difficult to distinguish bacterial protein 
bands from IgA cleavage products. Additional 
experiments were performed in which the concentration 
of test bacteria was increased to make sure that 
sufficient enzyme was present. The incubation times of 
the assay mixtures (bacterial suspensions in diluted 
human myeloma serum or human SIgA) were also increased 
from 18 hours to 48 hours at 37°C. Again SDS-PAGE was 
still used to detect cleavage products. Results 
obtained from these experiments indicated that both 
H.influenzae and Capnocytophaga strains cleaved human
myeloma IgA and human SIgA. However, the protein bands 
corresponding to IgA bands in the control lanes were 
still evident in the gel but with substantially reduced 
intensity. The difficulty of identifying cleavage 
products from bacterial protein bands was not resolved 
and thus more experiments were performed using similar 
incubation conditions but employing the more specific 
immunoblotting method for the detection of the cleavage 
products. Results obtained from these experiments 
indicated that both positive control organisms cleaved 
human myeloma IgA and human SIgA. However, there were 
extra protein bands in some blots, especially when 
Capnocytophaga species were used. These were probably 
bacterial proteins reacting non-specifically with the 
commercial anti-serum used for immunoblotting. This 
tends to be confirmed by the fact that bands with 
similar mobility were usually present in the identical 
gels when stained with Coommassie blue. Also these 
bands were not detected in all blots which further 
suggests that they are bacterial proteins and not 
cleavage products. Therefore, H.influenzae was used in 
the main experiments as the positive control. A number 
of changes were made to reduce the non-specific 
reactivity observed in some blots. The constituents of
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the blocking buffer were modified by increasing the 
concentration of milk from 1% to 10%, and the 
incubation of blots was carried out at 37°C instead of 
room temperature in some of the experiments. Dried milk 
was also added to the washing buffer. These measures 
improved the assay substantially. Immunoblotting 
proved to be a reproducible, relatively rapid assay
since multiple samples could be examined in a single
experiment.
4.6.2 Cleavage of human myeloma IgA and human SIgA by 
Capnocytophaga species
Ten strains of oral Capnocytophaga species were tested 
for their ability to produce IgA protease capable of 
cleaving human myeloma IgA. All tested strains cleaved 
human myeloma IgA as detected by SDS-PAGE and
immunoblotting. Results obtained in the present study 
were similar to those reported in the literature. 
Kilian (1981) examined a number of bacterial species 
suspected of being involved aetiologically in human 
periodontal disease, including Capnocytophaga species, 
and reported that all tested Capnocytophaga strains 
were capable of producing IgA protease that
specifically cleaved human IgAl in the hinge region to
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yield intact Fab and Fc fragments. Furthermore, human 
IgG was cleaved by all Capnocytophaga strains, but IgA2 
was not cleaved (Kilian, 1981). Similar results for 
Capnocytophaga species were reported by Frandsen, 
Reinholdt and Kilian (1987), who characterized the IgAl 
protease from strains of Capnocytophaga species and 
other potential oral pathogens (for example Bacteroides 
species) . They reported that IgAl protease from 
Capnocytophaga cleaved human IgAl from the hinge 
region, leaving intact Fab and Fc fragments and they 
described the IgAl protease prepared from 
Capnocytophaga species as a metallo-enzyme (Frandsen, 
Reinholdt and Kilian, 1987) . Furthermore, Frandsen, 
Reinholdt and Kilian (1991) have shown in vivo activity 
of IgAl proteases from Capnocytophaga species and other 
suspected oral pathogens.
During the course of the present experiments it was 
observed that Capnocytophaga species were able to 
cleave the secretory component from SIgA as evident in 
the SDS-PAGE gels. This degradation was complete, since 
there was no reactivity when samples were immunoblotted 
by using anti-secretory-component serum. However, 
whether the IgA protease itself cleaved the secretory 
component or whether it was cleaved by another
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proteolytic enzyme is not clear. Although no specific 
work was performed to determine the time sequence 
required for the cleavage of the secretory component, 
it was observed in some of these experiments that 
cleavage occurred after 12 hours of incubation. If the 
cleavage was due to the action of IgA protease, then 
this may suggest that IgA protease cleaves the SIgA 
molecule in two different steps. The first would 
involve removal of secretory component, since the 
secretory component makes SIgA more resistant to 
cleavage by IgA proteases and other proteolytic 
enzymes. The second step would be cleavage of the 
unprotected molecule. This mechanism merits additional 
investigation.
4.6.3 Cleavage of human myeloma IgA by 
A.actinomycetemcomitans and H.aphrophilus
In the preliminary experiments discussed in the 
previous section, selected strains of
A.actinomycetemcomitans and H.aphrophilus were tested 
for their ability to cleave human SIgA. Results 
obtained from these experiments indicated that none of 
the tested strains produced IgA protease capable of 
cleaving human SIgA and the final experiments were,
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therefore, performed by using the human myeloma IgA 
only.
Twenty five A. actinomycetemcomitans and 3 0 
H .aphrophilus strains were tested for their ability to 
cleave human myeloma IgA in vitro. None of the tested 
strains of either organism cleaved human myeloma IgA 
under the experimental conditions employed in the 
present study, with no evidence of cleavage products by 
immunoblotting. This is believed to be the first study 
in which H .aphrophilus strains have been tested for 
their ability to cleave human IgA. Kilian et al. ,
(1983) screened a large number of microorganisms for 
IgA protease activity. H.aphrophilus was not included, 
but hundreds of different species were screened and 
only a few were found to possess IgA protease activity. 
The results obtained in the present study were not, 
therefore, surprising.
Microorganisms shown to produce IgAl protease include 
H,influenzae, H.aegyptius. N.meningitidis.
N,gonorrhoeas, S.sanguis. S.oralis and S.pneumoniae. 
Among the suspected periodontopathic bacteria, 
Capnocytophaga species and certain Porphyromonas and 
Prevotella (Bacteroides) species have been shown to 
produce IgA protease (Kilian, Mestecky and
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Schrohenloher, 1979; Mulks and Plaut, 1978; Frandsen, 
Reinholdt and Kilian, 1987).
In the present study a number of oral microorganisms 
were screened for human IgA protease activity. Some of 
these are implicated as aetiological agents in
destructive periodontal disease, namely
A.actinomycetemcomitans and Capnocytophaga species. 
Only Capnocytophaga species were demonstrated to
possess IgA protease capable of cleaving human myeloma 
IgA and the more resistant human SIgA.
The significance of IgA protease in virulence is not 
completely clear. However, there is some evidence to 
suggest that it has a pathogenic function, since among 
the hundreds of different bacterial species screened 
for human IgA protease activity only a few actually 
possess such activity and most are pathogens associated 
with specific infections, all these infections take 
place on mucosal surfaces where IgA is present and 
provides a means of defence for the host. The 3
leading causative agents of meningitis produce IgA
protease, whereas related, non-pathogenic species do 
not (Senior, Loomes and Kerr, 1991). Furthermore, 
Frandsen, Reinholdt and Kilian (1991) investigated
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whether IgA proteases from Capnocytophaga species were 
active in vivo by using an enzyme-linked immunosorbent 
assays and reported that IgAl protease from 
Capnocytophaga species actually cleaved human IgAl in 
vivo. Frandsen et al. , (1995) examined sera by ELIZA,
from a group of periodontal disease patients for the 
presence of antibodies against the antigenically 
distinct neoepitope on the IgAl Fab fragments produced 
by the cleavage of IgAl by Capnocytophaga protease. 
These antibodies were detected in 42 serum samples out 
of 92 samples analysed (Frandsen et al. , 1995) . It is
also important to mention that an elevated level of IgA 
subclass IgAl to antigens of A.actimomycetemcomitans 
has been demonstrated in patients with localized 
juvenile periodontitis. The presence of IgAl suggests 
that the protective effects against A.actinomycetemcom- 
itans could be compromised by bacterial IgAl proteases 
that may be present in the same environment and which 
may add to the virulence of A. actinomycetemcomitans 
(Brown et al. , 1991).
Cole and Hale (1991) also reported that H. influenzae 
IgAl protease cleaved the SIgA of a chimpanzee. This 
finding is important since it will provide the use of
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an animal model to further examine the significance of 
IgAl protease production and its role in pathogenesis.
4.6.4 Conclusions
Ten Capnocytophaga species were found to possess an IgA 
protease capable of cleaving human myeloma IgA as 
detected by immunoblotting methods. The cleavage 
pattern was similar to that observed with H.influenzae. 
Five strains of Capnocytophaga species degraded the 
secretory component completely, as there was no 
reactivity detected with immunoblotting methods when 
probed by commercial anti secretory component serum. 
However, the significance of this finding is unclear 
and probably merits further investigation.
Twenty five A.actinomycetemcomitans strains and 30
H.aphrophilus strains were included in this study, none 
of which cleaved human myeloma IgA under the 
experimental conditions employed.
It is clear that more detailed studies are required to 
examine the properties of these enzymes in detail and 
to assess their significance in virulence. The role of 
IgA in immunity requires further study, since it is 
known in some cases that the inability to produce the
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IgA protease is not accompanied by the loss of 
pathogenicity. Thus, certain H .influenzae serotype b 
strains isolated from cases of meningitis were void of 
IgA-protease activity (Kilian et al., 1983).
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APPENDIX I 
MEDIA, BUFFERS AND REAGENTS COMPOSITION
Anaerobic blood Broth (ABB)
Tryptone 10 g
Beef extract 2.0 g
Liver extract 3.0 g
Yeast extract 5.0 g
Glucose 5.0 g
Sodium chloride 5.0 g
Vitamin K 0.005
Haemin 0.005
Cysteine hydrochloride 1.0 g
Dithiothreitol 0.1 g
Sodium bicarbonate 0.9 g
Preparation
Thirty two grams of the powdered medium was dissolved 
in 1000 ml distilled water by heating in a Koch 
steamer, sterilized by autoclaving at 121° C for 15 
minutes and stored.
Colombia Blood Agar
Composition:
Peptone 14 0 13 g
Peptone 100 6 g
Yeast extract 3 g
Beef extract 3 g
Starch 1 g
Sodium chloride 5 g
Agar 13 g
Defibrinated horse blood 50 ml
Preparation
Forty four g of the powder medium was dissolved in 
1000 ml of distilled water by steam heating, the 
medium pH was adjusted to 7.4. Dissolved medium 
aliquoted in 100 ml bottles and sterilized by 
autoclaving at 121°C for 15 minutes. After 
sterilization the medium cooled at room temperature 
and then 5 ml of blood was added to each aliquot (100 
ml). The medium was poured aseptically into sterile 
petri-dishes.
Tryptic Soy-Serum-Bacitracin-Vancomycin Agar (TSBV)
Composition:
Peptone 14 0 15 g
Peptone 110 5 g
Sodium chloride 5 g
Yeast extract 1 g
Horse serum 100 ml
Bacitracin 75 mg
Vancomycin 5 mg
Agar 15 g
Distilled water 1000 ml
Preparation
Fifty grams of Tryptic Soy Agar and 1 gram of yeast 
extract were dissolved in 1000 ml of distilled water 
by steam heating, the pH of the medium was adjusted to
7.4, aliquoted in 100 ml volumes and sterilized by 
autoclaving at 121° C for 15 minutes. The medium was 
cooled to about 45°C, after which 10 ml of serum, 1 ml 
of bacitracin and 1 ml of vancomycin were added 
aseptically and poured into sterile petri-dishes.
Tryptic Soy Serum Bacitracin Vancomycin Fluoride Agar
(TSBVF)
Composition:
Peptone 14 0 15 g
Peptone 110 5 g
Sodium chloride 5 g
Yeast extract 1 g
Horse serum 100 ml
Bacitracin 75 mg
Vancomycin 5 mg
Sodium fluoride 50 mg
Agar 15 g
Distilled water 1000 ml
Preparation
Fifty grams of Tryptic Soy Agar and 1 gram of yeast 
extract were dissolved in 1000 ml of distilled water 
by steam heating, the pH of the medium was adjusted to
7.4, aliquoted in 100 ml volumes and sterilized by 
autoclaving at 121° C for 15 minutes. The medium was 
cooled to about 45°C, after which 10 ml of serum, 1.0 
ml of bacitracin, 1.0 ml of vancomycin and 1.0 ml of 
sodium fluoride were added aseptically and medium then 
poured into sterile petri-dishes.
RPMI 1640 medium: 
Amino acids
Composition
L-Arginine 200 mg/1
L-Asparagine 50 mg/1
L-Aspartic acid 20 mg/1
L-Cystine 50 mg/1
L-Glutamic acid 20 mg/1
L-Glutamine 300 mg/1
Glycine 10 mg/1
L-Histidine 15 mg/1
L-Hydroxproline 20 mg/1
L-Isoleucine 50 mg/1
L-Luecine 50 mg/1
L-Lysine.HCl 40 mg/1
L-Methionine 15 mg/1
L-phenylalanine 15 mg/1
L-Proline 200 mg/1
L-Serine 30 mg/1
L-Threonine 20 mg/1
L-Tryptophan 5 mg/1
L-Tyrosine 20 mg/1
L-Valine 20 mg/1
Vitamins
Biotin 0.2 mg/1
D-Ca Pantothenate 0.25 mg/1
Choline Chloride 3 mg/1
Folic acid 1 mg/1
i-Inositol 35 mg/1
Nicotinamide 1 mg/1
Para-amonobenzoic acid 1 mg/1
Pyridoxine HCl 1 mg/1
Riboflavin 0.2 mg/1
Thiamine HCl 1 mg/1
Vitamin B12 0.005 mg/1
Salts
Ca (N03) 2 . 4H20 100 mg/1
KCL 400 mg/1
MgS04 . 7H20 100 mg/1
NaCl 6000 mg/1
NaHC03 2000 mg/1
Na2HP04. 7H20 1512 mg/1
Other components
D-Glucose 2000 mg/1
Glutathione 1.0 mg/1
Phenol red 5.0 mg/1
RPMI 1640 medium is commercially supplied in a liquid 
form, and is stored at 4°C.
Phosphate Buffered Saline Dulbecco's Formula
(Modified)*
Composition
Disodium hydrogen orthophosphate 1.15 g/1
Potassium dihydrogen orthophosphate 0.2 g/1
Sodium chloride 8.0 g/1
Potassium chloride 0.2 g/1
One sachet of already made powder was dissolved in a 
liter of distilled water, pH was adjusted as required. 
The buffer was then sterilized by autoclaving and 
stored at room temperature.
* without magnesium and calcium
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